Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

1161 records found for:
Title = Opioid
Year =

» NOTE! More than 1000 records were found. Only the top 1000 are displayed below.
» Please refine your search.

  1. Bergman AA, Oberman RS, Taylor SL, Kranke B, Chang ET. Prescribing and Acceptance of Medications for Opioid Use Disorder in VA Primary Care: Veteran and Provider Perspectives. Journal of general internal medicine. 2024 Apr 8.
  2. Takada S, Seamans MJ, Javanbakht M, Bone C, Ijadi-Maghsoodi R, Shoptaw S, Gelberg L. Nativity and the risk of opioid use disorder among Hispanic/Latinx women in primary care in Los Angeles, CA. Journal of ethnicity in substance abuse. 2024 Feb 7; 1-15.
  3. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over one year of follow-up after initiating short-acting opioid formulations. Pain medicine (Malden, Mass.). 2024 Jan 18; doi:10.1093/pm/pnad169.
  4. Dember LM, Hsu JY, Bernardo L, Cavanaugh KL, Charytan DM, Crowley ST, Cukor D, Doorenbos AZ, Edwards DA, Esserman D, Fischer MJ, Jhamb M, Joffe S, Johansen KL, Kalim S, Keefe FJ, Kimmel PL, Krebs EE, Kuzla N, Mehrotra R, Mishra P, Pellegrino B, Steel JL, Unruh ML, White DM, Yabes JG, Becker WC, HOPE Consortium. The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysis. Contemporary clinical trials. 2023 Dec 10; 136:107409.
  5. Matthias MS, Myers LJ, Coffing JM, Carter JL, Daggy JK, Slaven JE, Bair MJ, Bravata DM, McGuire AB. Patterns of Opioid Prescriptions in the Veterans Health Administration for Patients With Chronic Low-Back Pain After the Onset of the COVID-19 Pandemic: A Retrospective Cohort Analysis. The journal of pain. 2023 Dec 9.
  6. Khouja T, Shah NH, Suda KJ, Polk DE. Trajectories of opioid prescribing by general dentists, specialists, and oral and maxillofacial surgeons in the United States, 2015-2019. Journal of the American Dental Association (1939). 2024 Jan 1; 155(1):7-16.e7.
  7. Wang L, Hong PJ, Jiang W, Rehman Y, Hong BY, Couban RJ, Wang C, Hayes CJ, Juurlink DN, Busse JW. Predictors of fatal and nonfatal overdose after prescription of opioids for chronic pain: a systematic review and meta-analysis of observational studies. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2023 Oct 23; 195(41):E1399-E1411.
  8. Carr MM, Wolkowicz NR, Cave S, Martino S, Masheb R, Midboe AM. Weight change in a national cohort of U.S. Military Veterans engaged in medication treatment for opioid use disorder. Journal of psychiatric research. 2023 Dec 1; 168:204-212.
  9. Fortney JC, Ratzliff AD, Blanchard BE, Johnson M, Ferro L, Austin EJ, Williams EC, Duncan MH, Merrill JO, Thomas J, Kitay B, Schoenbaum M, Heagerty PJ, Saxon AJ. Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis? Annals of internal medicine. 2023 Oct 1; 176(10):1431-1433.
  10. Griffin AC, Perez T, Avoundjian T, Becker W, Midboe AM. A Tool to Identify and Engage Patients on Risky Opioid Regimens. Applied clinical informatics. 2023 Oct 1; 14(5):1018-1026.
  11. Li Y, Barr KD, Trafton JA, Oliva EM, Garrido MM, Frakt AB, Strombotne KL. Impact of Mandated Case Review Policy on Opioid Discontinuation and Mortality Among High-Risk Long-Term Opioid Therapy Patients: The STORM Stepped-Wedge Cluster Randomized Controlled Trial. Substance Abuse. 2023 Oct 1; 44(4):292-300.
  12. Drexler K, Edens EL, Trafton JA, Compton WM. In the balance: No new diagnosis needed in addition to opioid use disorder to study harms associated with long-term opioid therapy. [Editorial]. Addiction (Abingdon, England). 2024 Jan 1; 119(1):6-8.
  13. McElfresh DC, Chen L, Oliva E, Joyce V, Rose S, Tamang S. A call for better validation of opioid overdose risk algorithms. Journal of the American Medical Informatics Association : JAMIA. 2023 Sep 25; 30(10):1741-1746.
  14. Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. Journal of substance use and addiction treatment. 2023 Sep 24; 209175.
  15. Miller WA, Gordon AJ, Clothier BA, Ackland PE, Bounthavong M, Garcia C, Kenny ME, Noorbaloochi S, Hagedorn HJ. Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study. Implementation research and practice. 2023 Sep 14; 4:26334895231199463.
  16. Huang LC, Bleicher J, Torre M, Johnson JE, Presson A, Millar MM, Gordon AJ, Brooke BS, Kaphingst KA, Harris AHS. Evaluating a health system-wide opioid disposal intervention distributing home-disposal bags. Health services research. 2023 Dec 1; 58(6):1256-1265.
  17. Austin EJ, O'Brien QE, Ruiz MS, Ratzliff AD, Williams EC, Koch U. Patient and Provider Perspectives on Processes of Engagement in Outpatient Treatment for Opioid Use Disorder: A Scoping Review. Community mental health journal. 2023 Sep 5.
  18. Zammit A, Coquet J, Hah J, El Hajouji O, Asch SM, Carroll I, Curtin CM, Hernandez-Boussard T. Postoperative opioid prescribing patients with diabetes: Opportunities for personalized pain management. PLoS ONE. 2023 Aug 24; 18(8):e0287697.
  19. Shabet CL, Bicket MC, Blair E, Hu HM, Langa KM, Kabeto MU, Levine DA, Waljee J. The Association of Cognitive Status and Post-Operative Opioid Prescribing in Older Adults. Annals of surgery open : perspectives of surgical history, education, and clinical approaches. 2023 Sep 1; 4(3):e320.
  20. Wang K, Fenton BT, Skanderson M, Black AC, Becker WC, Seng EK, Anthony SE, Guirguis AB, Altalib HH, Kimber A, Lorenze N, Scholten JD, Graham GD, Sandbrink F, Sico JJ. Changes in opioid prescribing in veterans with headache during the COVID-19 pandemic: A regression discontinuity in time analysis. Headache. 2023 Oct 1; 63(9):1295-1303.
  21. Garcia CC, Bounthavong M, Gordon AJ, Gustavson AM, Kenny ME, Miller W, Esmaeili A, Ackland PE, Clothier BA, Bangerter A, Noorbaloochi S, Harris AHS, Hagedorn HJ. Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder. Implementation science communications. 2023 Aug 10; 4(1):91.
  22. Edmond SN, Wesolowicz DM, Snow JL, Currie S, Jankelovits A, Chhabra MS, Becker WC. Qualitative Analysis of Patient Perspectives of Buprenorphine After Transitioning From Long-Term, Full-Agonist Opioid Therapy Among Veterans With Chronic Pain. The journal of pain. 2024 Jan 1; 25(1):132-141.
  23. Bridges NC, Taber R, Foulds AL, Bear TM, Cloutier RM, McDonough BL, Gordon AJ, Cochran GT, Donohue JM, Adair D, DiDomenico E, Pringle JL, Gellad WF, Kelley D, Cole ES, Cole ES. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences. Journal of substance use and addiction treatment. 2023 Nov 1; 154:209133.
  24. Austin EJ, Chen J, Briggs ES, Ferro L, Barry P, Heald A, Merrill JO, Curran GM, Saxon AJ, Fortney JC, Ratzliff AD, Williams EC. Integrating Opioid Use Disorder Treatment Into Primary Care Settings. JAMA Network Open. 2023 Aug 1; 6(8):e2328627.
  25. El Hajouji O, Sun RS, Zammit A, Humphreys K, Asch SM, Carroll I, Curtin CM, Hernandez-Boussard T. Prediction of opioid-related outcomes in a medicaid surgical population: Evidence to guide postoperative opiate therapy and monitoring. PLoS computational biology. 2023 Aug 1; 19(8):e1011376.
  26. Roberts E, Humphreys K. Does the advent of depot therapy represent a step change in our understanding of opioid use disorder and its treatment? Drug and Alcohol Review. 2023 Jul 31.
  27. Joyce VR, Oliva EM, Garcia CC, Trafton J, Asch SM, Wagner TH, Humphreys K, Owens DK, Bounthavong M. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder. Addiction (Abingdon, England). 2023 Nov 1; 118(11):2203-2214.
  28. Piette JD, Thomas L, Newman S, Marinec N, Krauss J, Chen J, Wu Z, Bohnert ASB. An Automatically Adaptive Digital Health Intervention to Decrease Opioid-Related Risk While Conserving Counselor Time: Quantitative Analysis of Treatment Decisions Based on Artificial Intelligence and Patient-Reported Risk Measures. Journal of medical Internet research. 2023 Jul 11; 25:e44165.
  29. Kehne A, Bernstein SJ, Thomas J, Bicket MC, Bohnert ASB, Madden EF, Powell VD, Lagisetty P. Improving Access to Care for Patients Taking Opioids for Chronic Pain: Recommendations from a Modified Delphi Panel in Michigan. Journal of pain research. 2023 Jul 10; 16(1):2321-2330.
  30. Lagisetty P, Kertesz S. Harms Versus Harms: Rethinking Treatment for Patients on Long-Term Opioids. Substance Abuse. 2023 Jul 1; 44(3):112-114.
  31. Merlin J, Black AC, Midboe AM, Troszak L, Asch S, Bohnert A, Fenton B, Giannitrapani K, Glassman P, Kerns RD, Silveira M. Long-term opioid therapy trajectories and overdose in patients with and without cancer. BMJ Oncology. 2023 Jul 1; 2(e000023):doi: 10.1136/bmjonc-2022-000023.
  32. Billig JI, Bicket MC, Yazdanfar M, Gunaseelan V, Sears ED, Brummett CM, Waljee JF. Cohort study of new off-label gabapentin prescribing in chronic opioid users. Regional Anesthesia and Pain Medicine. 2023 Jun 27.
  33. Nugent SM, Slatore CG, Winchell K, Handley R, Clayburgh D, Chandra R, Hooker ER, Knight SJ, Morasco BJ. Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer. Head & neck. 2023 Aug 1; 45(8):2058-2067.
  34. Sharif L, Gunaseelan V, Lagisetty P, Bicket M, Waljee J, Englesbe M, Brummett CM. High-risk Prescribing Following Surgery Among Payer Types for Patients on Chronic Opioids. Annals of surgery. 2023 Dec 1; 278(6):1060-1067.
  35. Suda KJ, Boyer TL, Blosnich JR, Cashy JP, Hubbard CC, Sharp LK. Opioid and High-Risk Prescribing Among Racial and Ethnic Minority Veterans. American journal of preventive medicine. 2023 Nov 1; 65(5):863-875.
  36. Austin AE, Tang L, Kim JY, Allen L, Barnes AJ, Chang CH, Clark S, Cole ES, Durrance CP, Donohue JM, Gordon AJ, Huskamp HA, McDuffie MJ, Mehrotra A, Mohamoud S, Talbert J, Ahrens KA, Applegate M, Hammerslag LR, Lanier P, Tossone K, Zivin K, Burns ME. Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs. JAMA health forum. 2023 Jun 2; 4(6):e231422.
  37. Peng C, Dayer L, Williams A, Luciana L, Lowery J, Butterfield B, Painter JT. CO90 Correlation Between Length of Surgery and Opioid Overprescribing at Hospital Discharge. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2023 Jun 1; 26(6):Supplement, S31,doi.org/10.1016/j.jval.2023.03.164.
  38. French R, Worley J, Lowenstein M, Bogner HR, Calderbank T, DePhilippis D, Forrest A, Connolly Gibbons MB, Harris RA, Heywood S, Kampman K, Mandell DS, McKay JR, Newman ST, Oslin DW, Wadden S, Wolk CB. Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care. Families, systems & health : the journal of collaborative family healthcare. 2023 Sep 1; 41(3):377-388.
  39. Ahrens K, Sharbaugh M, Jarlenski MP, Tang L, Allen L, Austin AE, Barnes AJ, Burns ME, Clark S, Zivin K, Mack A, Liu G, Mohamoud S, McDuffie MJ, Hammerslag L, Gordon AJ, Donohue JM, Writing Committee for Medicaid Outcomes Distributed Research Network. Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016-2019. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2023 May 24; 76(10):1793-1801.
  40. Carr MM, Lou R, Macdonald-Gagnon G, Peltier MR, Funaro MC, Martino S, Masheb RM. Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review. The American journal of drug and alcohol abuse. 2023 May 18; 1-15.
  41. Claypool AL, DiGennaro C, Russell WA, Yildirim MF, Zhang AF, Reid Z, Stringfellow EJ, Bearnot B, Schackman BR, Humphreys K, Jalali MS. Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids. JAMA health forum. 2023 May 5; 4(5):e231080.
  42. Frost MC, Soyer EM, Achtmeyer CE, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Addiction science & clinical practice. 2023 May 4; 18(1):26.
  43. Gordon AJ, Saxon AJ, Kertesz S, Wyse JJ, Manhapra A, Lin LA, Chen W, Hansen J, Pinnell D, Huynh T, Baylis JD, Cunningham FE, Ghitza UE, Bart G, Yu H, Sauer BC. Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug and Alcohol Dependence. 2023 Jul 1; 248:109902.
  44. Frost MC, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2023 May 1; 17(3):278-285.
  45. Turner AP, Arewasikporn A, Hawkins EJ, Suri P, Burns SP, Leipertz SL, Haselkorn JK. Risk Factors for Chronic Prescription Opioid Use in Multiple Sclerosis. Archives of physical medicine and rehabilitation. 2023 May 1.
  46. Somohano VC, Smith CL, Saha S, McPherson S, Morasco BJ, Ono SS, Zaccari B, Lovejoy J, Lovejoy T. Patient-Provider Shared Decision-Making, Trust, and Opioid Misuse Among US Veterans Prescribed Long-Term Opioid Therapy for Chronic Pain. Journal of general internal medicine. 2023 Sep 1; 38(12):2755-2760.
  47. Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. Journal of substance use and addiction treatment. 2023 Jul 1; 150:209055.
  48. Ackland PE, Kenny ME, Clothier BA, Salameh HA, Boening N, Gordon AJ, Noorbaloochi S, Gustavson AM, Miller W, Hagedorn HJ. What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities. Journal of general internal medicine. 2023 Sep 1; 38(12):2647-2654.
  49. Liao JM, Sun C, Yan XS, Patel MS, Small DS, Isenberg WM, Landa HM, Bond BL, Rareshide CAL, Volpp KG, Delgado MK, Lei VJ, Shen Z, Navathe AS. How Physician Self-Perceptions Affect the Impact of Peer Comparison Feedback on Opioid Prescribing. American journal of medical quality : the official journal of the American College of Medical Quality. 2023 May 1; 38(3):129-136.
  50. Goulet J, Cheng Y, Becker W, Brandt C, Sandbrink F, Workman TE, Ma P, Libin A, Shara N, Spevak C, Kupersmith J, Zeng-Treitler Q. Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers. Frontiers in public health. 2023 Apr 4; 11:1148189.
  51. Thompson RG, Bollinger M, Mancino MJ, Hasin D, Han X, Bush KA, Kilts CD, James GA. Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial. Trials. 2023 Apr 4; 24(1):255.
  52. Bounthavong M. Is Providing Medications for Opioid Use Disorder to Incarcerated Individuals a Cost-effective Strategy? JAMA Network Open. 2023 Apr 3; 6(4):e237001.
  53. Nguemeni Tiako MJ, Shofer F, Dolan A, Goldberg EB, Rhodes KV, Hess EP, Bellamkonda VR, Perrone J, Cannuscio CC, Becker L, Rodgers MA, Zyla MM, Bell JJ, McCollum S, Engel-Rebitzer E, Schapira MM, Meisel ZF. Personalized risk communication and opioid prescribing in association with nonprescribed opioid use: A secondary analysis of a randomized controlled trial. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023 Aug 1; 30(8):851-858.
  54. Jones KF, Malinowski J, Paice J, Childers J, Bulls HW, Morrison J, Ho JJ, Alsbrook K, Nugent S, Broglio K, Nickels K, Holbein M, Parajuli J, Merlin JS. Opioid-prescribing considerations in patients with cancer and substance misuse or substance use disorder: a scoping review protocol. JBI evidence synthesis. 2023 Apr 1; 21(4):812-825.
  55. MacLean RR, Heapy AA, Waters AJ, Wolkowicz N, Szollosy SK, Meyerovich J, Sofuoglu M. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results. Drug and Alcohol Dependence. 2023 May 1; 246:109857.
  56. Zaman T, Bravata DM, Byers AL, Krebs EE, Leonard SJ, Sandbrink F, Barker W, Keyhani S. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care. BMC psychiatry. 2023 Mar 17; 23(1):177.
  57. Nichols MA, Riley EG, Chao AS, Sales CG, Miller ML, Curran GM, Ott CA, Snyder ME, Hudmon KS. Opioid Use Disorder Curricular Content in US-Based Doctor of Pharmacy Programs. American Journal of Pharmaceutical Education. 2023 Jun 1; 87(6):100061.
  58. Sasson C, Dieujuste N, Klocko R, Basrai Z, Celedon M, Hsiao J, Himstreet J, Hoffman J, Pfaff C, Malmstrom R, Smith J, Holstein A, Johnson-Koenke R. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023 Apr 1; 30(4):289-298.
  59. Lott AM, Danner AN, Malte CA, Williams EC, Gordon AJ, Halvorson MA, Saxon AJ, Hagedorn HJ, Sayre GG, Hawkins EJ. Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. Journal of addiction medicine. 2023 Jul 1; 17(4):e262-e268.
  60. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. The Clinical Journal of Pain. 2023 Mar 1; 39(3):107-118.
  61. Riggs KR, Cherrington AL, Kertesz SG, Richman JS, DeRussy AJ, Varley AL, Becker WC, Morris MS, Singh JA, Markland AD, Goodin BR. Higher Pain Catastrophizing and Preoperative Pain is Associated with Increased Risk for Prolonged Postoperative Opioid Use. Pain physician. 2023 Mar 1; 26(2):E73-E82.
  62. Stringfellow EJ, Lim TY, DiGennaro C, Zhang Z, Paramasivam P, Bearnot B, Humphreys K, Jalali MS. Long-Term Effects of Increasing Buprenorphine Treatment Seeking, Duration, and Capacity on Opioid Overdose Fatalities: A Model-based Analysis. Journal of addiction medicine. 2023 Jul 1; 17(4):439-446.
  63. DeBar LL, Bushey MA, Kroenke K, Bobb JF, Schoenbaum M, Thompson EE, Justice M, Zatzick D, Hamilton LK, McMullen CK, Hallgren KA, Benes LL, Forman DP, Caldeiro RM, Brown RP, Campbell NL, Anderson ML, Son S, Haggstrom DA, Whiteside L, Schleyer TKL, Bradley KA. A patient-centered nurse-supported primary care-based collaborative care program to treat opioid use disorder and depression: Design and protocol for the MI-CARE randomized controlled trial. Contemporary clinical trials. 2023 Apr 1; 127:107124.
  64. Solanki PA, Hubbard CC, Poggensee L, Evans CT, Suda KJ. Adverse outcomes associated with opioid prescription by dentists in the Veterans Health Administration: A national cross-sectional study from 2015 to 2018. Journal of public health dentistry. 2023 Jun 1; 83(2):136-146.
  65. Watson DP, Phalen P, Medcalf S, Messmer S, McGuire A. Evaluation of post-discharge engagement for emergency department patients with opioid use history who received telehealth recovery coaching services. Substance abuse treatment, prevention, and policy. 2023 Feb 11; 18(1):9.
  66. Bray BC, Watson DP, Salisbury-Afshar E, Taylor L, McGuire A. Patterns of opioid use behaviors among patients seen in the emergency department: Latent class analysis of baseline data from the POINT pragmatic trial. Journal of substance use and addiction treatment. 2023 Mar 1; 146:208979.
  67. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain. Journal of cancer survivorship : research and practice. 2023 Feb 8; doi.org.10.1007/s11764-023-01338-9.
  68. Goldsmith ES, Krebs EE, Ramirez MR, MacLehose RF. Opioid-related Mortality in United States Death Certificate Data: A Quantitative Bias Analysis With Expert Elicitation of Bias Parameters. Epidemiology (Cambridge, Mass.). 2023 May 1; 34(3):421-429.
  69. Howell BA, Black AC, Grau LE, Lin HJ, Greene C, Lee H, Heimer R, Hawk KE, D'Onofrio G, Fiellin DA, Becker WC. Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis. Drug and Alcohol Dependence. 2023 Mar 1; 244:109788.
  70. Wyse JJ, Shull S, Lindner S, Morasco BJ, Gordon AJ, Carlson KF, Korthuis PT, Ono SS, Liberto JG, Lovejoy TI. Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities. Journal of general internal medicine. 2023 Jun 1; 38(8):1871-1876.
  71. Kim KC, Khouja T, Burgette JM, Evans CT, Calip GS, Gellad WF, Suda KJ. Trends in dispensed prescriptions for opioids, sedatives, benzodiazepines, gabapentin, and stimulants to children by general dentists, 2012-2019. Pharmacoepidemiology and drug safety. 2023 Jun 1; 32(6):625-634.
  72. Auty SG, Barr KD, Frakt AB, Garrido MM, Strombotne KL. Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial. Addiction (Abingdon, England). 2023 May 1; 118(5):870-879.
  73. Conrad M, Steffensmeier KS, Van Tiem J, Obrecht A, Mares J, Mosher HJ, Weg MWV, Sibenaller Z, Stout L, Patel P, Hadlandsmyth K. Military Veterans' Perspectives on Postoperative Opioid Use: A Secondary Analysis of Qualitative Data. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses. 2023 Jun 1; 38(3):483-487.
  74. Margraf AM, Davoodi NM, Chen K, Shield RR, McAuliffe LM, Collins CM, Zullo AR. Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023 Jan 5; 80(2):53-60.
  75. Qian G, Rao I, Humphreys K, Owens DK, Brandeau ML. Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence. 2023 Feb 1; 243:109762.
  76. Klaiman T, Nelson MN, Yan XS, Navathe AS, Patel MS, Refai F, Delgado MK, Pagnotti DR, Liao JM. Clinician Perceptions of Receiving Different Forms of Feedback on their Opioid Prescribing. American journal of medical quality : the official journal of the American College of Medical Quality. 2023 Jan 1; 38(1):1-8.
  77. Mahashabde RV, Shrikhande MA, Han X, Martin BC, ElHassan NO, Hayes CJ. Concordance of opioid exposure in all-payer claims databases with prescription drug monitoring program database using Arkansas as a case example. Health services research. 2023 Aug 1; 58(4):938-947.
  78. Smith AM, Acharya M, Hudson T, Hayes C, Porter A, Turpin J, Bona J, Utecht J, Martin BC. Evaluating the temporal association between the recency of prescribed controlled substance acquisition and fatal and non-fatal opioid overdose. Journal of the American Pharmacists Association : JAPhA. 2022 Dec 23; 63(2):648-654.e3.
  79. Baxley C, Borsari B, Reavis JV, Manuel JK, Herbst E, Becker W, Pennington D, Batki SL, Seal K. Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials. Addictive Behaviors. 2023 Apr 1; 139:107589.
  80. Lee AH, LeBrett WG, Benhammou J, Prause N, Chang L, Patel AA. Opioid Prescription Patterns and Disparities during Ambulatory Encounters in Patients with Cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2022 Dec 9.
  81. Coquet J, Zammit A, Hajouji OE, Humphreys K, Asch SM, Osborne TF, Curtin CM, Hernandez-Boussard T. Changes in postoperative opioid prescribing across three diverse healthcare systems, 2010-2020. Frontiers in digital health. 2022 Dec 6; 4:995497.
  82. Kelley AT, Wilcox J, Baylis JD, Crossnohere NL, Magel J, Jones AL, Gordon AJ, Bridges JFP. Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. Journal of general internal medicine. 2023 Jul 1; 38(9):2147-2155.
  83. Draper P, Bleicher J, Kobayashi JK, Stauder EL, Stoddard GJ, Johnson JE, Cohan JN, Kaphingst KA, Harris AHS, Huang LC. Patient Willingness to Dispose of Leftover Opioids After Surgery: A Mixed Methods Study. Annals of surgery open : perspectives of surgical history, education, and clinical approaches. 2022 Dec 1; 3(4):e223.
  84. Gibbons JB, McCullough JS, Zivin K, Brown ZY, Norton EC. Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder. JAMA psychiatry. 2022 Dec 1; 79(12):1173-1179.
  85. Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JFP. Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Substance Abuse. 2022 Dec 1; 43(1):1286-1299.
  86. Keyhani S, Leonard S, Byers AL, Zaman T, Krebs E, Austin PC, Moss-Vazquez T, Austin C, Sandbrink F, Bravata DM. Association of a Positive Drug Screening for Cannabis With Mortality and Hospital Visits Among Veterans Affairs Enrollees Prescribed Opioids. JAMA Network Open. 2022 Dec 1; 5(12):e2247201.
  87. Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, Shannon C, Cohen-Mekelburg SA, Higgins PDR, Berinstein JA. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases. 2022 Dec 1; 28(12):1904-1914.
  88. Nevedal AL, Timko C, Lor MC, Hoggatt KJ. Patient and Provider Perspectives on Benefits and Harms of Continuing, Tapering, and Discontinuing Long-Term Opioid Therapy. Journal of general internal medicine. 2023 Jun 1; 38(8):1802-1811.
  89. Buonora MJ, Sung ML, Falker CG, Black AC, Becker WC. Self-reported Use of Prescribed Buprenorphine Among US Adults With Nonmedical Use of Prescription Opioids Motivated by Pain. JAMA Network Open. 2022 Nov 1; 5(11):e2241670.
  90. Bushey MA, Slaven JE, Outcalt SD, Kroenke K, Kempf C, Froman A, Sargent C, Baecher B, Zillich AJ, Damush TM, Saha C, French DD, Bair MJ. Effect of Medication Optimization vs Cognitive Behavioral Therapy Among US Veterans With Chronic Low Back Pain Receiving Long-term Opioid Therapy: A Randomized Clinical Trial. JAMA Network Open. 2022 Nov 1; 5(11):e2242533.
  91. Livingston NA, Davenport M, Head M, Henke R, LeBeau LS, Gibson TB, Banducci AN, Sarpong A, Jayanthi S, Roth C, Camacho-Cook J, Meng F, Hyde J, Mulvaney-Day N, White M, Chen DC, Stein MD, Weisberg R. The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study. Drug and Alcohol Dependence. 2022 Dec 1; 241:109678.
  92. Medicaid Outcomes Distributed Research Network (MODRN), Cole ES, Allen L, Austin A, Barnes A, Chang CH, Clark S, Crane D, Cunningham P, Fry CE, Gordon AJ, Hammerslag L, Idala D, Kennedy S, Kim JY, Krishnan S, Lanier P, Mahakalanda S, Mauk R, McDuffie MJ, Mohamoud S, Talbert J, Tang L, Zivin K, Donohue JM. Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states. Drug and Alcohol Dependence. 2022 Dec 1; 241:109670.
  93. Hsiao JJ, Celedon MA, Basrai ZI, Sasson C, Cordasco KM. Medications for Opioid Use Disorder Program in a VA Emergency Department. MDEdge: Federal Practioner [Internet]. 2022 Oct 20:(MDedge):258618. Available from: https://www.mdedge.com/fedprac/article/258618/addiction-medicine/medications-opioid-use-disorder-program-va-emergency.
  94. Nichols MA, Kepley KL, Rosko KS, Hudmon KS, Curran GM, Ott CA, Snyder ME, Miller ML. Community pharmacist-provided opioid intervention frequencies and barriers. Journal of the American Pharmacists Association : JAPhA. 2022 Oct 14; 63(1):336-342.
  95. Barrett AK, Sandbrink F, Mardian A, Oliva EM, Torrise V, Zhang R, Bukowski K, Burk M, Cunningham FE. Medication Use Evaluation of High-Dose Long-Term Opioid De-prescribing in Multiple Veterans Affairs Medical Centers. Journal of general internal medicine. 2022 Dec 1; 37(16):4037-4046.
  96. Moyo P, Eliot M, Shah A, Goodyear K, Jutkowitz E, Thomas K, Zullo AR. Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries. Addiction science & clinical practice. 2022 Oct 8; 17(1):57.
  97. Frost MC, Zhang L, Kim HM, Lin LA. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Network Open. 2022 Oct 3; 5(10):e2236298.
  98. Kember RL, Vickers-Smith R, Xu H, Toikumo S, Niarchou M, Zhou H, Hartwell EE, Crist RC, Rentsch CT, Million Veteran Program, Davis LK, Justice AC, Sanchez-Roige S, Kampman KM, Gelernter J, Kranzler HR. Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction. Nature neuroscience. 2022 Oct 1; 25(10):1279-1287.
  99. Buta E, Gordon KS, Gueorguieva R, Becker WC, Heapy A, Bathulapalli H, Zeng Q, Redd D, Brandt C, Goulet J. Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain. Pharmacoepidemiology and drug safety. 2022 Dec 1; 31(12):1262-1271.
  100. Quinn PD, Chang Z, Pujol TA, Bair MJ, Gibbons RD, Kroenke K, D'Onofrio BM. Association between prescribed opioid dose and risk of motor vehicle crashes. Pain. 2023 Apr 1; 164(4):e228-e236.
  101. Edmond SN, Snow JL, Pomeranz J, Van Cleve R, Black AC, Compton P, Becker WC. Delphi study to explore a new diagnosis for "ineffective" long-term opioid therapy for chronic pain. Pain. 2023 Apr 1; 164(4):870-876.
  102. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Current Medical Research and Opinion. 2022 Nov 1; 38(11):1947-1957.
  103. Johnson DG, Ho VT, Hah JM, Humphreys K, Carroll I, Curtin C, Asch SM, Hernandez-Boussard T. Prescription quantity and duration predict progression from acute to chronic opioid use in opioid-naïve Medicaid patients. PLOS digital health. 2022 Aug 25; 1(8).
  104. Sharp LK, Solanki P, Boyer T, Vivo A, Kale I, Hughes AM, Gibson G, Jurasic MM, Evans CT, Suda KJ. A qualitative exploration of dentists' opioid prescribing decisions within U.S. veterans affairs facilities. Pain. 2023 Apr 1; 164(4):749-757.
  105. Zeliadt SB, Douglas JH, Gelman H, Coggeshall S, Taylor SL, Kligler B, Bokhour BG. Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain. BMC health services research. 2022 Aug 17; 22(1):1053.
  106. Epperson MV, VanHorn A, Kim HM, Kim JC, Zopf D. Pain management after microtia repair with costal cartilage: De-escalation and opioid use reduction. International journal of pediatric otorhinolaryngology. 2022 Oct 1; 161:111270.
  107. Zhang IY, Wong ES, Rosen JE, Gordon DB, Flum DR, Liao JM. Association Between Statewide Medicaid Opioid Policy and Postoperative Opioid Prescribing among Surgeons at a Large Safety-Net Hospital. Journal of the American College of Surgeons. 2022 Sep 1; 235(3):519-528.
  108. Evans CT, Fitzpatrick MA, Poggensee L, Gonzalez B, Gibson G, Jurasic MM, Echevarria K, McGregor JC, Gellad WF, Suda KJ. High prescribing of antibiotics is associated with high prescribing of opioids in medical and dental providers. Pharmacotherapy. 2022 Sep 1; 42(9):716-723.
  109. Mosher H. Treating hospitalized people who have opioid use disorder: Coming to consensus. Journal of hospital medicine. 2022 Sep 1; 17(9):774-775.
  110. Cavallari LH, Cicali E, Wiisanen K, Fillingim RB, Chakraborty H, Myers RA, Blake KV, Asiyanbola B, Baye JF, Bronson WH, Cook KJ, Elwood EN, Gray CF, Gong Y, Hines L, Kannry J, Kucher N, Lynch S, Nguyen KA, Obeng AO, Pratt VM, Prieto HA, Ramos M, Sadeghpour A, Singh R, Rosenman M, Starostik P, Thomas CD, Tillman E, Dexter PR, Horowitz CR, Orlando LA, Peterson JF, Skaar TC, Van Driest SL, Volpi S, Voora D, Parvataneni HK, Johnson JA, IGNITE Pragmatic Trials Network. Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators. Clinical and translational science. 2022 Oct 1; 15(10):2479-2492.
  111. Dolan AR, Goldberg EB, Cannuscio CC, Abrams MP, Feuerstein-Simon R, Luna Marti X, Mazique J, Schapira MM, Meisel ZF. Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial. JAMA Network Open. 2022 Aug 1; 5(8):e2227650.
  112. Hepner KA, Roth CP, Sherry TB, McBain RK, Ruder T, Engel CC. Assessing the Quality of Outpatient Pain Care and Opioid Prescribing in the Military Health System. Rand health quarterly. 2022 Aug 1; 9(4):19.
  113. Larochelle MR, Lodi S, Yan S, Clothier BA, Goldsmith ES, Bohnert ASB. Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy. JAMA Network Open. 2022 Aug 1; 5(8):e2226523.
  114. Lin LA, Zhang L, Kim HM, Frost MC. Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder. The American journal of psychiatry. 2022 Oct 1; 179(10):740-747.
  115. Deak JD, Zhou H, Galimberti M, Levey DF, Wendt FR, Sanchez-Roige S, Hatoum AS, Johnson EC, Nunez YZ, Demontis D, Børglum AD, Rajagopal VM, Jennings MV, Kember RL, Justice AC, Edenberg HJ, Agrawal A, Polimanti R, Kranzler HR, Gelernter J. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci. Molecular Psychiatry. 2022 Oct 1; 27(10):3970-3979.
  116. Sousa JL, Raja P, Huskamp HA, Mehrotra A, Busch AB, Barnett ML, Uscher-Pines L. Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences. Journal of addiction medicine. 2022 Nov 1; 16(6):702-708.
  117. Yan CH, Ramanathan S, Suda KJ, Khouja T, Rowan SA, Evans CT, Lee TA, Calip GS, Gellad WF, Sharp LK, National Dental Practice-Based Research Network Collaborative Group. Barriers to and facilitators of opioid prescribing by dentists in the United States: A qualitative study. Journal of the American Dental Association (1939). 2022 Oct 1; 153(10):957-969.e1.
  118. Edmond SN, Wesolowicz DM, Moore BA, Ibarra J, Chhabra M, Fraenkel L, Becker WC. Opioid tapering support using a web-based app: Development and protocol for a pilot randomized controlled trial. Contemporary clinical trials. 2022 Aug 1; 119:106857.
  119. Fernandez AC, Bohnert A, Gunaseelan V, Motamed M, Waljee JF, Brummett CM. Identifying Persistent Opioid Use After Surgery: The Reliability of Pharmacy Dispensation Databases. Annals of surgery. 2023 Jul 1; 278(1):e20-e26.
  120. Powell VD, Macleod C, Sussman J, Lin LA, Bohnert ASB, Lagisetty P. Variation in Clinical Characteristics and Longitudinal Outcomes in Individuals with Opioid Use Disorder Diagnosis Codes. Journal of general internal medicine. 2023 Feb 1; 38(3):699-706.
  121. Danek R, Blackburn J, Harle CA, Bair M, Kara A, Mazurenko O. Inpatient opioid receipt and care experiences for vaginal delivery. The American journal of managed care. 2022 Jul 1; 28(7):e248-e254.
  122. Nikpour J, Broome M, Silva S, Allen KD. Patient demographics and clinical characteristics influence opioid and nonopioid pain management prescriptions of primary care NPs, PAs, and physicians. Journal of the American Association of Nurse Practitioners. 2022 Jul 1; 34(7):883-890.
  123. Peng C. , Dayer L., Burlett M., Clement C., Azhar G., Painter JT. EPH44 Relationship between Concurrent Use of Opioids and Gabapentin and Falls Among Older Adults with Chronic Opioid Therapy. [Abstract]. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2022 Jul 1; 25(7, Supplement):S442.
  124. Hayes CJ, Koonce RM, Gressler LE, Hu B, Williams JS, Martin BC. Association between opioid therapy trajectories and potential opioid-related adverse health events. Pharmacoepidemiology and drug safety. 2022 Oct 1; 31(10):1075-1090.
  125. Candon M, Strominger J, Gotlieb E, Maust DT. Nursing Home Characteristics Associated with High and Low Levels of Antipsychotic, Benzodiazepine, and Opioid Prescribing to Residents with Alzheimer's Disease and Related Dementias: A Cross-Sectional Analysis. Journal of The American Medical Directors Association. 2022 Nov 1; 23(11):1780-1786.e2.
  126. Stringfellow EJ, Lim TY, Humphreys K, DiGennaro C, Stafford C, Beaulieu E, Homer J, Wakeland W, Bearnot B, McHugh RK, Kelly J, Glos L, Eggers SL, Kazemi R, Jalali MS. Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis. Science advances. 2022 Jun 24; 8(25):eabm8147.
  127. Kim TW, Samet JH, Lodi S, Kimmel SD, Forman LS, Lira MC, Liebschutz JM, Williams EC, Walley AY. Functional Impairment and Cognitive Symptoms Among People with HIV Infection on Chronic Opioid Therapy for Pain: The Impact of Gabapentin and Other Sedating Medications. AIDS and behavior. 2022 Dec 1; 26(12):3889-3896.
  128. Wyse JJ, Mackey K, Lovejoy TI, Kansagara D, Tuepker A, Gordon AJ, Todd Korthuis P, Herreid-O'Neill A, Williams B, Morasco BJ. Expanding access to medications for opioid use disorder through locally-initiated implementation. Addiction science & clinical practice. 2022 Jun 20; 17(1):32.
  129. Minegishi T, Garrido MM, Lewis ET, Oliva EM, Pizer SD, Strombotne KL, Trafton JA, Tenso K, Sohoni PS, Frakt AB. Randomized Policy Evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM). Journal of general internal medicine. 2022 Nov 1; 37(14):3746-3750.
  130. Lin LA, Powell VD, Macleod C, Bohnert ASB, Lagisetty P. Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder. Journal of substance abuse treatment. 2022 Oct 1; 141:108827.
  131. Yan CH, Hubbard CC, Lee TA, Sharp LK, Evans CT, Calip GS, Rowan SA, McGregor JC, Gellad WF, Suda KJ. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids. JDR clinical and translational research. 2023 Oct 1; 8(4):402-412.
  132. Burns M, Tang L, Chang CH, Kim JY, Ahrens K, Allen L, Cunningham P, Gordon AJ, Jarlenski MP, Lanier P, Mauk R, McDuffie MJ, Mohamoud S, Talbert J, Zivin K, Donohue J. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study. Addiction (Abingdon, England). 2022 Dec 1; 117(12):3079-3088.
  133. Stern JR, Kou A, Kapoor A, Regala S, He H, Stafford RS, Mariano ER, Mudumbai SC. Single-center cross-sectional study of high opioid prescribing among U.S. veterans with peripheral arterial disease. Regional Anesthesia and Pain Medicine. 2022 Oct 1; 47(10):651-652.
  134. Holeman TA, Buys MJ, Bayless K, Anderson Z, Hales J, Brooke BS. Complete opioid cessation after surgery improves patient-reported pain measures among chronic opioid users. Surgery. 2022 Sep 1; 172(3):943-948.
  135. Frost MC, Richards JE, Blosnich JR, Hawkins EJ, Tsui JI, Edelman EJ, Williams EC. Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder. Drug and Alcohol Dependence. 2022 Aug 1; 237:109521.
  136. Hadlandsmyth K, Mosher HJ, Bayman EO, Mares JG, Odom AS, Lund BC. Opioid prescribing patterns for acute pain. European journal of pain (London, England). 2022 Aug 1; 26(7):1523-1531.
  137. Black AC, Zeliadt SB, Kerns RD, Skanderson M, Wang R, Gelman H, Douglas JH, Becker WC. Association Between Exposure to Complementary and Integrative Therapies and Opioid Analgesic Daily Dose Among Patients on Long-term Opioid Therapy. The Clinical Journal of Pain. 2022 Jun 1; 38(6):405-409.
  138. Goldstick JE, Guy GP, Losby JL, Baldwin GT, Myers MG, Bohnert ASB. Patterns in Nonopioid Pain Medication Prescribing After the Release of the 2016 Guideline for Prescribing Opioids for Chronic Pain. JAMA Network Open. 2022 Jun 1; 5(6):e2216475.
  139. Lo-Ciganic WH, Donohue JM, Yang Q, Huang JL, Chang CY, Weiss JC, Guo J, Zhang HH, Cochran G, Gordon AJ, Malone DC, Kwoh CK, Wilson DL, Kuza CC, Gellad WF. Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study. The Lancet. Digital health. 2022 Jun 1; 4(6):e455-e465.
  140. Hadlandsmyth K, Burgess DJ, Leparski RF, Odom AS, Campbell EJ, Obrecht AA, Adamowicz JL, Cho H, Steffensmeier KS, Johnson NL, Richards CC, Vander Weg MW, Lund BC, Yoon P, Mosher HJ. The Perioperative Pain Self-Management (PePS) randomized controlled trial protocol: Preventing chronic post-surgical pain and prolonged opioid use. Contemporary clinical trials. 2022 Jul 1; 118:106810.
  141. Lim TY, Stringfellow EJ, Stafford CA, DiGennaro C, Homer JB, Wakeland W, Eggers SL, Kazemi R, Glos L, Ewing EG, Bannister CB, Humphreys K, Throckmorton DC, Jalali MS. Modeling the evolution of the US opioid crisis for national policy development. Proceedings of the National Academy of Sciences of the United States of America. 2022 Jun 7; 119(23):e2115714119.
  142. Austin EJ, Briggs ES, Ferro L, Barry P, Heald A, Curran GM, Saxon AJ, Fortney J, Ratzliff AD, Williams EC. Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics. Journal of general internal medicine. 2023 Feb 1; 38(2):332-340.
  143. Avoundjian T, Troszak L, Cohen J, Foglia MB, Trafton J, Midboe A. Impact of Informed Consent and Education on Care Engagement After Opioid Initiation in the Veterans Health Administration. Journal of pain research. 2022 May 25; 15:1553-1562.
  144. Stimmel MA, Smelson D, Finlay AK. Moving Beyond the Medication or Psychosocial Treatment Dichotomy to Address the Opioid Epidemic. Psychiatric services (Washington, D.C.). 2022 Dec 1; 73(12):1320-1321.
  145. Love T, Shabalin AA, Kember RL, Docherty AR, Zhou H, Koppelmans V, Gelernter J, Baker AK, Hartwell E, Dubroff J, Zubieta JK, Kranzler HR. Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022 Sep 1; 47(10):1784-1790.
  146. Vitzthum LK, Nalawade V, Riviere P, Marar M, Furnish T, Lin LA, Thompson R, Murphy JD. Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment. Journal of the National Cancer Institute. 2022 May 9; 114(5):753-760.
  147. Strombotne KL, Legler A, Minegishi T, Trafton JA, Oliva EM, Lewis ET, Sohoni P, Garrido MM, Pizer SD, Frakt AB. Effect of a Predictive Analytics-Targeted Program in Patients on Opioids: a Stepped-Wedge Cluster Randomized Controlled Trial. Journal of general internal medicine. 2023 Feb 1; 38(2):375-381.
  148. Gomes T, Kim KC, Suda KJ, Garg R, Tadrous M. International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID-19 pandemic: A cross-sectional analysis of 66 countries. Pharmacoepidemiology and drug safety. 2022 Jul 1; 31(7):779-787.
  149. Lo-Ciganic WH, Hincapie-Castillo J, Wang T, Ge Y, Jones BL, Huang JL, Chang CY, Wilson DL, Lee JK, Reisfield GM, Kwoh CK, Delcher C, Nguyen KA, Zhou L, Shorr RI, Guo J, Marcum ZA, Harle CA, Park H, Winterstein A, Yang S, Huang PL, Adkins L, Gellad WF. Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models. Addiction (Abingdon, England). 2022 Jul 1; 117(7):1982-1997.
  150. Zaller N, Gardner A, Borders T, Drummond KL. A Qualitative Exploration of Primary Care Practitioner Views About Training to Treat Opioid Use Disorder. SSRN Electronic Journal. 2022 Apr 15; http://dx.doi.org/10.2139/ssrn.4078644.
  151. Thakrar AP, Kleinman RA. Opioid withdrawal management in the fentanyl era. Addiction (Abingdon, England). 2022 Sep 1; 117(9):2560-2561.
  152. Wang H, Cai S, Caprio T, Goulet J, Intrator O. Opioid administration trends among long-stay community living centers residents with dementia. Journal of the American Geriatrics Society. 2022 Aug 1; 70(8):2393-2403.
  153. Boyer TL, Blosnich JR, Hubbard CC, Sharp LK, Cashy JP, Suda KJ. Comparing Outpatient Opioids, High-Risk Prescribing, and Opioid Poisoning Between Transgender and Cisgender Veterans: A Cross-sectional Analysis. American journal of preventive medicine. 2022 Aug 1; 63(2):168-177.
  154. Guo J, Gellad WF, Yang Q, Weiss JC, Donohue JM, Cochran G, Gordon AJ, Malone DC, Kwoh CK, Kuza CC, Wilson DL, Lo-Ciganic WH. Changes in predicted opioid overdose risk over time in a state Medicaid program: a group-based trajectory modeling analysis. Addiction (Abingdon, England). 2022 Aug 1; 117(8):2254-2263.
  155. Grant AD, Miller MM, Anastas TM, Quinn P, Lok B, Hirsh AT. Opioid-related risk perceptions in chronic pain: influence of patient gender and previous misuse behaviors. Pain. 2022 Apr 1; 163(4):711-718.
  156. Quinn PD, Chang Z, Bair MJ, Rickert ME, Gibbons RD, Kroenke K, D'Onofrio BM. Associations of opioid prescription dose and discontinuation with risk of substance-related morbidity in long-term opioid therapy. Pain. 2022 Apr 1; 163(4):e588-e595.
  157. Radmall AO, Calder S, Codell N, Kelley AT, Hawkins E, Jones AL, Hagedorn HJ, Reynolds MA, Gordon AJ. Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of addictions nursing. 2022 Apr 1; 33(2):70-79.
  158. Bergen AW, Baurley JW, Ervin CM, McMahan CS, Bible J, Stafford RS, Mudumbai SC, Saxon AJ. Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials. International journal of environmental research and public health. 2022 Mar 30; 19(7).
  159. Pickard JG, van den Berk-Clark C, Matthieu MM. Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities. Military medicine. 2022 Mar 28; 187(3-4):504-512.
  160. Suda KJ, Evans CT, Gibson G, Jurasic MM, Poggensee L, Gonzalez B, Hubbard CC, Vivo A, Cunningham FE, McGregor JC, Gellad WF. Opioid Prescribing by Dentists in the Veterans Health Administration. American journal of preventive medicine. 2022 Sep 1; 63(3):371-383.
  161. Chanfreau-Coffinier C, Tuteja S, Hull LE, MacDonald S, Efimova O, Bates J, Voora D, Oslin DW, DuVall SL, Lynch JA. Drug-drug-gene interaction risk among opioid users in the U.S. Department of Veterans Affairs. Pain. 2022 Dec 1; 163(12):2390-2397.
  162. Townsend TN, Bohnert ASB, Lagisetty P, Haffajee RL. Did prescribing laws disproportionately affect opioid dispensing to Black patients? Health services research. 2022 Jun 1; 57(3):482-496.
  163. Beckman KL, Williams EC, Hebert P, Hawkins EJ, Littman AJ, Lehavot K. The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder. Journal of substance abuse treatment. 2022 Aug 1; 139:108775.
  164. Morasco BJ, Adams MH, Hooker ER, Maloy PE, Krebs EE, Lovejoy TI, Saha S, Dobscha SK. A Cluster-Randomized Clinical Trial to Decrease Prescription Opioid Misuse: Improving the Safety of Opioid Therapy (ISOT). Journal of general internal medicine. 2022 Nov 1; 37(15):3805-3813.
  165. Oldfield BJ, Li Y, Vickers-Smith R, Barry DT, Crystal S, Gordon KS, Kerns RD, Williams EC, Marshall BDL, Edelman EJ. Longitudinal analysis of the prevalence and correlates of heavy episodic drinking and self-reported opioid use among a national cohort of patients with HIV. Alcoholism, clinical and experimental research. 2022 Apr 1; 46(4):600-613.
  166. Van Cleve R, Edmond S, Snow J, Black AC, Pomeranz JL, Becker W. Classification of Patients for Whom Benefit of Long-term Opioid Therapy No Longer Outweighs Harm: Protocol for a Delphi Study. JMIR research protocols. 2022 Mar 4; 11(3):e33310.
  167. Bicket MC, Gunaseelan V, Lagisetty P, Fernandez AC, Bohnert A, Assenmacher E, Sequeira M, Englesbe MJ, Brummett CM, Waljee JF. Association of opioid exposure before surgery with opioid consumption after surgery. Regional Anesthesia and Pain Medicine. 2022 Jun 1; 47(6):346-352.
  168. Cochran G, Cole ES, Sharbaugh M, Nagy D, Gordon AJ, Gellad WF, Pringle J, Bear T, Warwick J, Drake C, Chang CH, DiDomenico E, Kelley D, Donohue J. Provider and Patient-panel Characteristics Associated With Initial Adoption and Sustained Prescribing of Medication for Opioid Use Disorder. Journal of addiction medicine. 2022 Mar 1; 16(2):e87-e96.
  169. Kral LA, Bettinger JJ, Vartan CM, Hadlandsmyth K, Kullgren J, Smith MA. A Survey on Opioid Tapering Practices, Policies, and Perspectives by Pain and Palliative Care Pharmacists. Journal of Pain & Palliative Care Pharmacotherapy. 2022 Mar 1; 36(1):2-10.
  170. Navathe AS, Liao JM, Yan XS, Delgado MK, Isenberg WM, Landa HM, Bond BL, Small DS, Rareshide CAL, Shen Z, Pepe RS, Refai F, Lei VJ, Volpp KG, Patel MS. The Effect Of Clinician Feedback Interventions On Opioid Prescribing. Health affairs (Project Hope). 2022 Mar 1; 41(3):424-433.
  171. Thakrar AP. Short-Acting Opioids for Hospitalized Patients With Opioid Use Disorder. JAMA internal medicine. 2022 Mar 1; 182(3):247-248.
  172. Ameral V, Hocking E, Leviyah X, Newberger NG, Timko C, Livingston N. Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder. Drug and Alcohol Dependence. 2022 Apr 1; 233:109379.
  173. Yan CH, Lee TA, Sharp LK, Hubbard CC, Evans CT, Calip GS, Rowan SA, McGregor JC, Gellad WF, Suda KJ. Trends in Opioid Prescribing by General Dentists and Dental Specialists in the U.S., 2012-2019. American journal of preventive medicine. 2022 Jul 1; 63(1):3-12.
  174. Lahidji S, Oliva E, Jarzebowski M, Mudumbai SC, Lake T, Krishnamoorthy V, Raghunathan K, Bryan WE. Naloxone Dispensing in Patients at Risk for Opioid Overdose After Total Knee Arthroplasty Within the Veterans Health Administration. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2022 Feb 10; 39(2):64-69.
  175. Gorfinkel LR, Hasin D, Saxon AJ, Wall M, Martins SS, Cerdá M, Keyes K, Fink DS, Keyhani S, Maynard CC, Olfson M. Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018. The journal of pain. 2022 Jul 1; 23(7):1187-1195.
  176. Hayes CJ, Goree J, Turpin J, Ortiz H, Smith GR, Gokarakonda SB, Hyde C, Cucciare MA. Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas. Journal of prevention (2022). 2022 Jun 1; 43(3):337-357.
  177. Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, Chen JH, Cuéllar MF, Hurd YL, Juurlink DN, Koh HK, Krebs EE, Lembke A, Mackey SC, Larrimore Ouellette L, Suffoletto B, Timko C. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet (London, England). 2022 Feb 5; 399(10324):555-604.
  178. Atkins D, Bohnert ASB. The Work-Opioid Connection: What Do Construction Workers and Military Veterans Have in Common? American journal of public health. 2022 Feb 1; 112(S1):S33-S35.
  179. Bicket MC, Lin LA, Waljee J. New Persistent Opioid Use After Surgery: A Risk Factor for Opioid Use Disorder? Annals of surgery. 2022 Feb 1; 275(2):e288-e289.
  180. Merlin JS, Wachterman MW, Becker WC, Bohnert ASB. Serious Illness and Limitations of Death Certificate-Based Data: Urgent Lessons From the Opioid Epidemic. American journal of public health. 2022 Feb 1; 112(S1):S36-S38.
  181. Pro G, Hayes C, Brown CC, Goree J, Zaller N. Individual and Health Policy Factors Associated With Positive Heroin and Opioid Treatment Response: United States, 2018. American journal of public health. 2022 Feb 1; 112(S1):S66-S76.
  182. Kramer JR, Puenpatom A, Cao Y, Yu X, El-Serag HB, Kanwal F. Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population. The American journal of drug and alcohol abuse. 2022 Jul 4; 48(4):445-453.
  183. Faiz J, Bernstein E, Dugas JN, Schechter-Perkins EM, Nentwich L, Nelson KP, Cleveland Manchanda EC, Young L, Pare JR. Racial equity in linkage to inpatient opioid use disorder treatment in patients that received emergency care. The American journal of emergency medicine. 2022 Apr 1; 54:221-227.
  184. Burgess DJ, Krebs EE, Roth CS. Taking the Bait from the Prescription Opioid Industry: a Mea Culpa. Journal of general internal medicine. 2022 Jun 1; 37(8):2072-2073.
  185. Rubin JB, Lai JC, Leonard S, Seal K, Hoggatt KJ, Keyhani S. Long-Term Opioid Use Among Veterans with Cirrhosis: High-Dose Prescriptions in an Exceedingly High-Risk Population. Journal of general internal medicine. 2022 Sep 1; 37(12):3205-3207.
  186. Incze MA, Kelley AT, Gordon AJ. Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment. Journal of general internal medicine. 2022 May 1; 37(7):1771-1773.
  187. Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Drexler K, Hagle H, Molfenter T, Levin FR, Becker WC, Edelman EJ. Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. Journal of addiction medicine. 2022 Sep 1; 16(5):505-513.
  188. Kosakowski S, Benintendi A, Lagisetty P, Larochelle MR, Bohnert ASB, Bazzi AR. Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering. Journal of general internal medicine. 2022 May 1; 37(7):1722-1728.
  189. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Jordan N, Keefer LA, Lambert BL. Opioid-related emergency department visits and hospitalizations among patients with chronic gastrointestinal symptoms and disorders dually enrolled in the Department of Veterans Affairs and Medicare Part D. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022 Jan 5; 79(2):78-93.
  190. Ervin-Sikhondze BA, Moser SE, Pierce J, Dickens JR, Lagisetty PA, Urquhart AG, Hallstrom BR, Brummett CM, McAfee J. Reasons for Preoperative Opioid Use Are Associated with Persistent Use following Surgery Among Patients Undergoing Total Knee and Hip Arthroplasty. Pain medicine (Malden, Mass.). 2022 Jan 3; 23(1):19-28.
  191. Hagedorn HJ, Gustavson AM, Ackland PE, Bangerter A, Bounthavong M, Clothier B, Harris AHS, Kenny ME, Noorbaloochi S, Salameh HA, Gordon AJ. Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities. Journal of general internal medicine. 2022 Nov 1; 37(14):3594-3602.
  192. Frank CJ, Lin LA. Defining and supporting high-quality telehealth for patients with opioid use disorder: The promise and potential pitfalls of telehealth expansion. Substance Abuse. 2022 Jan 1; 43(1):1370-1373.
  193. Hayes CJ, Cucciare MA, Martin BC, Hudson TJ, Bush K, Lo-Ciganic W, Yu H, Charron E, Gordon AJ. Using data science to improve outcomes for persons with opioid use disorder. Substance Abuse. 2022 Jan 1; 43(1):956-963.
  194. Priest KC, King CA, Englander H, Lovejoy TI, McCarty D. Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis. Substance Abuse. 2022 Jan 1; 43(1):1251-1259.
  195. Thakrar AP, Jablonski L, Ratner J, Rastegar DA. Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists. Journal of addiction medicine. 2022 Jan 1; 16(1):122-124.
  196. Edmond SN, Snow JL, Pomeranz J, Van Cleve R, Becker WC. Arguments for and Against a New Diagnostic Entity for Patients With Chronic Pain on Long-Term Opioid Therapy for Whom Harms Outweigh Benefits. The journal of pain. 2022 Jun 1; 23(6):958-966.
  197. Huang LC, Johnson JE, Bleicher J, Blumling AN, Savarise M, Wetter DW, Cohan JN, Harris AAS, Kaphingst KA. Promoting Disposal of Left-Over Opioids After Surgery in Rural Communities: A Qualitative Description Study. Health education & behavior : the official publication of the Society for Public Health Education. 2023 Apr 1; 50(2):281-289.
  198. Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study. Drug and Alcohol Dependence. 2022 Feb 1; 231:109236.
  199. Agbalajobi OM, Gmelin T, Moon AM, Alexandre W, Zhang G, Gellad WF, Jonassaint N, Rogal SS. Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action. PLoS ONE. 2021 Dec 17; 16(12):e0261377.
  200. Bushey MA, Wu J, Outcalt SD, Krebs EE, Ang D, Kline M, Yu Z, Bair MJ. Opioid Use as a Predictor of Pain Outcomes in Iraq and Afghanistan Veterans with Chronic Pain: Analysis of a Randomized Controlled Trial. Pain medicine (Malden, Mass.). 2021 Dec 11; 22(12):2964-2970.
  201. Townsend TN, Bohnert ASB, Merlin JS. Opioid Prescribing to Patients With Advanced Cancer: Unanswered Questions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Jan 20; 40(3):311-312.
  202. Hagan S, Achtmeyer CE, Hood C, Hawkins EJ, Williams EC. Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report. Addiction science & clinical practice. 2021 Dec 3; 16(1):71.
  203. Arnold J, Zhao X, Cashy JP, Sileanu FE, Mor MK, Moyo P, Thorpe CT, Good CB, Radomski TR, Fine MJ, Gellad WF. An Interrupted Time-series Evaluation of the Association Between State Laws Mandating Prescriber Use of Prescription Drug Monitoring Programs and Discontinuation of Chronic Opioid Therapy in US Veterans. Medical care. 2021 Dec 1; 59(12):1042-1050.
  204. Hawkins EJ, Malte CA, Gordon AJ, Williams EC, Hagedorn HJ, Drexler K, Blanchard BE, Burden JL, Knoeppel J, Danner AN, Lott A, Liberto JG, Saxon AJ. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System. JAMA Network Open. 2021 Dec 1; 4(12):e2137238.
  205. Khouja T, Zhou J, Gellad WF, Mitsantisuk K, Hubbard CC, Yan CH, Sharp LK, Calip GS, Evans CT, Suda KJ. Serious opioid-related adverse outcomes associated with opioids prescribed by dentists. Pain. 2022 Aug 1; 163(8):1571-1580.
  206. Bounthavong M, Christopher MLD, Veenstra DL, Basu A, Devine EB. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs. Journal of pharmacy practice. 2023 Jun 1; 36(3):514-522.
  207. Mitra A, Ahsan H, Li W, Liu W, Kerns RD, Tsai J, Becker W, Smelson DA, Yu H. Risk Factors Associated With Nonfatal Opioid Overdose Leading to Intensive Care Unit Admission: A Cross-sectional Study. JMIR medical informatics. 2021 Nov 8; 9(11):e32851.
  208. Beckman KL, Williams EC, Hebert PL, Frost MC, Rubinsky AD, Hawkins EJ, Littman AJ, Lehavot K. Associations Among Military Sexual Trauma, Opioid Use Disorder, and Gender. American journal of preventive medicine. 2022 Mar 1; 62(3):377-386.
  209. Ward R, Weeda E, Taber DJ, Axon RN, Gebregziabher M. Advanced models for improved prediction of opioid-related overdose and suicide events among Veterans using administrative healthcare data. Health services & outcomes research methodology. 2021 Nov 2; 22(2):275-295.
  210. Morasco BJ, Kansagara D. Cannabis as a Substitute for Opioids in Patients with Chronic Pain. The Systematically Testing the Evidence on Marijuana Project [Internet]. 2021 Nov 1: Available from: https://www.cannabisevidence.org/clinician-resources/clinician-briefs/cannabis-as-a-substitute-for-opioids-in-patients-with-chronic-pain/.
  211. Townsend T, Cerdá M, Bohnert A, Lagisetty P, Haffajee RL. CDC Guideline For Opioid Prescribing Associated With Reduced Dispensing To Certain Patients With Chronic Pain. Health affairs (Project Hope). 2021 Nov 1; 40(11):1766-1775.
  212. Huskamp HA, Riedel L, Uscher-Pines L, Busch AB, Barnett ML, Raja P, Mehrotra A. Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act. Journal of general internal medicine. 2022 Jan 1; 37(1):162-167.
  213. Hayes CJ, Krebs EE, Li C, Brown J, Hudson T, Martin BC. Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study. Addiction (Abingdon, England). 2022 Apr 1; 117(4):946-968.
  214. Karlic KJ, Hummel EK, Houchens N, Meddings J. Use of opioids for refractory dyspnoea in hospitalised patients with serious illness: a narrative review. Postgraduate Medical Journal. 2023 May 19; 99(1169):139-144.
  215. Bounthavong M, Suh K, Li M, Spoutz PM, Stottlemyer BA, Sepassi A. Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017. Substance abuse treatment, prevention, and policy. 2021 Oct 20; 16(1):80.
  216. Townsend TN, Salz T, Haffajee RL, Caram MEV, Chino F, Bohnert ASB. Has Declining Opioid Dispensing to Cancer Patients Been Tailored to Risk of Opioid Harms? Journal of pain and symptom management. 2022 Feb 1; 63(2):179-188.
  217. Han BH, Tuazon E, Y Wei M, Paone D. Multimorbidity and Inpatient Utilization Among Older Adults with Opioid Use Disorder in New York City. Journal of general internal medicine. 2022 May 1; 37(7):1634-1640.
  218. Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addiction science & clinical practice. 2021 Oct 11; 16(1):62.
  219. Hatoum AS, Wendt FR, Galimberti M, Polimanti R, Neale B, Kranzler HR, Gelernter J, Edenberg HJ, Agrawal A. Ancestry may confound genetic machine learning: Candidate-gene prediction of opioid use disorder as an example. Drug and Alcohol Dependence. 2021 Dec 1; 229(Pt B):109115.
  220. Fernandez AC, Lin LA, Bazzi AR, Boissoneault J, Borsari B, Blow F. Beliefs About Perioperative Opioid and Alcohol Use among Elective Surgical Patients Who Report Unhealthy Drinking: A Qualitative Study. Pain medicine (Malden, Mass.). 2021 Oct 8; 22(10):2384-2392.
  221. Sowicz TJ, Hausmann LRM. Veterans' Experiences of an Opioid Specialty Clinic. Pain medicine (Malden, Mass.). 2021 Oct 8; 22(10):2242-2251.
  222. Timko C, Kroenke K, Nevedal A, Lor MC, Oliva E, Drexler K, Sandbrink F, Hoggatt K. Development and field testing of primary care screening tools for harms of long-term opioid therapy continuation and tapering to discontinuation: a study protocol. BMJ open. 2021 Oct 7; 11(10):e053524.
  223. Tobin DG, Lockwood MB, Kimmel PL, Dember LM, Eneanya ND, Jhamb M, Nolin TD, Becker WC, Fischer MJ, HOPE Consortium. Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nature reviews. Nephrology. 2022 Feb 1; 18(2):113-128.
  224. Essien UR, Ifidon A, Sue KL. Black Pain Matters: Prioritizing Antiracism and Equity in the Opioid Epidemic. [Editorial]. Journal of hospital medicine. 2021 Oct 1; 16(10):638-639.
  225. Spelman JF, Edens EL, Maya S, Moore BA, Boggs A, MacLean RR, Ackland P, Becker WC, Lynch D, Garcia-Vassallo M, Burgo AL, Rosen MI, Gordon AJ. A Facility-Wide Plan to Increase Access to Medication for Opioid Use Disorder in Primary Care and General Mental Health Settings. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2021 Oct 1; 38(10):460-464.
  226. Taylor EN, Timko C, Binswanger IA, Harris AHS, Stimmel M, Smelson D, Finlay AK. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Substance Abuse. 2021 Sep 29; 43(1):556-563.
  227. Ward R, Tang YL, Axon RN, Casarella J, Whitfield N, Rauch SAM. Effectiveness of a substance use treatment program for veterans with chronic pain and opioid use disorder. Journal of substance abuse treatment. 2022 Jan 1; 132:108635.
  228. Cochran G, Brown J, Yu Z, Frede S, Bryan MA, Ferguson A, Bayyari N, Taylor B, Snyder ME, Charron E, Adeoye-Olatunde OA, Ghitza UE, Winhusen T. Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test. Drug and Alcohol Dependence. 2021 Nov 1; 228:109067.
  229. Kiang MV, Barnett ML, Wakeman SE, Humphreys K, Tsai AC. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States. Drug and Alcohol Dependence. 2021 Nov 1; 228:109081.
  230. Magel J, Kietrys D, Kruger ES, Fritz JM, Gordon AJ. Physical therapists should play a greater role in managing patients with opioid use and opioid misuse. Substance Abuse. 2021 Sep 15; 42(3):255-260.
  231. Finlay AK, Palframan KM, Stimmel M, McCarthy JF. Legal System Involvement and Opioid-Related Overdose Mortality in U.S. Department of Veterans Affairs Patients. American journal of preventive medicine. 2022 Jan 1; 62(1):e29-e37.
  232. Quinlan TAG, Roberts AW, Frank JW, Whittington MD. Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use. Health services research. 2021 Dec 1; 56(6):1233-1244.
  233. Wyse JJ, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Kennedy AJ, Oldfield BJ, Gaither JR, Gordon KS, Skanderson M, Barry DT, Bryant K, Crystal S, Justice AC, Kraemer KL. Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV. AIDS and behavior. 2022 Mar 1; 26(3):975-985.
  234. Hawkins EJ, Danner AN, Malte CA, Blanchard BE, Williams EC, Hagedorn HJ, Gordon AJ, Drexler K, Burden JL, Knoeppel J, Lott A, Sayre GG, Midboe AM, Saxon AJ. Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities. Addiction science & clinical practice. 2021 Sep 6; 16(1):55.
  235. Ashraf AJ, Gilbert TA, Holmer HK, Cook LJ, Carlson KF. Receipt of Concurrent VA and Non-VA Opioid and Sedative-Hypnotic Prescriptions Among Post-9/11 Veterans With Traumatic Brain Injury. The Journal of head trauma rehabilitation. 2021 Sep 1; 36(5):364-373.
  236. Gold LS, Marcum ZA, Meier EN, Turner JA, James KT, Kallmes DF, Luetmer PH, Griffith B, Sherman KJ, Friedly JL, Suri P, Deyo RA, Johnston SK, Avins AL, Heagerty PJ, Jarvik JG. Patient, Provider, and Clinic Characteristics Associated with Opioid and Non-Opioid Pain Prescriptions for Patients Receiving Low Back Imaging in Primary Care. Journal of the American Board of Family Medicine : JABFM. 2021 Sep 1; 34(5):950-963.
  237. Holmer HK, Gilbert TA, Ashraf AJ, O'Neil ME, Carlson KF. Opioid and Sedative-Hypnotic Prescriptions Among Post-9/11 Veteran VA Users Nationwide With Traumatic Brain Injury, 2012-2020. The Journal of head trauma rehabilitation. 2021 Sep 1; 36(5):354-363.
  238. Kelley AT, Dungan MT, Gordon AJ. Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19. Journal of addiction medicine. 2021 Sep 1; 15(5):439-440.
  239. Ly DP. Association of Patient Race and Ethnicity With Differences in Opioid Prescribing by Primary Care Physicians for Older Adults With New Low Back Pain. JAMA health forum. 2021 Sep 1; 2(9):e212333.
  240. Powell VD, Rosenberg JM, Yaganti A, Garpestad C, Lagisetty P, Shannon C, Silveira MJ. Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review. JAMA Network Open. 2021 Sep 1; 4(9):e2124152.
  241. Baker JF, Stokes A, Pedro S, Mikuls TR, George M, England BR, Sayles H, Wolfe F, Michaud K. Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis. Arthritis care & research. 2021 Oct 1; 73(10):1405-1412.
  242. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Keefer LA, Jordan N. Characteristics of Opioid Prescriptions to Veterans With Chronic Gastrointestinal Symptoms and Disorders Dually Enrolled in the Department of Veterans Affairs and Medicare Part D. Military medicine. 2021 Aug 28; 186(9-10):943-950.
  243. Lei L, Bynum JP, Maust DT. Opioid and CNS-Depressant Medication Prescribing among Older Adults Enrolled in Medicare Advantage Versus Fee-for-Service Medicare. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2022 Feb 1; 30(2):249-255.
  244. Riedel L, Uscher-Pines L, Mehrotra A, Busch AB, Barnett ML, Raja P, Huskamp HA. Use of telemedicine for opioid use disorder treatment - Perceptions and experiences of opioid use disorder clinicians. Drug and Alcohol Dependence. 2021 Nov 1; 228:108999.
  245. Goree JH, Srinivasan N, Cucciare MA, Zaller N, Byers L, Boateng B, Hayes CJ. Video-Based, Patient-Focused Opioid Education in the Perioperative Period Increases Self-Perceived Opioid-Related Knowledge: A Pilot Study. Journal of pain research. 2021 Aug 24; 14:2583-2592.
  246. Chow SL, Sasson C, Benjamin IJ, Califf RM, Compton WM, Oliva EM, Robson C, Sanchez EJ. Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association. Circulation. 2021 Sep 28; 144(13):e218-e232.
  247. Larochelle MR, Cruz R, Kosakowski S, Gourlay DL, Alford DP, Xuan Z, Krebs EE, Yan S, Lasser KE, Samet JH, Liebschutz JM. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain? Journal of general internal medicine. 2022 Aug 1; 37(10):2365-2372.
  248. Brown-Taylor L, Beckner A, Scaff KE, Fritz JM, Buys MJ, Patel S, Bayless K, Brooke BS. Relationships between physical therapy intervention and opioid use: A scoping review. PM & R : the journal of injury, function, and rehabilitation. 2022 Jul 1; 14(7):837-854.
  249. Blevins D, Henry BF, Sung M, Edelman EJ, Black AC, Dawes M, Molfenter T, Hagle H, Drexler K, Cates-Wessel K, Levin FR. Well-Being of Health Care Professionals Treating Opioid Use Disorder During the COVID-19 Pandemic: Results From a National Survey. Psychiatric services (Washington, D.C.). 2022 Apr 1; 73(4):374-380.
  250. Evans CT, Fitzpatrick MA, Poggensee L, Gonzalez B, Gibson G, Jurasic MM, Echevarria K, McGregor JC, Cunningham F, Gellad WF, Suda KJ. Outpatient Prescribing of Antibiotics and Opioids by Veterans Health Administration Providers, 2015-2017. American journal of preventive medicine. 2021 Nov 1; 61(5):e235-e244.
  251. Gustavson AM, Kenny ME, Wisdom JP, Salameh HA, Ackland PE, Gordon AJ, Hagedorn HJ. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention. Addiction science & clinical practice. 2021 Aug 6; 16(1):51.
  252. Larochelle M, Lagisetty PA, Bohnert ASB. Opioid Tapering Practices-Time for Reconsideration? [Editorial]. JAMA. 2021 Aug 3; 326(5):388-389.
  253. Bonar EE, Kidwell KM, Bohnert ASB, Bourque CA, Carter PM, Clark SJ, Glantz MD, King CA, Losman ED, McCabe SE, Philyaw-Kotov ML, Prosser LA, Voepel-Lewis T, Zheng K, Walton MA. Optimizing scalable, technology-supported behavioral interventions to prevent opioid misuse among adolescents and young adults in the emergency department: A randomized controlled trial protocol. Contemporary clinical trials. 2021 Sep 1; 108:106523.
  254. Chua KP, Brummett CM, Ng S, Bohnert ASB. Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk. JAMA Network Open. 2021 Aug 2; 4(8):e2120353.
  255. Magaletta PR, Morasco BJ. Perspectives on opioid misuse from public service psychology: An introduction. Psychological Services. 2021 Aug 1; 18(3):285-286.
  256. Wehler CJ, Panchal NH, Cotchery DL, Farooqi OA, Ferguson DK, Foran D, Hakki OW, Silva R, Smith GM, Gibson G. Alternatives to opioids for acute pain management after dental procedures: A Department of Veterans Affairs consensus paper. Journal of the American Dental Association (1939). 2021 Aug 1; 152(8):641-652.
  257. Rao IJ, Humphreys K, Brandeau ML. Effectiveness of Policies for Addressing the US Opioid Epidemic: A Model-Based Analysis from the Stanford-Lancet Commission on the North American Opioid Crisis. Lancet Regional Health. Americas. 2021 Nov 1; 3.
  258. Andrea SB, Gilbert TA, Morasco BJ, Saha S, Carlson KF. Factors Related to Prescription Drug Monitoring Program Queries for Veterans Receiving Long-Term Opioid Therapy. Pain medicine (Malden, Mass.). 2021 Jul 25; 22(7):1548-1558.
  259. Hawkins EJ, Lott AM, Danner AN, Malte CA, Hagedorn HJ, Berger D, Donovan LM, Sayre GG, Mariano AJ, Saxon AJ. Primary Care and Mental Health Prescribers, Key Clinical Leaders, and Clinical Pharmacist Specialists' Perspectives on Opioids and Benzodiazepines. Pain medicine (Malden, Mass.). 2021 Jul 25; 22(7):1559-1569.
  260. Medicaid Outcomes Distributed Research Network (MODRN) , Donohue JM, Jarlenski MP, Kim JY, Tang L, Ahrens K, Allen L, Austin A, Barnes AJ, Burns M, Chang CH, Clark S, Cole E, Crane D, Cunningham P, Idala D, Junker S, Lanier P, Mauk R, McDuffie MJ, Mohamoud S, Pauly N, Sheets L, Talbert J, Zivin K, Gordon AJ, Kennedy S. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018. JAMA. 2021 Jul 13; 326(2):154-164.
  261. Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, Goldhaber-Fiebert JD, Asch SM, Brandeau ML, Owens DK. Cost-effectiveness of Treatments for Opioid Use Disorder. JAMA psychiatry. 2021 Jul 1; 78(7):767-777.
  262. Goldstick JE, Guy GP, Losby JL, Baldwin G, Myers M, Bohnert ASB. Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain. JAMA Network Open. 2021 Jul 1; 4(7):e2116860.
  263. Rogal S, Youk A, Agbalajobi O, Zhang H, Gellad W, Fine MJ, Belperio P, Morgan T, Good CB, Kraemer K. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. The American journal of gastroenterology. 2021 Jul 1; 116(7):1406-1413.
  264. Becker WC, Li Y, Caniglia EC, Vickers-Smith R, Feinberg T, Marshall BDL, Edelman EJ. Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study. AIDS Care. 2022 Apr 1; 34(4):469-477.
  265. Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study. The journal of pain. 2021 Dec 1; 22(12):1709-1721.
  266. Kelley AT, Smid MC, Baylis JD, Charron E, Binns-Calvey AE, Archer S, Weiner SJ, Begaye LJ, Cochran G. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addiction science & clinical practice. 2021 Jun 25; 16(1):40.
  267. Khouja T, Tadrous M, Matusiak L, Suda K. Opioid Prescribing in United States Health Systems, 2015 to 2019. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2021 Sep 1; 24(9):1279-1284.
  268. Giannitrapani KF, Brown-Johnson C, McCaa M, Mckelvey J, Glassman P, Holliday J, Sandbrink F, Lorenz KA. Opportunities for improving opioid disposal practices in the Veterans Health Administration. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021 Jun 23; 78(13):1216-1222.
  269. Hayes CJ, Gressler LE, Hu B, Jones BL, Williams JS, Martin BC. Trajectories of Opioid Coverage After Long-Term Opioid Therapy Initiation Among a National Cohort of US Veterans. Journal of pain research. 2021 Jun 14; 14:1745-1762.
  270. Oldfield BJ, Li Y, Vickers-Smith R, Becker WC, Barry DT, Crystal S, Gordon KS, Kerns RD, Rentsch CT, Marshall BDL, Edelman EJ. Sociodemographic and clinical correlates of gabapentin receipt with and without opioids among a national cohort of patients with HIV. AIDS Care. 2022 Aug 1; 34(8):1053-1063.
  271. Ching JH, Owens DK, Trafton JA, Goldhaber-Fiebert JD, Salomon JA. Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration. Addiction (Abingdon, England). 2021 Dec 1; 116(12):3494-3503.
  272. Teeter BS, Thannisch MM, Martin B, Zaller ND, Jones D, Mosley CL, Curran GM. Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study. Exploratory Research in Clinical and Social Pharmacy. 2021 Jun 1; 2:doi.org/10.1016/j.rcsop.2021.100019.
  273. Kennedy AJ, McGinnis KA, Merlin JS, Edelman EJ, Gordon AJ, Korthuis PT, Skanderson M, Williams EC, Wyse J, Oldfield B, Bryant K, Justice A, Fiellin DA, Kraemer KL. Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. Journal of substance abuse treatment. 2022 Jan 1; 132:108509.
  274. Lin LA, Fortney JC, Bohnert ASB, Coughlin LN, Zhang L, Piette JD. Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder. Journal of substance abuse treatment. 2022 Feb 1; 133:108492.
  275. Kasman AM, Schmidt B, Spradling K, Chow C, Hunt R, Wu M, Sockol A, Liao J, Leppert JT, Shah J, Conti SL. Postoperative opioid-free ureteroscopy discharge: A quality initiative pilot protocol. Current urology. 2021 Sep 1; 15(3):176-180.
  276. Bushey MA, Slaven J, Outcalt SD, Kroenke K, Kempf C, Froman A, Sargent C, Baecher B, Zillich A, Damush TM, Saha C, French DD, Bair MJ. Design and methods of the Care Management for the Effective Use of Opioids (CAMEO) trial. Contemporary clinical trials. 2021 Jul 1; 106:106456.
  277. Vakkalanka P, Lund BC, Arndt S, Field W, Charlton M, Ward MM, Carnahan RM. Association Between Buprenorphine for Opioid Use Disorder and Mortality Risk. American journal of preventive medicine. 2021 Sep 1; 61(3):418-427.
  278. Robles M, Mortazavi L, Vannerson J, Matthias MS. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder. Teaching and learning in medicine. 2021 May 11; 34(5):514-521.
  279. Chen J, Cabudol M, Williams EC, Merrill JO, Tsui JI, Klein JW. Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care. Journal of substance abuse treatment. 2021 Jul 1; 126:108463.
  280. Muzzio K, Chandler M, Painter JT, Dragic L. Characterizing Patients after Opioid Taper in a VA Medical Center. Journal of Pain & Palliative Care Pharmacotherapy. 2021 Jun 1; 35(2):84-90.
  281. Giannitrapani KF, Silveira MJ, Azarfar A, Glassman PA, Singer SJ, Asch SM, Midboe AM, Zenoni MA, Gamboa RC, Becker WC, Lorenz KA. Cross Disciplinary Role Agreement is Needed When Coordinating Long-Term Opioid Prescribing for Cancer: a Qualitative Study. Journal of general internal medicine. 2021 Jul 1; 36(7):1867-1874.
  282. Udayachalerm S, Bair MJ, Illingworth Plake KS, Huang CY, Murray MD, Foster DR. Opioid prescribing and health outcomes in opioid-naive patients: Analysis of a statewide health information exchange. Journal of the American Pharmacists Association : JAPhA. 2021 Sep 1; 61(5):623-631.e3.
  283. Brown CR, Groeneveld P, Desai N. Persistent Opioid Use May Be a Failure of Pain Management Rather Than Prescribing-Reply. JAMA cardiology. 2021 May 1; 6(5):602-603.
  284. Lagisetty P, Macleod C, Thomas J, Slat S, Kehne A, Heisler M, Bohnert ASB, Bohnert KM. Assessing reasons for decreased primary care access for individuals on prescribed opioids: an audit study. Pain. 2021 May 1; 162(5):1379-1386.
  285. Lo GH. Is There a Place for Opioids in Treating Osteoarthritis?. The Journal of rheumatology. 2021 Dec 1; 48(12):1774-1775.
  286. Moore MN, Wallace BI. Glucocorticoid and opioid use in rheumatoid arthritis management. Current opinion in rheumatology. 2021 May 1; 33(3):277-283.
  287. Slat S, Yaganti A, Thomas J, Helminski D, Heisler M, Bohnert A, Lagisetty P. Opioid Policy and Chronic Pain Treatment Access Experiences: A Multi-Stakeholder Qualitative Analysis and Conceptual Model. Journal of pain research. 2021 Apr 27; 14:1161-1169.
  288. Finlay AK, Harris AHS, Timko C, Yu M, Smelson D, Stimmel M, Binswanger IA. Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2021 Apr 1; 15(2):143-149.
  289. Jasuja GK, Bettano A, Smelson D, Bernson D, Rose AJ, Byrne T, Berlowitz DR, McCullough MB, Miller DR. Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts. Medical care. 2021 Apr 1; 59(Suppl 2):S165-S169.
  290. Bryson WC, Morasco BJ, Cotton BP, Thielke SM. Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment. Substance use & misuse. 2021 Mar 22; 56(5):697-703.
  291. Polusny MA, Hintz S, Mallen M, Thuras P, Krebs EE, Erbes CR, Arbisi PA. Pre-deployment personality traits predict prescription opioid receipt over 2-year post-deployment period in a longitudinal cohort of deployed National Guard soldiers. Addictive Behaviors. 2021 Aug 1; 119:106919.
  292. Hubbard CC, Evans CT, Calip GS, Rowan SA, Gellad WF, Campbell A, Gross AE, Hershow RC, McGregor JC, Sharp LK, Suda KJ. Characteristics Associated With Opioid and Antibiotic Prescribing by Dentists. American journal of preventive medicine. 2021 May 1; 60(5):648-657.
  293. Benintendi A, Kosakowski S, Lagisetty P, Larochelle M, Bohnert ASB, Bazzi AR. "I felt like I had a scarlet letter": Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain. Drug and Alcohol Dependence. 2021 May 1; 222:108664.
  294. Ganguly AP, Lira MC, Lodi S, Forman LS, Colasanti JA, Williams EC, Liebschutz JM, Del Rio C, Samet JH, Tsui JI. Race and satisfaction with pain management among patients with HIV receiving long-term opioid therapy. Drug and Alcohol Dependence. 2021 May 1; 222:108662.
  295. Lo-Ciganic WH, Donohue JM, Hulsey EG, Barnes S, Li Y, Kuza CC, Yang Q, Buchanich J, Huang JL, Mair C, Wilson DL, Gellad WF. Integrating human services and criminal justice data with claims data to predict risk of opioid overdose among Medicaid beneficiaries: A machine-learning approach. PLoS ONE. 2021 Mar 18; 16(3):e0248360.
  296. Dezfulian C, Orkin AM, Maron BA, Elmer J, Girotra S, Gladwin MT, Merchant RM, Panchal AR, Perman SM, Starks MA, van Diepen S, Lavonas EJ, American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Council on Clinical Cardiology. Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association. Circulation. 2021 Apr 20; 143(16):e836-e870.
  297. Gerlach LB, Kales HC, Kim HM, Zhang L, Strominger J, Covinsky K, Teno J, Bynum JPW, Maust DT. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016. Journal of the American Geriatrics Society. 2021 Jun 1; 69(6):1479-1489.
  298. Morse E, Binswanger IA, Taylor E, Gray C, Stimmel M, Timko C, Harris AHS, Smelson D, Finlay AK. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. Journal of substance abuse treatment. 2021 Oct 1; 129:108353.
  299. Sherva R, Zhu C, Wetherill L, Edenberg HJ, Johnson E, Degenhardt L, Agrawal A, Martin NG, Nelson E, Kranzler HR, Gelernter J, Farrer LA. Genome-wide association study of phenotypes measuring progression from first cocaine or opioid use to dependence reveals novel risk genes. Exploration of medicine. 2021 Feb 28; 2:60-73.
  300. Harris RA, Mandell DS, Kampman KM, Bao Y, Campbell K, Cidav Z, Coviello DM, French R, Livesey C, Lowenstein M, Lynch KG, McKay JR, Oslin DW, Wolk CB, Bogner HR. Collaborative care in the treatment of opioid use disorder and mental health conditions in primary care: A clinical study protocol. Contemporary clinical trials. 2021 Apr 1; 103:106325.
  301. Spencer NE, Taubenberger SP, Roberto R, Krishnamurti LS, Chang JC, Hacker K. "Stories of starting": Understanding the complex contexts of opioid misuse initiation. Substance Abuse. 2021 Feb 22; 1-16.
  302. Cole ES, Drake C, DiDomenico E, Sharbaugh M, Kim JY, Nagy D, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kmiec J, Kelley D, Donohue JM. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population. Drug and Alcohol Dependence. 2021 Apr 1; 221:108633.
  303. Gustavson AM, Wisdom JP, Kenny ME, Salameh HA, Ackland PE, Clothier B, Noorbaloochi S, Gordon AJ, Hagedorn HJ. Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration. Implementation science communications. 2021 Feb 15; 2(1):20.
  304. Watson DP, Weathers T, McGuire A, Cohen A, Huynh P, Bowes C, O'Donnell D, Brucker K, Gupta S. Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes. Drug and Alcohol Dependence. 2021 Apr 1; 221:108595.
  305. Lagisetty P, Garpestad C, Larkin A, Macleod C, Antoku D, Slat S, Thomas J, Powell V, Bohnert ASB, Lin LA. Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug and Alcohol Dependence. 2021 Apr 1; 221:108583.
  306. Titan A, Doyle A, Pfaff K, Baiu I, Lee A, Graham L, Shelton A, Hawn M. Impact of policy-based and institutional interventions on postoperative opioid prescribing practices. American journal of surgery. 2021 Oct 1; 222(4):766-772.
  307. Adams JW, Li Y, Barry DT, Gordon KS, Kerns RD, Oldfield BJ, Rentsch CT, Marshall BDL, Edelman EJ. Long-term Patterns of Self-reported Opioid Use, VACS Index, and Mortality Among People with HIV Engaged in Care. AIDS and behavior. 2021 Sep 1; 25(9):2951-2962.
  308. DeRonne BM, Wong KR, Schultz E, Jones E, Krebs EE. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021 Feb 8; 78(4):354-359.
  309. Marcum ZA, Gold LS, James KT, Meier EN, Turner JA, Kallmes DF, Cherkin DC, Deyo RA, Sherman KJ, Luetmer PH, Avins AL, Griffith B, Friedly JL, Suri P, Heagerty PJ, Jarvik JG. Effects of Including Epidemiologic Data in Lumbar Spine Imaging Reports on Prescribing Non-Opioid Medications for Pain. Journal of general internal medicine. 2021 Aug 1; 36(8):2237-2243.
  310. Incze MA, Kelley AT, Gordon AJ. Improving Opioid Use Disorder Treatment through Quality Assessment. Journal of general internal medicine. 2021 Sep 1; 36(9):2820-2822.
  311. Giannitrapani KF, Fereydooni S, Silveira MJ, Azarfar A, Glassman PA, Midboe A, Zenoni M, Becker WC, Lorenz KA. How Patients and Providers Weigh the Risks and Benefits of Long-Term Opioid Therapy for Cancer Pain. JCO oncology practice. 2021 Jul 1; 17(7):e1038-e1047.
  312. Gadd S, Cox N, Samuelson J, Kenney A, Turner K, Cochran G. Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective. Therapeutic Drug Monitoring. 2021 Feb 1; 43(1):35-41.
  313. Borsari B, Li Y, Tighe J, Manuel JK, Gökbayrak NS, Delucchi K, Morasco BJ, Abadjian L, Cohen BE, Baxley C, Seal KH. A pilot trial of collaborative care with motivational interviewing to reduce opioid risk and improve chronic pain management. Addiction (Abingdon, England). 2021 Sep 1; 116(9):2387-2397.
  314. Guo J, Lo-Ciganic WH, Yang Q, Huang JL, Weiss JC, Cochran G, Malone DC, Kuza CC, Gordon AJ, Donohue JM, Gellad WF. Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose. Journal of general internal medicine. 2021 Apr 1; 36(4):908-915.
  315. Vina ER, Quinones C, Hausmann LRM, Ibrahim SA, Kwoh CK. Association of Patients' Familiarity and Perceptions of Efficacy and Risks With the Use of Opioid Medications in the Management of Osteoarthritis. The Journal of rheumatology. 2021 Dec 1; 48(12):1863-1870.
  316. Bohnert ASB, Lin LA. It is time to recognize that synthetic opioids are not going away. Addiction (Abingdon, England). 2021 Jun 1; 116(6):1316-1317.
  317. Becker WC, Heimer R, Dormitzer CM, Doernberg M, D'Onofrio G, Grau LE, Hawk K, Lin HJ, Secora AM, Fiellin DA. Merging statewide data in a public/university collaboration to address opioid use disorder and overdose. Addiction science & clinical practice. 2021 Jan 4; 16(1):1.
  318. Baum LVM, Bruzelius E, Kiang MV, Humphreys K, Basu S, Baum A. Analysis of unused prescription opioids and benzodiazepines remaining after death among Medicare decedents. Drug and Alcohol Dependence. 2021 Feb 1; 219:108502.
  319. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Jordan N, Keefer LA. High-Dose Opioid Use Among Veterans with Unexplained Gastrointestinal Symptoms Versus Structural Gastrointestinal Diagnoses. Digestive diseases and sciences. 2021 Nov 1; 66(11):3938-3950.
  320. Brintz CE, Cheatle MD, Dember LM, Heapy AA, Jhamb M, Shallcross AJ, Steel JL, Kimmel PL, Cukor D, HOPE Consortium. Nonpharmacologic Treatments for Opioid Reduction in Patients With Advanced Chronic Kidney Disease. Seminars in Nephrology. 2021 Jan 1; 41(1):68-81.
  321. Cron DC, Tincopa MA, Lee JS, Waljee AK, Hammoud A, Brummett CM, Waljee JF, Englesbe MJ, Sonnenday CJ. Prevalence and Patterns of Opioid Use Before and After Liver Transplantation. Transplantation. 2021 Jan 1; 105(1):100-107.
  322. Khatri UG, Aronowitz SV. Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment. Journal of substance abuse treatment. 2021 Apr 1; 123:108258.
  323. Becker WC, Humphreys K, Atkins D, Clancy CM. Mounting a Scientifically Informed Response to the Opioid Crisis in the Veterans Health Administration. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):883-885.
  324. Fodeh SJ, Al-Garadi M, Elsankary O, Perrone J, Becker W, Sarker A. Utilizing a multi-class classification approach to detect therapeutic and recreational misuse of opioids on Twitter. Computers in biology and medicine. 2021 Feb 1; 129:104132.
  325. Maciejewski ML, Zepel L, Hale SL, Wang V, Diamantidis CJ, Blaz JW, Olin S, Wilson-Frederick SM, James CV, Smith VA. Opioid Prescribing in the 2016 Medicare Fee-for-Service Population. Journal of the American Geriatrics Society. 2021 Feb 1; 69(2):485-493.
  326. Rhee TG, Maust DT, Fiellin DA, Olfson M. Trends in Co-Prescribing of Opioids and Opioid Potentiators Among U.S. Adults, 2007-2018. American journal of preventive medicine. 2021 Mar 1; 60(3):434-437.
  327. Howell BA, Abel EA, Park D, Edmond SN, Leisch LJ, Becker WC. Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study. Journal of general internal medicine. 2021 May 1; 36(5):1264-1270.
  328. Manhapra A, Sullivan MD, Ballantyne JC, MacLean RR, Becker WC. Complex Persistent Opioid Dependence with Long-term Opioids: a Gray Area That Needs Definition, Better Understanding, Treatment Guidance, and Policy Changes. [Editorial]. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):964-971.
  329. Becker WC, Krebs EE, Edmond SN, Lin LA, Sullivan MD, Weiss RD, Gordon AJ. A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):978-982.
  330. Chang ET, Oberman RS, Cohen AN, Taylor SL, Gumm E, Mardian AS, Toy S, Revote A, Lewkowitz B, Yano EM. Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):918-926.
  331. Frank JW, Bohnert ASB, Sandbrink F, McGuire M, Drexler K. Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):983-987.
  332. Frank JW, Carey E, Nolan C, Hale A, Nugent S, Krebs EE. Association Between Opioid Dose Reduction Against Patients' Wishes and Change in Pain Severity. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):910-917.
  333. Kertesz SG, McCullough MB, Darnall BD, Varley AL. Promoting Patient-Centeredness in Opioid Deprescribing: a Blueprint for De-implementation Science. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):972-977.
  334. Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):935-944.
  335. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):954-963.
  336. Minegishi T, Garrido MM, Stein M, Oliva EM, Frakt AB. Opioid Discontinuation Among Patients Receiving High-Dose Long-Term Opioid Therapy in the Veterans Health Administration. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):903-909.
  337. Morasco BJ, Smith N, Dobscha SK, Deyo RA, Hyde S, Yarborough BJ. Prospective Investigation of Factors Associated with Prescription Opioid Dose Escalation among Patients in Integrated Health Systems. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):895-902.
  338. Priest KC, McCarty D, Lovejoy TI. Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):886-890.
  339. Veazie S, Mackey K, Peterson K, Bourne D. Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):945-953.
  340. Lipkin JS, Thorpe JM, Gellad WF, Hanlon JT, Zhao X, Thorpe CT, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Good CB, Fine MJ, Hausmann LRM. Identifying sociodemographic profiles of veterans at risk for high-dose opioid prescribing using classification and regression trees. Journal of opioid management. 2020 Nov 1; 16(6):409-424.
  341. Hah JM, Trafton JA, Narasimhan B, Krishnamurthy P, Hilmoe H, Sharifzadeh Y, Huddleston JI, Amanatullah D, Maloney WJ, Goodman S, Carroll I, Mackey SC. Efficacy of motivational-interviewing and guided opioid tapering support for patients undergoing orthopedic surgery (MI-Opioid Taper): A prospective, assessor-blind, randomized controlled pilot trial. EClinicalMedicine. 2020 Nov 1; 28:100596.
  342. Koffel E, DeRonne B, Hawkins EJ. Co-prescribing of Opioids with Benzodiazepines and Other Hypnotics for Chronic Pain and Insomnia: Trends and Health Outcomes. Pain medicine (Malden, Mass.). 2020 Oct 1; 21(10):2055-2059.
  343. Mazurenko O, Blackburn J, Bair MJ, Kara AY, Harle CA. Receipt of opioids and patient care experiences among nonsurgical hospitalized adults. Health services research. 2020 Oct 1; 55(5):651-659.
  344. Zhou H, Rentsch CT, Cheng Z, Kember RL, Nunez YZ, Sherva RM, Tate JP, Dao C, Xu K, Polimanti R, Farrer LA, Justice AC, Kranzler HR, Gelernter J, Veterans Affairs Million Veteran Program. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. JAMA psychiatry. 2020 Oct 1; 77(10):1072-1080.
  345. Gordon KS, Manhapra A, Crystal S, Dziura J, Edelman EJ, Skanderson M, Kerns RD, Justice AC, Tate J, Becker WC. All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors. Drug and Alcohol Dependence. 2020 Nov 1; 216:108291.
  346. Gustavson AM, Gordon AJ, Kenny ME, McHenry H, Gronek J, Ackland PE, Hagedorn HJ. Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder. Substance Abuse. 2020 Sep 16; 41(4):413-418.
  347. Rogal SS. Opioid Avoidance After Liver Transplantation: The Ever-Shifting Pain Management Paradigm. [Editorial]. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2020 Oct 1; 26(10):1221-1223.
  348. Steffens C, Sung M, Bastian LA, Edelman EJ, Brackett A, Gunderson CG. The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis. Journal of general internal medicine. 2020 Nov 1; 35(11):3315-3322.
  349. Zhou J, Calip GS, Rowan S, McGregor JC, Perez RI, Evans CT, Gellad WF, Suda KJ. Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data. Pharmacotherapy. 2020 Oct 1; 40(10):992-1001.
  350. Chen K, Yaggi HK, Fiellin DA, DeRycke EC, Athar W, Haskell S, Bastian LA. Associations between obstructive sleep apnea and prescribed opioids among veterans. Pain. 2020 Sep 1; 161(9):2035-2040.
  351. Giannitrapani KF, Ackland PE, Holliday J, Zeliadt S, Olson J, Kligler B, Taylor SL. Provider Perspectives of Battlefield Acupuncture: Advantages, Disadvantages and Its Potential Role in Reducing Opioid Use for Pain. Medical care. 2020 Sep 1; 58 Suppl 2 9S:S88-S93.
  352. Gibson CJ, Grasso J, Li Y, Purcell N, Tighe J, Zamora K, Nicosia F, Seal KH. An Integrated Pain Team Model: Impact on Pain-Related Outcomes and Opioid Misuse in Patients with Chronic Pain. Pain medicine (Malden, Mass.). 2020 Sep 1; 21(9):1977-1984.
  353. Goldsmith ES, MacLehose RF, Jensen AC, Clothier B, Noorbaloochi S, Martinson BC, Donaldson MT, Krebs EE. Complementary, Integrative, and Nondrug Therapy Use for Pain Among US Military Veterans on Long-term Opioids. Medical care. 2020 Sep 1; 58 Suppl 2 9S:S116-S124.
  354. Hirsh AT, Anastas TM, Miller MM, Quinn PD, Kroenke K. Patient race and opioid misuse history influence provider risk perceptions for future opioid-related problems. The American Psychologist. 2020 Sep 1; 75(6):784-795.
  355. Lobo CP, Cochran G, Chang CH, Gellad WF, Gordon AJ, Jalal H, Lo-Ciganic WH, Karp JF, Kelley D, Donohue JM. Associations Between the Specialty of Opioid Prescribers and Opioid Addiction, Misuse, and Overdose Outcomes. Pain medicine (Malden, Mass.). 2020 Sep 1; 21(9):1871-1890.
  356. Oldfield BJ, Becker WC. Improving Guideline Adherence for Opioid Prescribing in Community Health Centers. [Editorial]. Pain medicine (Malden, Mass.). 2020 Sep 1; 21(9):1739-1741.
  357. Wilson AC, Morasco BJ, Holley AL, Feldstein Ewing SW. Patterns of opioid use in adolescents receiving prescriptions: The role of psychological and pain factors. The American Psychologist. 2020 Sep 1; 75(6):748-760.
  358. Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett M, Huskamp HA. Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine. Journal of substance abuse treatment. 2020 Nov 1; 118:108124.
  359. Buys MJ, Bayless K, Romesser J, Anderson Z, Patel S, Zhang C, Presson AP, Brooke BS. Opioid use among veterans undergoing major joint surgery managed by a multidisciplinary transitional pain service. Regional Anesthesia and Pain Medicine. 2020 Nov 1; 45(11):847-852.
  360. Bokhour BG, Gelman H, Gaj L, Thomas E, Barker A, Whittington M, Douglas J, DeFaccio R, Taylor S, Zeliadt S. Addressing Consumer and Patients' Preferences and Needs Whole Health System of Care Improves Health and Well-Being and Reduces Opioid Use for Veterans with Chronic Pain. [Abstract]. Health services research. 2020 Aug 20; 55(51):7-8.
  361. Maust DT, Strominger J, Bynum JPW, Langa KM, Gerlach LB, Zivin K, Marcus SC. Prevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US. JAMA. 2020 Aug 18; 324(7):706-708.
  362. Brown CR, Chen Z, Khurshan F, Groeneveld PW, Desai ND. Development of Persistent Opioid Use After Cardiac Surgery. JAMA cardiology. 2020 Aug 1; 5(8):889-896.
  363. Chan B, Freeman M, Ayers C, Korthuis PT, Paynter R, Kondo K, Kansagara D. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders. Drug and Alcohol Dependence. 2020 Nov 1; 216:108193.
  364. Darnall BD, Mackey SC, Lorig K, Kao MC, Mardian A, Stieg R, Porter J, DeBruyne K, Murphy J, Perez L, Okvat H, Tian L, Flood P, McGovern M, Colloca L, King H, Van Dorsten B, Pun T, Cheung M. Comparative Effectiveness of Cognitive Behavioral Therapy for Chronic Pain and Chronic Pain Self-Management within the Context of Voluntary Patient-Centered Prescription Opioid Tapering: The EMPOWER Study Protocol. Pain medicine (Malden, Mass.). 2020 Aug 1; 21(8):1523-1531.
  365. Lagisetty P, Bohnert A, Goesling J, Hu HM, Travis B, Lagisetty K, Brummett CM, Englesbe MJ, Waljee J. Care Coordination for Patients on Chronic Opioid Therapy Following Surgery: A Cohort Study. Annals of surgery. 2020 Aug 1; 272(2):304-310.
  366. Leonard CE, Brensinger CM, Pham Nguyen TP, Horn JR, Chung S, Bilker WB, Dublin S, Soprano SE, Dawwas GK, Oslin DW, Wiebe DJ, Hennessy S. Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2020 Oct 1; 130:110531.
  367. Kwan SY, Lancaster E, Dixit A, Inglis-Arkell C, Manuel S, Suh I, Shen WT, Seib CD. Reducing Opioid Use in Endocrine Surgery Through Patient Education and Provider Prescribing Patterns. The Journal of surgical research. 2020 Dec 1; 256:303-310.
  368. Gicquelais RE, Bohnert ASB, Fernandez AC. Opportunities to boost naloxone awareness among people who misuse opioid analgesics who have not used illegal opioids. Substance Abuse. 2020 Jul 21; 1-5.
  369. Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Kwoh CK, Donohue JM, Gordon AJ, Cochran G, Malone DC, Kuza CC, Gellad WF. Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study. PLoS ONE. 2020 Jul 17; 15(7):e0235981.
  370. Bishop MO, Bayman EO, Hadlandsmyth K, Lund BC, Kang S. Opioid use trajectories after thoracic surgery among veterans in the United States. European journal of pain (London, England). 2020 Sep 1; 24(8):1569-1584.
  371. George MD, Baker JF, Leonard CE, Mehta S, Miano TA, Hennessy S. Risk of Nonunion with Nonselective NSAIDs, COX-2 Inhibitors, and Opioids. The Journal of Bone and Joint Surgery. American volume. 2020 Jul 15; 102(14):1230-1238.
  372. Lin LA, Bohnert ASB, Blow FC, Gordon AJ, Ignacio RV, Kim HM, Ilgen MA. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction (Abingdon, England). 2021 Jan 1; 116(1):96-104.
  373. Hser YI, Mooney LJ. Integrating Telemedicine for Medication Treatment for Opioid Use Disorder in Rural Primary Care: Beyond the COVID Pandemic. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2021 Jan 1; 37(1):246-248.
  374. Khatri UG, Perrone J. Opioid Use Disorder and COVID-19: Crashing of the Crises. Journal of addiction medicine. 2020 Jul 1; 14(4):e6-e7.
  375. Shover CL, Vest NA, Chen D, Stueber A, Falasinnu TO, Hah JM, Kim J, Mackey I, Weber KA, Ziadni M, Humphreys K. Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication. JAMA Network Open. 2020 Jul 1; 3(7):e2010001.
  376. Womack JA, Justice AC. The OATH Syndemic: opioids and other substances, aging, alcohol, tobacco, and HIV. Current opinion in HIV and AIDS. 2020 Jul 1; 15(4):218-225.
  377. Young SR, Azari S, Becker WC, Edelman EJ, Liebschutz JM, Roy P, Starrels JL, Merlin JS. Common and Challenging Behaviors Among Individuals on Long-term Opioid Therapy. Journal of addiction medicine. 2020 Jul 1; 14(4):305-310.
  378. Finlay AK, Morse E, Stimmel M, Taylor E, Timko C, Harris AHS, Smelson D, Yu M, Blue-Howells J, Binswanger IA. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study. Journal of general internal medicine. 2020 Sep 1; 35(9):2529-2536.
  379. Rogal SS, Chinman M, Gellad WF, Mor MK, Zhang H, McCarthy SA, Mauro GT, Hale JA, Lewis ET, Oliva EM, Trafton JA, Yakovchenko V, Gordon AJ, Hausmann LRM. Tracking implementation strategies in the randomized rollout of a Veterans Affairs national opioid risk management initiative. Implementation science : IS. 2020 Jun 23; 15(1):48.
  380. Caulkins JP, Humphreys KN. Preventing opioid use and addiction: New thinking and the latest evidence. The Opioid Crisis In America: A paper series from the Foreign Policy and Global Economy & Development programs at Brookings [Internet]. 2020 Jun 22: Available from: Washington, DC.
  381. Dora-Laskey AD, Goldstick JE, Arterberry BJ, Roberts SJ, Haffajee RL, Bohnert ASB, Cunningham RM, Carter PM. Prevalence and Predictors of Driving after Prescription Opioid Use in an Adult ED Sample. The western journal of emergency medicine. 2020 Jun 19; 21(4):831-840.
  382. Baldassarri SR, Beitel M, Zinchuk A, Redeker NS, Oberleitner DE, Oberleitner LMS, Carrasco D, Madden LM, Lipkind N, Fiellin DA, Bastian LA, Chen K, Yaggi HK, Barry DT. Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment. Sleep & Breathing = Schlaf & Atmung. 2020 Dec 1; 24(4):1729-1737.
  383. Mazurenko O, Andraka-Christou BT, Bair MJ, Kara AY, Harle CA. Clinical perspectives on hospitals' role in the opioid epidemic. BMC health services research. 2020 Jun 8; 20(1):521.
  384. Becker WC. "Clues" That Patients May Be Willing to Consider Opioid Reductions. [Editorial]. Journal of general internal medicine. 2020 Jun 1; 35(6):1629-1630.
  385. Morasco BJ, Smith N, Dobscha SK, Deyo RA, Hyde S, Yarborough BJH. Outcomes of prescription opioid dose escalation for chronic pain: results from a prospective cohort study. Pain. 2020 Jun 1; 161(6):1332-1340.
  386. Vu JV, Cron DC, Lee JS, Gunaseelan V, Lagisetty P, Wixson M, Englesbe MJ, Brummett CM, Waljee JF. Classifying Preoperative Opioid Use for Surgical Care. Annals of surgery. 2020 Jun 1; 271(6):1080-1086.
  387. Timko C, Hoggatt K. Commentary on Gibson et al. (2020): Medications for opioid use disorder- access, retention, and safety. Addiction (Abingdon, England). 2020 Nov 1; 115(11):2077-2078.
  388. Gicquelais RE, Jannausch M, Bohnert ASB, Thomas L, Sen S, Fernandez AC. Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose. Drug and Alcohol Dependence. 2020 Jul 1; 212:108041.
  389. Yan BW, Sloan FA, Boscardin WJ, Guo F, Dudley RA. The Opioid Epidemic Blunted the Mortality Benefit of Medicaid Expansion. Medical care research and review : MCRR. 2021 Apr 1; 78(2):103-112.
  390. Dieujuste N, Johnson-Koenke R, Christopher M, Gunzburger EC, Emmendorfer T, Kessler C, Haukoos J, Smith J, Sasson C. Feasibility Study of a Quasi-experimental Regional Opioid Safety Prescribing Program in Veterans Health Administration Emergency Departments. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2020 Aug 1; 27(8):734-741.
  391. Lagisetty P, Zhang K, Haffajee RL, Lin LA, Goldstick J, Brownlee R, Bohnert A, Larochelle MR. Opioid prescribing history prior to heroin overdose among commercially insured adults. Drug and Alcohol Dependence. 2020 Jul 1; 212:108061.
  392. Hand Surgery Quality Consortium. Quality Measures to Reduce Opioid Use After Common Soft Tissue Hand and Wrist Procedures. The Journal of hand surgery. 2020 Jul 1; 45(7):582-588.e4.
  393. Lagisetty P, Smith A, Antoku D, Winter S, Smith M, Jannausch M, Mi Choe H, Bohnert ASB, Heisler M. A physician-pharmacist collaborative care model to prevent opioid misuse. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2020 May 7; 77(10):771-780.
  394. Maciejewski ML, Smith VA, Berkowitz TSZ, Arterburn DE, Bradley KA, Olsen MK, Liu CF, Livingston EH, Funk LM, Mitchell JE. Long-term opioid use after bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2020 Aug 1; 16(8):1100-1110.
  395. Carlson KF. 219 Trends in the Prevalence of Concurrent Non-VA Opioid and Benzodiazepine Prescriptions among Veterans Receiving Long-term Opioid Therapy from the VA. [Abstract]. Injury Prevention : Journal of The International Society For Child and Adolescent Injury Prevention. 2020 May 5; 26(Suppl 1):A38.
  396. Vangala C, Niu J, Montez-Rath ME, Yan J, Navaneethan SD, Naik AD, Winkelmayer WC. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. Journal of the American Society of Nephrology : JASN. 2020 Jun 1; 31(6):1325-1334.
  397. Edelman EJ, Li Y, Barry D, Brennan Braden J, Crystal S, Kerns RD, Gaither JR, Gordon KS, Manhapra A, Merlin JS, Moore BA, Oldfield BJ, Park LS, Rentsch CT, Skanderson M, Williams EC, Justice AC, Tate JP, Becker WC, Marshall BDL. Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study. Journal of acquired immune deficiency syndromes (1999). 2020 May 1; 84(1):26-36.
  398. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on pain intensity: a retrospective cohort study. Pain. 2020 May 1; 161(5):979-988.
  399. Minegishi T, Strombotne KL, Frakt AB, Barr K. Preliminary findings of the evaluation of the Stratification Tool for Opioid Risk Mitigation, focused on Serious Adverse Events, mortality outcomes in the high risk (1-5% risk) dashboard patients: Briefing before the Program Evaluation and Resource Center, VA Office of Mental Health Operations (Jodie Trafton, Elizabeth Olivia, and Friedhelm Sandbrink); 2020 May 1; Telephone Briefing.
  400. Becker WC, Gordon KS, Edelman EJ, Goulet JL, Kerns RD, Marshall BDL, Fiellin DA, Justice AC, Tate JP. Are we missing opioid-related deaths among people with HIV? Drug and Alcohol Dependence. 2020 Jul 1; 212:108003.
  401. Krebs EE, Clothier B, Nugent S, Jensen AC, Martinson BC, Goldsmith ES, Donaldson MT, Frank JW, Rutks I, Noorbaloochi S. The evaluating prescription opioid changes in veterans (EPOCH) study: Design, survey response, and baseline characteristics. PLoS ONE. 2020 Apr 22; 15(4):e0230751.
  402. Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis. Journal of general internal medicine. 2020 Aug 1; 35(8):2365-2374.
  403. Becker WC, Frank JW, Edens EL. Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series. Annals of internal medicine. 2020 Jul 7; 173(1):70-71.
  404. Minegishi T, Strombotne KL, Frakt AB, Barr K. Preliminary findings of the policy analysis portion of the evaluation of the Stratification Tool for Opioid Risk Mitigation: Briefing before the Program Evaluation and Resource Center, VA Office of Mental Health Operations (Jody Trafton, Director); 2020 Apr 7; Telephone Briefing.
  405. Becker WC, Fiellin DA. When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis. [Editorial]. Annals of internal medicine. 2020 Jul 7; 173(1):59-60.
  406. Hadlandsmyth K, Mosher HJ, Vander Weg MW, O'Shea AM, McCoy KD, Lund BC. Utility of accumulated opioid supply days and individual patient factors in predicting probability of transitioning to long-term opioid use: An observational study in the Veterans Health Administration. Pharmacology research & perspectives. 2020 Apr 1; 8(2):e00571.
  407. Jeffery MM, Chaisson CE, Hane C, Rumanes L, Tucker J, Hang L, McCoy R, Chen CL, Bicket MC, Hooten WM, Larochelle M, Becker WC, Kornegay C, Racoosin JA, Sanghavi D. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance. JAMA Network Open. 2020 Apr 1; 3(4):e202875.
  408. Moon AM, Jiang Y, Rogal SS, Tapper EB, Lieber SR, Barritt AS. Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply. [Letter to the Editor]. Alimentary pharmacology & therapeutics. 2020 Apr 1; 51(7):743-744.
  409. Peltzman T, Ravindran C, Schoen PM, Morley SW, Drexler K, Katz IR, McCarthy JF. Brief Report: Opioid-Involved Overdose Mortality in United States Veterans. The American journal on addictions. 2020 Jul 1; 29(4):340-344.
  410. Stokes A, Lundberg DJ, Hempstead K, Berry KM, Baker JF, Preston SH. Obesity and Incident Prescription Opioid Use in the U.S., 2000-2015. American journal of preventive medicine. 2020 Jun 1; 58(6):766-775.
  411. Hadlandsmyth K, Mosher HJ, Bayman EO, Wikle JG, Lund BC. A Typology of New Long-term Opioid Prescribing in the Veterans Health Administration. Journal of general internal medicine. 2020 Sep 1; 35(9):2607-2613.
  412. Peahl AF, Morgan DM, Dalton VK, Zivin K, Lai YL, Hu HM, Langen E, Low LK, Brummett CM, Waljee JF, Bauer ME. New persistent opioid use after acute opioid prescribing in pregnancy: a nationwide analysis. American journal of obstetrics and gynecology. 2020 Oct 1; 223(4):566.e1-566.e13.
  413. Burke LG, Frakt AB. Considering differential trends in opioid-related harm. Addiction (Abingdon, England). 2020 Aug 1; 115(8):1593-1594.
  414. Marcial LH, Blumenfeld B, Harle C, Jing X, Keller MS, Lee V, Lin Z, Dover A, Midboe AM, Al-Showk S, Bradley V, Breen J, Fadden M, Lomotan E, Marco-Ruiz L, Mohamed R, O'Connor P, Rosendale D, Solomon H, Kawamoto K. Barriers, Facilitators, and Potential Solutions to Advancing Interoperable Clinical Decision Support: Multi-Stakeholder Consensus Recommendations for the Opioid Use Case. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2020 Mar 4; 2019:637-646.
  415. Oliva EM, Bowe T, Manhapra A, Kertesz S, Hah JM, Henderson P, Robinson A, Paik M, Sandbrink F, Gordon AJ, Trafton JA. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ (Clinical research ed.). 2020 Mar 4; 368:m283.
  416. Fithian A, Nathan K, Campbell ST, Finlay AK, Bishop J, Gardner MJ. Variability in Opioid Prescribing Following Fracture Fixation: A Retrospective Cohort Analysis. Current orthopaedic practice. 2020 Mar 1; 31(2):101-104.
  417. Krebs EE. Evaluating Consequences of Opioid Prescribing Policies. Journal of general internal medicine. 2020 Mar 1; 35(3):635-636.
  418. Mudumbai SC, Chung P, Nguyen N, Harris B, Clark JD, Wagner TH, Giori NJ, Stafford RS, Mariano ER. Perioperative Opioid Prescribing Patterns and Readmissions After Total Knee Arthroplasty in a National Cohort of Veterans Health Administration Patients. Pain medicine (Malden, Mass.). 2020 Mar 1; 21(3):595-603.
  419. Young SD, Lee SJ, Perez H, Gill N, Gelberg L, Heinzerling K. Social media as an emerging tool for reducing prescription opioid misuse risk factors. Heliyon. 2020 Mar 1; 6(3):e03471.
  420. Jones AL, Kertesz SG, Hausmann LRM, Mor MK, Suo Y, Pettey WBP, Schaefer JH, Gundlapalli AV, Gordon AJ. Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration. Journal of substance abuse treatment. 2020 Jun 1; 113:107996.
  421. Moon AM, Jiang Y, Rogal SS, Becker J, Barritt AS. In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge. PLoS ONE. 2020 Feb 26; 15(2):e0229497.
  422. Polimanti R, Walters RK, Johnson EC, McClintick JN, Adkins AE, Adkins DE, Bacanu SA, Bierut LJ, Bigdeli TB, Brown S, Bucholz KK, Copeland WE, Costello EJ, Degenhardt L, Farrer LA, Foroud TM, Fox L, Goate AM, Grucza R, Hack LM, Hancock DB, Hartz SM, Heath AC, Hewitt JK, Hopfer CJ, Johnson EO, Kendler KS, Kranzler HR, Krauter K, Lai D, Madden PAF, Martin NG, Maes HH, Nelson EC, Peterson RE, Porjesz B, Riley BP, Saccone N, Stallings M, Wall TL, Webb BT, Wetherill L, Psychiatric Genomics Consortium Substance Use Disorders Workgroup, Edenberg HJ, Agrawal A, Gelernter J. Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium. Molecular Psychiatry. 2020 Aug 1; 25(8):1673-1687.
  423. Chui PW, Gordon KS, Dziura J, Burg MM, Brandt CA, Sico JJ, Leapman MS, Cavanagh CE, Rosman L, Haskell S, Becker WC, Bastian LA. Association of prescription opioids and incident cardiovascular risk factors among post-9/11 Veterans. Preventive medicine. 2020 May 1; 134:106036.
  424. Melnick ER, Nath B, Ahmed OM, Brandt C, Chartash D, Dziura JD, Hess EP, Holland WC, Hoppe JA, Jeffery MM, Katsovich L, Li F, Lu CC, Maciejewski K, Maleska M, Mao JA, Martel S, Michael S, Paek H, Patel MD, Platts-Mills TF, Rajeevan H, Ray JM, Skains RM, Soares WE, Deutsch A, Solad Y, D'Onofrio G. Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder. Journal of psychiatry and brain science. 2020 Feb 21; 5.
  425. Brunet N, Moore DT, Lendvai Wischik D, Mattocks KM, Rosen MI. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine. Substance Abuse. 2020 Feb 20; 1-8.
  426. Zullo AR, Moyo P, Jutkowitz E, Zhang W, Thomas KS. Opioid Use Disorder Among Hospitalized Older Adults: Prevalence, Characteristics, and Discharge Status. Journal of The American Medical Directors Association. 2020 Apr 1; 21(4):557-559.
  427. Luckett T, Newton-John T, Phillips J, Holliday S, Giannitrapani K, Powell-Davies G, Lovell M, Liauw W, Rowett D, Pearson SA, Raymond B, Heneka N, Lorenz K. Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitioners. BMJ open. 2020 Feb 17; 10(2):e034363.
  428. Morasco BJ, Adams MH, Maloy PE, Hooker ER, Iacocca MO, Krebs EE, Carr TP, Lovejoy TI, Saha S, Dobscha SK. Research methods and baseline findings of the improving the safety of opioid therapy (ISOT) cluster-randomized trial. Contemporary clinical trials. 2020 Mar 1; 90:105957.
  429. Hartwell EE, Feinn R, Morris PE, Gelernter J, Krystal J, Arias AJ, Hoffman M, Petrakis I, Gueorguieva R, Schacht JP, Oslin D, Anton RF, Kranzler HR. Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder. Addiction (Abingdon, England). 2020 Aug 1; 115(8):1426-1437.
  430. Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2020 Apr 1; 23(4):451-460.
  431. Chalasani R, Lo-Ciganic WH, Huang JL, Guo J, Weiss JC, Kuza CC, Gellad WF. Occupational Patterns of Opioid-Related Overdose Deaths Among Arizona Medicaid Enrollees, 2008-2017. Journal of general internal medicine. 2020 Jul 1; 35(7):2210-2213.
  432. Suda KJ, Zhou J, Rowan SA, McGregor JC, Perez RI, Evans CT, Gellad WF, Calip GS. Overprescribing of Opioids to Adults by Dentists in the U.S., 2011-2015. American journal of preventive medicine. 2020 Apr 1; 58(4):473-486.
  433. Corcoran KL, Bastian LA, Gunderson CG, Steffens C, Brackett A, Lisi AJ. Association Between Chiropractic Use and Opioid Receipt Among Patients with Spinal Pain: A Systematic Review and Meta-analysis. Pain medicine (Malden, Mass.). 2020 Feb 1; 21(2):e139-e145.
  434. Hung A, Bush C, Greiner M, Campbell H, Hammill B, Maciejewski ML, McKethan A. Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population. Journal of managed care & specialty pharmacy. 2020 Feb 1; 26(2):169-175.
  435. Kwong JZ, Mudumbai SC, Hernandez-Boussard T, Popat RA, Mariano ER. Practice Patterns in Perioperative Nonopioid Analgesic Administration by Anesthesiologists in a Veterans Affairs Hospital. Pain medicine (Malden, Mass.). 2020 Feb 1; 21(2):e208-e214.
  436. Lin LA, Brummett CM, Waljee JF, Englesbe MJ, Gunaseelan V, Bohnert ASB. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults. Journal of general internal medicine. 2020 Feb 1; 35(2):420-427.
  437. Starrels JL, Young SR, Azari SS, Becker WC, Jennifer Edelman E, Liebschutz JM, Pomeranz J, Roy P, Saini S, Merlin JS. Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study. Pain medicine (Malden, Mass.). 2020 Feb 1; 21(2):247-254.
  438. Kiang MV, Humphreys K, Cullen MR, Basu S. Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study. BMJ (Clinical research ed.). 2020 Jan 29; 368:l6968.
  439. Essien UR, Sileanu FE, Zhao X, Liebschutz JM, Thorpe CT, Good CB, Mor MK, Radomski TR, Hausmann LRM, Fine MJ, Gellad WF. Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose. Journal of general internal medicine. 2020 May 1; 35(5):1537-1544.
  440. Moon AM, Jiang Y, Rogal SS, Tapper EB, Lieber SR, Barritt AS. Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis. Alimentary pharmacology & therapeutics. 2020 Mar 1; 51(6):652-660.
  441. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction (Abingdon, England). 2020 Jun 1; 115(6):1098-1112.
  442. Humphreys KN, Caulkins JP, Felbab-Brown V. Order from Chaos: What the US and Canada Can Learn From Other Countries to Combat the Opioid Crisis. Brookings Institution [Internet]. 2020 Jan 13:Order From Chaos(Blog):1. Available from: Washington, DC.
  443. Frank JW, Binswanger IA. Commentary on Rhee & Rosenheck (2019): Buprenorphine prescribing for opioid use disorder in medical practice - can office-based out-patient care address the opiate crisis in the United States?. [Letter to the Editor]. Addiction (Abingdon, England). 2020 Apr 1; 115(4):786-787.
  444. Cox JW, Sherva RM, Lunetta KL, Johnson EC, Martin NG, Degenhardt L, Agrawal A, Nelson EC, Kranzler HR, Gelernter J, Farrer LA. Genome-Wide Association Study of Opioid Cessation. Journal of clinical medicine. 2020 Jan 9; 9(1).
  445. Humphreys K. Commentary on Burke et al. (2020): Safer and less-frequent opioid prescribing are both essential for US public health. Addiction (Abingdon, England). 2020 Mar 1; 115(3):505-506.
  446. Kilaru AS, Perrone J, Kelley D, Siegel S, Lubitz SF, Mitra N, Meisel ZF. Participation in a Hospital Incentive Program for Follow-up Treatment for Opioid Use Disorder. JAMA Network Open. 2020 Jan 3; 3(1):e1918511.
  447. Coupet E, Werner RM, Polsky D, Karp D, Delgado MK. Impact of the Young Adult Dependent Coverage Expansion on Opioid Overdoses and Deaths: a Quasi-Experimental Study. Journal of general internal medicine. 2020 Jun 1; 35(6):1783-1788.
  448. Chen CL, Jeffery MM, Krebs EE, Thiels CA, Schumacher MA, Schwartz AJ, Thombley R, Finlayson E, Rodriguez-Monguio R, Ward D, Dudley RA. Long-Term Trends in Postoperative Opioid Prescribing, 1994 to 2014. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews. 2020 Jan 1; 4(1).
  449. Cochran G, Bruneau J, Cox N, Gordon AJ. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse. 2020 Jan 1; 41(3):269-274.
  450. Gordon AJ, Drexler K, Hawkins EJ, Burden J, Codell NK, Mhatre-Owens A, Dungan MT, Hagedorn H. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Substance Abuse. 2020 Jan 1; 41(3):275-282.
  451. Matthias MS. Opioid Tapering and the Patient-Provider Relationship. [Editorial]. Journal of general internal medicine. 2020 Jan 1; 35(1):8-9.
  452. Burke LG, Zhou X, Boyle KL, Orav EJ, Bernson D, Hood ME, Land T, Bharel M, Frakt AB. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014. Addiction (Abingdon, England). 2020 Mar 1; 115(3):493-504.
  453. Seal KH, Rife T, Li Y, Gibson C, Tighe J. Opioid Reduction and Risk Mitigation in VA Primary Care: Outcomes from the Integrated Pain Team Initiative. Journal of general internal medicine. 2020 Apr 1; 35(4):1238-1244.
  454. Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. Journal of the American Pharmacists Association : JAPhA. 2020 Jan 1; 60(1):244-247.
  455. Cuellar MF, Humphreys KN. The Political Economy of the Opioid Epidemic. Yale Law & Policy Review. 2020 Jan 5; 38(1):SSRN: https://ssrn.com/abstract=3503149.
  456. Turvey CL, Lund BC, Jones D, Arndt S. Community Treatment for Opioid Use Disorders in Urban and Rural Veterans. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2020 Mar 1; 36(2):167-176.
  457. Andrews CM, Humphreys K, Grogan CM. How Medicaid work requirements could exacerbate the opioid epidemic. The American journal of drug and alcohol abuse. 2019 Dec 4; 46(1):1-3.
  458. Jasuja GK, Ameli O, Reisman JI, Rose AJ, Miller DR, Berlowitz DR, Bhasin S. Health Outcomes Among Long-term Opioid Users With Testosterone Prescription in the Veterans Health Administration. JAMA Network Open. 2019 Dec 2; 2(12):e1917141.
  459. Yang BZ, Zhou H, Cheng Z, Kranzler HR, Gelernter J. Genomewide Gene-by-Sex Interaction Scans Identify ADGRV1 for Sex Differences in Opioid Dependent African Americans. Scientific reports. 2019 Dec 2; 9(1):18070.
  460. Lund BC, Ohl ME, Hadlandsmyth K, Mosher HJ. Regional and Rural-Urban Variation in Opioid Prescribing in the Veterans Health Administration. Military medicine. 2019 Dec 1; 184(11-12):894-900.
  461. Rentsch CT, Edelman EJ, Justice AC, Marshall BDL, Xu K, Smith AH, Crystal S, Gaither JR, Gordon AJ, Smith RV, Kember RL, Polimanti R, Gelernter J, Fiellin DA, Tate JP, Kranzler HR, Becker WC, VACS Project Team. Patterns and Correlates of Prescription Opioid Receipt Among US Veterans: A National, 18-Year Observational Cohort Study. AIDS and behavior. 2019 Dec 1; 23(12):3340-3349.
  462. Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, PROUD Collaborative Investigators. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug and Alcohol Dependence. 2020 Feb 1; 207:107732.
  463. Rosen IM, Aurora RN, Kirsch DB, Carden KA, Malhotra RK, Ramar K, Abbasi-Feinberg F, Kristo DA, Martin JL, Olson EJ, Rosen CL, Rowley JA, Shelgikar AV, American Academy of Sleep Medicine Board of Directors. Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2019 Nov 15; 15(11):1671-1673.
  464. Chen JA. Capsule Commentary on Sullivan et al., Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction. Journal of general internal medicine. 2020 Mar 1; 35(3):980.
  465. Krause JS, Dismuke-Greer CE, Reed KS, Li C. Employment status, hours working, and gainful earnings after spinal cord injury: relationship with pain, prescription medications for pain, and nonprescription opioid use. Spinal Cord. 2020 Mar 1; 58(3):275-283.
  466. Maloy PE, Iacocca MO, Morasco BJ. CE: Implementing Guidelines for Treating Chronic Pain with Prescription Opioids. The American Journal of Nursing. 2019 Nov 1; 119(11):22-29.
  467. Agnoli A, Jerant A, Becker W, Franks P. Opioid Prescriptions and Short-Term Mortality: a U.S. National Study. Journal of general internal medicine. 2020 Mar 1; 35(3):656-661.
  468. Mooney LJ, Valdez J, Cousins SJ, Yoo C, Zhu Y, Hser YI. Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results. Journal of substance abuse treatment. 2020 Jan 1; 108:115-122.
  469. Derefinko KJ, Salgado García FI, Johnson KC, Hand S, Murphy JG, McDevitt-Murphy M, Suda KJ, Andrasik F, Bursac Z, Chiu CY, Talley K, Brooks JH. A randomized pilot program to reduce opioid use following dental surgery and increase safe medication return. Addictive Behaviors. 2020 Mar 1; 102:106190.
  470. Maruti S, Desjardins I, Bagge CL, Althoff RR. Commentary: Opioid use disorder and suicide: An important opportunity to address two significant public health epidemics. Preventive medicine. 2019 Nov 1; 128:105854.
  471. Wang MC, Lozen AM, Laud PW, Nattinger AB, Krebs EE. Factors associated with chronic opioid use after cervical spine surgery for degenerative conditions. Journal of neurosurgery. Spine. 2019 Oct 11; 1-8.
  472. Lowenstein M, Hossain E, Yang W, Grande D, Perrone J, Neuman MD, Ashburn M, Delgado MK. Impact of a State Opioid Prescribing Limit and Electronic Medical Record Alert on Opioid Prescriptions: a Difference-in-Differences Analysis. Journal of general internal medicine. 2020 Mar 1; 35(3):662-671.
  473. Dayer LE, Breckling MN, Kling BS, Lakkad M, McDade ER, Painter JT. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing. The Journal of emergency medicine. 2019 Nov 1; 57(5):597-602.
  474. Yamamoto A, Needleman J, Gelberg L, Kominski G, Shoptaw S, Tsugawa Y. Association between homelessness and opioid overdose and opioid-related hospital admissions/emergency department visits. Social science & medicine (1982). 2019 Dec 1; 242:112585.
  475. Lagisetty PA, Lin LA, Ganoczy D, Haffajee RL, Iwashyna TJ, Bohnert ASB. Opioid Prescribing After Opioid-related Inpatient Hospitalizations by Diagnosis: A Cohort Study. Medical care. 2019 Oct 1; 57(10):815-821.
  476. Moyo P, Gellad WF, Sabik LM, Cochran GT, Cole ES, Gordon AJ, Kelley DK, Donohue JM. Opioid Prescribing Safety Measures in Medicaid Enrollees With and Without Cancer. American journal of preventive medicine. 2019 Oct 1; 57(4):540-544.
  477. Thornhill MH, Suda KJ, Durkin MJ, Lockhart PB. Is it time US dentistry ended its opioid dependence?. Journal of the American Dental Association (1939). 2019 Oct 1; 150(10):883-889.
  478. Shover CL, Humphreys K. Predictors of availability of long-acting medication for opioid use disorder. Drug and Alcohol Dependence. 2019 Nov 1; 204:107586.
  479. Brunette MF, Oslin DW, Dixon LB, Adler DA, Berlant J, Erlich M, First MB, Goldman B, Levine B, Siris S, Winston H. The Opioid Epidemic and Psychiatry: The Time for Action Is Now. Psychiatric services (Washington, D.C.). 2019 Dec 1; 70(12):1168-1171.
  480. Banerjee G, Edelman EJ, Barry DT, Crystal S, Gordon KS, Gordon AJ, Gaither JR, Green TC, Kerns RD, Manhapra A, Moore BA, Fiellin DA, Marshall BDL. High-dose prescribed opioids are associated with increased risk of heroin use among United States military veterans. Pain. 2019 Sep 1; 160(9):2126-2135.
  481. Oldfield BJ, Fuller WS, Becker WC. Opioids Are Not Better than Non-opioid Pain Medications for Chronic Back, Hip, or Knee Pain. Journal of general internal medicine. 2019 Sep 1; 34(9):1854-1856.
  482. Wyse JJ, Ganzini L, Dobscha SK, Krebs EE, Zamudio J, Morasco BJ. Clinical Strategies for the Treatment and Management of Patients Prescribed Long-term Opioid Therapy. Pain medicine (Malden, Mass.). 2019 Sep 1; 20(9):1737-1744.
  483. Giannitrapani KF, Fereydooni S, Azarfar A, Silveira MJ, Glassman PA, Midboe AM, Bohnert ABS, Zenoni MA, Kerns RD, Pearlman RA, Asch SM, Becker WC, Lorenz KA. Signature Informed Consent for Long-Term Opioid Therapy in Patients With Cancer: Perspectives of Patients and Providers. Journal of pain and symptom management. 2020 Jan 1; 59(1):49-57.
  484. Gibson CJ, Li Y, Huang AJ, Rife T, Seal KH. Menopausal Symptoms and Higher Risk Opioid Prescribing in a National Sample of Women Veterans with Chronic Pain. Journal of general internal medicine. 2019 Oct 1; 34(10):2159-2166.
  485. Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2?years: Results from a multisite randomized trial of adults with opioid use disorder. Journal of substance abuse treatment. 2019 Nov 1; 106:19-28.
  486. Chen Q, Hsia HL, Overman R, Bryan W, Pepin M, Mariano ER, Mudumbai SC, Buchheit T, Krishnamoorthy V, Good CB, Brookhart MA, Raghunathan K. Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series Analysis. Anesthesiology. 2019 Aug 1; 131(2):369-380.
  487. Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Evidence Brief: Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain. 2019 Aug 1.
  488. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder. 2019 Aug 1.
  489. Midboe AM, Byrne T, Smelson D, Jasuja G, McInnes K, Troszak LK. The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed. Health affairs (Project Hope). 2019 Aug 1; 38(8):1289-1297.
  490. Veazie S, Mackey K, Bourne D, Peterson K. Evidence Brief: Managing Acute Pain in Patients with Opioid Use Disorder on Medication-assisted Treatment. 2019 Aug 1.
  491. Humphreys K, Saitz R. Cannabis as a Substitute for Opioids-Reply. JAMA. 2019 Jul 16; 322(3):273-274.
  492. Klueh MP, Sloss KR, Dossett LA, Englesbe MJ, Waljee JF, Brummett CM, Lagisetty PA, Lee JS. Postoperative opioid prescribing is not my job: A qualitative analysis of care transitions. Surgery. 2019 Nov 1; 166(5):744-751.
  493. Hawkins EJ, Goldberg SB, Malte CA, Saxon AJ. New Coprescription of Opioids and Benzodiazepines and Mortality Among Veterans Affairs Patients With Posttraumatic Stress Disorder. The Journal of clinical psychiatry. 2019 Jul 9; 80(4).
  494. Humphreys KN. We can't fight opioids by controlling demand alone. Washington Post. 2019 Jul 5.
  495. Lagisetty PA, Healy N, Garpestad C, Jannausch M, Tipirneni R, Bohnert ASB. Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids. JAMA Network Open. 2019 Jul 3; 2(7):e196928.
  496. Andrews CM, Humphreys K. Investing in Medicaid to End the Opioid Epidemic. Psychiatric services (Washington, D.C.). 2019 Jul 1; 70(7):537.
  497. Gonzales-Castaneda R, Mooney LJ, Rawson RA. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks, Offering a Public Health Perspective-A Commentary on Camenga et al. Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):403-405.
  498. Vest N, Humphreys KN. Do We Know Enough to Prescribe Opioid-Agonist Therapies to Adolescents With Problematic Opioid Use? A Commentary on Camenga et al. (2019). Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):406-407.
  499. Hernandez-Boussard T, Graham LA, Carroll I, Dasinger EA, Titan AL, Morris MS, Hawn MT. Perioperative opioid use and pain-related outcomes in the Veterans Health Administration. American journal of surgery. 2020 Jun 1; 219(6):969-975.
  500. McGuire AB, Powell KG, Treitler PC, Wagner KD, Smith KP, Cooperman N, Robinson L, Carter J, Ray B, Watson DP. Emergency department-based peer support for opioid use disorder: Emergent functions and forms. Journal of substance abuse treatment. 2020 Jan 1; 108:82-87.
  501. Larochelle MR, Bohnert ASB. Opportunities to Address First Opioid Prescriptions to Reduce Incident Long-Term Opioid Use. Annals of internal medicine. 2019 Jul 16; 171(2):129-130.
  502. Tas B, Humphreys K, McDonald R, Strang J. Should we worry that take-home naloxone availability may increase opioid use? Addiction (Abingdon, England). 2019 Oct 1; 114(10):1723-1725.
  503. Wolk CB, Doubeni CA, Klusaritz HA, Bilger A, Paterson E, Oslin DW. Perspectives and Practice in the Identification and Treatment of Opioid Use, Alcohol Use, and Depressive Disorders. Psychiatric services (Washington, D.C.). 2019 Oct 1; 70(10):940-943.
  504. Matthias MS, Talib TL, Huffman MA. Managing Chronic Pain in an Opioid Crisis: What Is the Role of Shared Decision-Making?. Health communication. 2020 Sep 1; 35(10):1239-1247.
  505. Shover CL, Davis CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences of the United States of America. 2019 Jun 25; 116(26):12624-12626.
  506. Watson DP, Brucker K, McGuire A, Snow-Hill NL, Xu H, Cohen A, Campbell M, Robison L, Sightes E, Buhner R, O'Donnell D, Kline JA. Replication of an emergency department-based recovery coaching intervention and pilot testing of pragmatic trial protocols within the context of Indiana's Opioid State Targeted Response plan. Journal of substance abuse treatment. 2020 Jan 1; 108:88-94.
  507. Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder. JAMA Network Open. 2019 Jun 5; 2(6):e196373.
  508. Young SG, Hayes CJ, Aram J, Tait MA. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use. Pharmacoepidemiology and drug safety. 2019 Aug 1; 28(8):1117-1124.
  509. Duncan MH, Ratzliff AD, Powers DM, Banta-Green CJ, Saxon AJ. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Annals of internal medicine. 2019 Jun 4; 170(11):820-821.
  510. Lagisetty PA, Bohnert A. Role of an Accurate Treatment Locator and Cash-Only Practices in Access to Buprenorphine for Opioid Use Disorders. [Editorial]. Annals of internal medicine. 2019 Jul 2; 171(1):58-59.
  511. Hadlandsmyth K, Stewart KR, Paez MB, Steffen M, Meth M, Reisinger HS, Mosher HJ. Patient Perspectives on Opioids: Views of Inpatient Veterans with Chronic Pain. Pain medicine (Malden, Mass.). 2019 Jun 1; 20(6):1141-1147.
  512. Merlin JS, Long D, Becker WC, Cachay ER, Christopolous KA, Claborn KR, Crane HM, Edelman EJ, Lovejoy TI, Mathews WC, Morasco BJ, Napravnik S, O'Cleirigh C, Saag MS, Starrels JL, Gross R, Liebschutz JM. Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People Living With HIV and Chronic Pain. Journal of acquired immune deficiency syndromes (1999). 2019 Jun 1; 81(2):231-237.
  513. Yarborough BJH, Stumbo SP, Stoneburner A, Smith N, Dobscha SK, Deyo RA, Morasco BJ. Correlates of Benzodiazepine Use and Adverse Outcomes Among Patients with Chronic Pain Prescribed Long-term Opioid Therapy. Pain medicine (Malden, Mass.). 2019 Jun 1; 20(6):1148-1155.
  514. Barnett ML, Zhao X, Fine MJ, Thorpe CT, Sileanu FE, Cashy JP, Mor MK, Radomski TR, Hausmann LRM, Good CB, Gellad WF. Emergency Physician Opioid Prescribing and Risk of Long-term Use in the Veterans Health Administration: an Observational Analysis. Journal of general internal medicine. 2019 Aug 1; 34(8):1522-1529.
  515. Lin LA, Peltzman T, McCarthy JF, Oliva EM, Trafton JA, Bohnert ASB. Changing Trends in Opioid Overdose Deaths and Prescription Opioid Receipt Among Veterans. American journal of preventive medicine. 2019 Jul 1; 57(1):106-110.
  516. Wilson MP, Cucciare MA, Porter A, Chalmers CE, Mullinax S, Mancino M, Oliveto AH. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids. The American journal of emergency medicine. 2020 Mar 1; 38(3):503-507.
  517. Mosher HJ. Nudging Our Way to Opioid 'Right-Sizing'. Joint Commission Journal on Quality and Patient Safety. 2019 Jun 1; 45(6):414-415.
  518. Chua KP, Brummett CM, Conti RM, Haffajee RL, Prosser LA, Bohnert ASB. Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids. JAMA Network Open. 2019 May 3; 2(5):e193673.
  519. Suda KJ, Durkin MJ, Calip GS, Gellad WF, Kim H, Lockhart PB, Rowan SA, Thornhill MH. Comparison of Opioid Prescribing by Dentists in the United States and England. JAMA Network Open. 2019 May 3; 2(5):e194303.
  520. Adams RS, Larson MJ, Meerwijk EL, Williams TV, Harris AHS. Postdeployment Polytrauma Diagnoses Among Soldiers and Veterans Using the Veterans Health Affairs Polytrauma System of Care and Receipt of Opioids, Nonpharmacologic, and Mental Health Treatments. The Journal of head trauma rehabilitation. 2019 May 1; 34(3):167-175.
  521. Bair MJ, Outcalt SD, Slaven JE, Kroenke K, Kempf C, Zillich AJ, Damush TM, Saha C, French DD, Krebs EE. Care Management for the Effective Use of Opioids (CAMEO): A Randomized Trial. Abstracts of the 77th Annual Scientific Meeting, March 6-9, 2019. Vancouver, BC, Canada. Abstract 1734. [Abstract]. Psychosomatic medicine. 2019 May 1; 81(4):A-149.
  522. Bixler FR, Radomski TR, Zickmund SL, Roman KM, Hausmann LRM, Thorpe CT, Hale JA, Sileanu FE, Gellad WF. Primary care physicians' perspectives on Veterans who obtain prescription opioids from multiple healthcare systems. Journal of opioid management. 2019 May 1; 15(3):183-191.
  523. Frank JW, Carey E, Nolan C, Kerns RD, Sandbrink F, Gallagher R, Ho PM. Increased Nonopioid Chronic Pain Treatment in the Veterans Health Administration, 2010-2016. Pain medicine (Malden, Mass.). 2019 May 1; 20(5):869-877.
  524. Mudumbai SC, Lewis ET, Oliva EM, Chung PD, Harris B, Trafton J, Mariano ER, Wagner T, Clark JD, Stafford RS. Overdose Risk Associated with Opioid Use upon Hospital Discharge in Veterans Health Administration Surgical Patients. Pain medicine (Malden, Mass.). 2019 May 1; 20(5):1020-1031.
  525. Purcell N, Zamora K, Gibson C, Tighe J, Chang J, Grasso J, Seal KH. Patient Experiences With Integrated Pain Care: A Qualitative Evaluation of One VA's Biopsychosocial Approach to Chronic Pain Treatment and Opioid Safety. Global advances in health and medicine. 2019 Apr 22; 8(8):2164956119838845.
  526. Wyse JJ, Ganzini L, Dobscha SK, Krebs EE, Morasco BJ. Setting Expectations, Following Orders, Safety, and Standardization: Clinicians' Strategies to Guide Difficult Conversations About Opioid Prescribing. Journal of general internal medicine. 2019 Jul 1; 34(7):1200-1206.
  527. Harbaugh CM, Lee JS, Chua KP, Kenney B, Iwashyna TJ, Englesbe MJ, Brummett CM, Bohnert AS, Waljee JF. Association Between Long-term Opioid Use in Family Members and Persistent Opioid Use After Surgery Among Adolescents and Young Adults. JAMA surgery. 2019 Apr 17; 154(4):e185838.
  528. Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, Fox AD. A conceptual model for understanding post-release opioid-related overdose risk. Addiction science & clinical practice. 2019 Apr 15; 14(1):17.
  529. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. Reply. [Letter to the Editor]. The New England journal of medicine. 2019 Apr 4; 380(14):1380.
  530. Kroenke K, Alford DP, Argoff C, Canlas B, Covington E, Frank JW, Haake KJ, Hanling S, Hooten WM, Kertesz SG, Kravitz RL, Krebs EE, Stanos SP, Sullivan M. Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report. Pain medicine (Malden, Mass.). 2019 Apr 1; 20(4):724-735.
  531. Morrow DJ, Fischer EP, Walder AM, Jubran NI. Nonopioid Alternatives to Addressing Pain Intensity: A Retrospective Look at 2 Noninvasive Pain Treatment Devices. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2019 Apr 1; 36(4):181-187.
  532. Mazurenko O, Blackburn J, Bair MJ, Kara A, Harle C. Examining the association between inpatient opioid prescribing and patient satisfaction. [Abstract]. Journal of clinical and translational science. 2019 Mar 26; 3(1):121-122.
  533. Cole ES, DiDomenico E, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kim JY, Kmiec J, Kelley D, Donohue JM. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. Journal of general internal medicine. 2019 Jun 1; 34(6):936-943.
  534. Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study. Annals of internal medicine. 2019 Apr 2; 170(7):433-442.
  535. Wyse JJ, Robbins JL, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Gaither JR, Gordon K, Skanderson M, Barry DT, Crystal S, Justice A, Kraemer KL. Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. Drug and Alcohol Dependence. 2019 May 1; 198:70-75.
  536. Frakt AB. The Opioid Dilemma: Saving Lives in the Long Run Can Take Lives in the Short Run. The New York Times. 2019 Mar 4: The Upshot.
  537. Brummett CM, Moser SE, Nallamothu BK. Errors in Analysis in Study of New Persistent Opioid Use After Surgery. JAMA surgery. 2019 Mar 1; 154(3):268-269.
  538. Darnall BD, Juurlink D, Kerns RD, Mackey S, Van Dorsten B, Humphreys K, Gonzalez-Sotomayor JA, Furlan A, Gordon AJ, Gordon DB, Hoffman DE, Katz J, Kertesz SG, Satel S, Lawhern RA, Nicholson KM, Polomano RC, Williamson OD, McAnally H, Kao MC, Schug S, Twillman R, Lewis TA, Stieg RL, Lorig K, Mallick-Searle T, West RW, Gray S, Ariens SR, Sharpe Potter J, Cowan P, Kollas CD, Laird D, Ingle B, Julian Grove J, Wilson M, Lockman K, Hodson F, Palackdharry CS, Fillingim RB, Fudin J, Barnhouse J, Manhapra A, Henson SR, Singer B, Ljosenvoor M, Griffith M, Doctor JN, Hardin K, London C, Mankowski J, Anderson A, Ellsworth L, Davis Budzinski L, Brandt B, Hartley G, Nickels Heck D, Zobrosky MJ, Cheek C, Wilson M, Laux CE, Datz G, Dunaway J, Schonfeld E, Cady M, LeDantec-Boswell T, Craigie M, Sturgeon J, Flood P, Giummarra M, Whelan J, Thorn BE, Martin RL, Schatman ME, Gregory MD, Kirz J, Robinson P, Marx JG, Stewart JR, Keck PS, Hadland SE, Murphy JL, Lumley MA, Brown KS, Leong MS, Fillman M, Broatch JW, Perez A, Watford K, Kruska K, Sophia You D, Ogbeide S, Kukucka A, Lawson S, Ray JB, Wade Martin T, Lakehomer JB, Burke A, Cohen RI, Grinspoon P, Rubenstein MS, Sutherland S, Walters K, Lovejoy T. International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering. Pain medicine (Malden, Mass.). 2019 Mar 1; 20(3):429-433.
  539. Edelman EJ, Gordon KS, Crothers K, Akgün K, Bryant KJ, Becker WC, Gaither JR, Gibert CL, Gordon AJ, Marshall BDL, Rodriguez-Barradas MC, Samet JH, Justice AC, Tate JP, Fiellin DA. Association of Prescribed Opioids With Increased Risk of Community-Acquired Pneumonia Among Patients With and Without HIV. JAMA internal medicine. 2019 Mar 1; 179(3):297-304.
  540. Hah JM, Cramer E, Hilmoe H, Schmidt P, McCue R, Trafton J, Clay D, Sharifzadeh Y, Ruchelli G, Goodman S, Huddleston J, Maloney WJ, Dirbas FM, Shrager J, Costouros JG, Curtin C, Mackey SC, Carroll I. Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2019 Mar 1; 2(3):e190168.
  541. Humphreys KN. Opioids, cannabis, and vaping: Using science to protect public health: Briefing before the Joint Hearing of Senate and General Assembly Health and Human Services Committee, State of Rhode Island; 2019 Mar 1; Providence, Rhode Island.
  542. Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, Donohue JM, Cochran G, Gordon AJ, Malone DC, Kuza CC, Gellad WF. Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions. JAMA Network Open. 2019 Mar 1; 2(3):e190968.
  543. Dasinger EA, Graham LA, Wahl TS, Richman JS, Baker SJ, Hawn MT, Hernandez-Boussard T, Rosen AK, Mull HJ, Copeland LA, Whittle JC, Burns EA, Morris MS. Preoperative opioid use and postoperative pain associated with surgical readmissions. American journal of surgery. 2019 Nov 1; 218(5):828-835.
  544. Humphreys K, Saitz R. Should Physicians Recommend Replacing Opioids With Cannabis? JAMA. 2019 Feb 19; 321(7):639-640.
  545. Kumthekar A, Shull S, Lovejoy TI, Morasco BJ, Chang M, Barton J. Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis. International journal of rheumatic diseases. 2019 Apr 1; 22(4):592-598.
  546. Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. Journal of general internal medicine. 2019 Aug 1; 34(8):1419-1426.
  547. Chinman M, Gellad WF, McCarthy S, Gordon AJ, Rogal S, Mor MK, Hausmann LRM. Protocol for evaluating the nationwide implementation of the VA Stratification Tool for Opioid Risk Management (STORM). Implementation science : IS. 2019 Jan 18; 14(1):5.
  548. Minegishi T, Frakt AB, Garrido MM, Gellad WF, Hausmann LRM, Lewis ET, Pizer SD, Trafton JA, Oliva EM. Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness. Substance Abuse. 2019 Jan 8; 40(1):14-19.
  549. Dasinger EA, Branch-Elliman W, Pizer SD, Abdulkerim H, Rosen AK, Charns MP, Hawn MT, Itani KMF, Mull HJ. Association between postoperative opioid use and outpatient surgical adverse events. American journal of surgery. 2019 Apr 1; 217(4):605-612.
  550. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. The New England journal of medicine. 2019 Jan 3; 380(1):71-79.
  551. Bohnert ASB, Larochelle MR. Are Temporal Trends Important Measures of Opioid-prescribing Risk?. Journal of addiction medicine. 2019 Jan 1; 13(1):5-6.
  552. Hser YI, Saxon AJ, Mooney LJ, Miotto K, Zhu Y, Yoo CK, Liang D, Huang D, Bell DS. Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder. Journal of addiction medicine. 2019 Jan 1; 13(1):41-46.
  553. Morasco BJ, Dobscha SK, Hyde S, Mitchell SH. Exploratory study examining associations between prescription opioid dose and delay discounting in patients with chronic pain. Journal of opioid management. 2019 Jan 1; 15(1):19-25.
  554. Morasco BJ, Krebs EE, Adams MH, Hyde S, Zamudio J, Dobscha SK. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain. The Clinical Journal of Pain. 2019 Jan 1; 35(1):1-6.
  555. Zivin K, White JO, Chao S, Christensen AL, Horner L, Petersen DM, Hobbs MR, Capreol G, Halbritter KA, Jones CM. Implementing Electronic Health Record Default Settings to Reduce Opioid Overprescribing: A Pilot Study. Pain medicine (Malden, Mass.). 2019 Jan 1; 20(1):103-112.
  556. Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Substance use & misuse. 2018 Dec 21; 54(2):331-339.
  557. Seal KH, Borsari B, Tighe J, Cohen BE, Delucchi K, Morasco BJ, Li Y, Sachs E, Abadjian L, Watson EC, Manuel JK, Vella L, Trafton J, Midboe A. Optimizing pain treatment interventions (OPTI): A pilot randomized controlled trial of collaborative care to improve chronic pain management and opioid safety-Rationale, methods, and lessons learned. Contemporary clinical trials. 2019 Feb 1; 77:76-85.
  558. Hagedorn H, Kenny M, Gordon AJ, Ackland PE, Noorbaloochi S, Yu W, Harris AHS. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addiction science & clinical practice. 2018 Dec 13; 13(1):25.
  559. Shields CG, Fuzzell LN, Christ SL, Matthias MS. Patient and provider characteristics associated with communication about opioids: An observational study. Patient education and counseling. 2019 May 1; 102(5):888-894.
  560. Thakral M, Walker RL, Saunders K, Shortreed SM, Dublin S, Parchman M, Hansen RN, Ludman E, Sherman KJ, Von Korff M. Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse Outcomes. Pain medicine (Malden, Mass.). 2018 Dec 1; 19(12):2450-2458.
  561. Rose AJ, McBain R, Schuler MS, LaRochelle MR, Ganz DA, Kilambi V, Stein BD, Bernson D, Chui KKH, Land T, Walley AY, Stopka TJ. Effect of Age on Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011 to 2015. Journal of the American Geriatrics Society. 2019 Jan 1; 67(1):128-132.
  562. Noureldin M, Higgins PDR, Govani SM, Cohen-Mekelburg S, Kenney BC, Stidham RW, Waljee JF, Waljee AK. Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids. Alimentary pharmacology & therapeutics. 2019 Jan 1; 49(1):74-83.
  563. Hadlandsmyth K, Lund BC, Mosher HJ. Associations between initial opioid exposure and the likelihood for long-term use. Journal of the American Pharmacists Association : JAPhA. 2019 Jan 1; 59(1):17-22.
  564. Finlay AK, Wong JJ, Ellerbe LS, Rubinsky A, Gupta S, Bowe TR, Schmidt EM, Timko C, Burden JL, Harris AHS. Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs. Journal of studies on alcohol and drugs. 2018 Nov 1; 79(6):909-917.
  565. Frakt AB, Humphries K. Just Say No to Opioids? Ads Could Actually Make Things Worse. The New York Times. 2018 Nov 1: The Upshot: A3.
  566. Frost MC, Williams EC, Kingston S, Banta-Green CJ. Interest in Getting Help to Reduce or Stop Substance Use Among Syringe Exchange Clients Who Use Opioids. Journal of addiction medicine. 2018 Nov 1; 12(6):428-434.
  567. Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, Berlowitz DR, Smelson DA. Overdose risk for veterans receiving opioids from multiple sources. The American journal of managed care. 2018 Nov 1; 24(11):536-540.
  568. Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications. Pain medicine (Malden, Mass.). 2018 Nov 1; 19(11):2201-2211.
  569. Sowicz TJ, Gordon AJ, Gellad WF, Zhao X, Zhang H, Emmendorfer T, Good CB. High Variability of Opioid Prescribing Within and Across Emergency Departments in the US Veterans Health Administration. Journal of general internal medicine. 2018 Nov 1; 33(11):1831-1832.
  570. Humphreys K. Evaluating dynamic impacts of abuse-deterrent prescription opioid formulations. Addiction (Abingdon, England). 2019 Mar 1; 114(3):400-401.
  571. Crockett S, Greer KB, Sultan S. Opioid-Induced Constipation (OIC) Guideline. Gastroenterology. 2019 Jan 1; 156(1):228.
  572. Dublin S, Walker RL, Shortreed SM, Ludman EJ, Sherman KJ, Hansen RN, Thakral M, Saunders K, Parchman ML, Von Korff M. Impact of initiatives to reduce prescription opioid risks on medically attended injuries in people using chronic opioid therapy. Pharmacoepidemiology and drug safety. 2019 Jan 1; 28(1):90-96.
  573. Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF. Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among Veterans. Research in social & administrative pharmacy : RSAP. 2019 Aug 1; 15(8):1007-1013.
  574. Rogal SS, Beste LA, Youk A, Fine MJ, Ketterer B, Zhang H, Leipertz S, Chartier M, Good CB, Kraemer KL, Chinman M, Morgan T, Gellad WF. Characteristics of Opioid Prescriptions to Veterans With Cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2019 May 1; 17(6):1165-1174.e3.
  575. Hanson B, Siddique SM, Scarlett Y, Sultan S, American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019 Jan 1; 156(1):229-253.e5.
  576. Humphreys KN. Medical cannabis, pain, and the opioid epidemic: Briefing before the House and Senate staff; 2018 Oct 15; Washington, DC.
  577. Brescia AA, Harrington CA, Mazurek AA, Ward ST, Lee JSJ, Hu HM, Brummett CM, Waljee JF, Lagisetty PA, Lagisetty KH. Factors Associated With New Persistent Opioid Usage After Lung Resection. The Annals of thoracic surgery. 2019 Feb 1; 107(2):363-368.
  578. Carico R, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Suda KJ, Stroupe K, Hanlon JT, Good CB, Fine MJ, Gellad WF. Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study. Annals of internal medicine. 2018 Nov 6; 169(9):593-601.
  579. Chui PW, Bastian LA, DeRycke E, Brandt CA, Becker WC, Goulet JL. Dual Use of Department of Veterans Affairs and Medicare Benefits on High-Risk Opioid Prescriptions in Veterans Aged 65 Years and Older: Insights from the VA Musculoskeletal Disorders Cohort. Health services research. 2018 Dec 1; 53 Suppl 3:5402-5418.
  580. Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS. Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. Journal of substance abuse treatment. 2018 Dec 1; 95:43-47.
  581. Starosta AJ, Hastings J, Nazem S, Ronzitti S, Goulet JL. Impact of Opioid Prescriptions on Suicide Risk Among Veterans With Musculoskeletal Disorder (MSD) Diagnoses. [Abstract]. Archives of physical medicine and rehabilitation. 2018 Oct 1; 99(10):e63.
  582. Vanneman ME, Larson MJ, Chen C, Adams RS, Williams TV, Meerwijk E, Harris AHS. Treatment of Low Back Pain With Opioids and Nonpharmacologic Treatment Modalities for Army Veterans. Medical care. 2018 Oct 1; 56(10):855-861.
  583. Hanks D. In Progress-4: Improving Opioid Safety. 2018 Sep 24; 3(4).
  584. Timko C, Cucciare MA. Commentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment. Addiction (Abingdon, England). 2018 Dec 1; 113(12):2259-2260.
  585. Wren AA, Bensen R, Sceats L, Dehghan M, Yu H, Wong JJ, MacIsaac D, Sellers ZM, Kin C, Park KT. Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015. Inflammatory Bowel Diseases. 2018 Sep 15; 24(10):2093-2103.
  586. Meshberg-Cohen S, Black AC, DeViva JC, Petrakis IL, Rosen MI. Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder. Addictive Behaviors. 2019 Feb 1; 89:29-34.
  587. Ilgen M. Pain, Opioids, and Suicide Mortality in the United States. Annals of internal medicine. 2018 Oct 2; 169(7):498-499.
  588. Von Korff M, Saunders K, Dublin S, Walker RL, Thakral M, Sherman KJ, Ludman EJ, Hansen RN, Parchman M, Shortreed SM. Impact of Chronic Opioid Therapy Risk Reduction Initiatives on Opioid Overdose. The journal of pain : official journal of the American Pain Society. 2019 Jan 1; 20(1):108-117.
  589. Herzig SJ, Mosher HJ, Calcaterra SL, Nuckols TK. Reply to "In Reference to 'Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine'". Journal of hospital medicine. 2018 Sep 1; 13(10):728.
  590. Leapman MS, DeRycke E, Skanderson M, Becker WC, Makarov DV, Gross CP, Driscoll M, Motamedinia P, Bathulapalli H, Mattocks K, Brandt CA, Haskell S, Bastian LA. Variation in National Opioid Prescribing Patterns Following Surgery for Kidney Stones. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S12-S18.
  591. Lisi AJ, Corcoran KL, DeRycke EC, Bastian LA, Becker WC, Edmond SN, Goertz CM, Goulet JL, Haskell SG, Higgins DM, Kawecki T, Kerns RD, Mattocks K, Ramsey C, Ruser CB, Brandt CA. Opioid Use Among Veterans of Recent Wars Receiving Veterans Affairs Chiropractic Care. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S54-S60.
  592. Midboe AM, Wu J, Erhardt T, Carmichael JM, Bounthavong M, Christopher MLD, Gale RC. Academic Detailing to Improve Opioid Safety: Implementation Lessons from a Qualitative Evaluation. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S46-S53.
  593. Oldfield BJ, Edens EL, Agnoli A, Bone CW, Cervone DJ, Edmond SN, Manhapra A, Sellinger JJ, Becker WC. Multimodal Treatment Options, Including Rotating to Buprenorphine, Within a Multidisciplinary Pain Clinic for Patients on Risky Opioid Regimens: A Quality Improvement Study. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S38-S45.
  594. Cohen-Mekelburg S, Rosenblatt R, Gold S, Burakoff R, Waljee AK, Saini S, Schackman BR, Scherl E, Crawford C. The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients. Journal of Crohn's & colitis. 2018 Aug 29; 12(9):1030-1035.
  595. Bohnert ASB, Guy GP, Losby JL. Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline. Annals of internal medicine. 2018 Sep 18; 169(6):367-375.
  596. Kertesz SG, Gordon AJ. A crisis of opioids and the limits of prescription control: United States. Addiction (Abingdon, England). 2019 Jan 1; 114(1):169-180.
  597. Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American journal of public health. 2018 Oct 1; 108(10):1394-1400.
  598. Barry DT, Marshall BDL, Becker WC, Gordon AJ, Crystal S, Kerns RD, Gaither JR, Gordon KS, Justice AC, Fiellin DA, Edelman EJ. Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care. Drug and Alcohol Dependence. 2018 Oct 1; 191:348-354.
  599. Riddle DL, Slover JD, Ang DC, Bair MJ, Kroenke K, Perera RA, Dumenci L. Opioid use prior to knee arthroplasty in patients who catastrophize about their pain: preoperative data from a multisite randomized clinical trial. Journal of pain research. 2018 Aug 21; 11:1549-1557.
  600. Sasson C, Smith J, Kessler C, Haukoos J, Himstreet J, Christopher M, Emmendorfer T. Variability in opioid prescribing in veterans affairs emergency departments and urgent cares. The American journal of emergency medicine. 2019 Jun 1; 37(6):1044-1047.
  601. Lowenstein M, Grande D, Delgado MK. Opioid Prescribing Limits for Acute Pain - Striking the Right Balance. The New England journal of medicine. 2018 Aug 9; 379(6):504-506.
  602. Zhu Y, Evans EA, Mooney LJ, Saxon AJ, Kelleghan A, Yoo C, Hser YI. Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2018 Dec 1; 13(4):488-497.
  603. Carlson KF, Gilbert TA, Morasco BJ, Wright D, Otterloo JV, Herrndorf A, Cook LJ. Linkage of VA and State Prescription Drug Monitoring Program Data to Examine Concurrent Opioid and Sedative-Hypnotic Prescriptions among Veterans. Health services research. 2018 Dec 1; 53 Suppl 3:5285-5308.
  604. Krebs EE, Gravely A, Noorbaloochi S. Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain-Reply. [Letter to the Editor]. JAMA. 2018 Aug 7; 320(5):508-509.
  605. Hulen E, Saha S, Morasco BJ, Zeigler C, Mackey K, Edwards ST. Sources of Distress in Primary Care Opioid Management and the Role of a Controlled Substance Review Group: A Qualitative Study. Pain medicine (Malden, Mass.). 2018 Aug 1; 19(8):1570-1577.
  606. Humphreys K. Reconciling the Present and the Future in Opioid Prescription Policy: An Ethical Dilemma. Pain medicine (Malden, Mass.). 2018 Aug 1; 19(8):1514-1515.
  607. Shayegani R, Pugh MJ, Kazanis W, Wilkening GL. Reducing coprescriptions of benzodiazepines and opioids in a veteran population. The American journal of managed care. 2018 Aug 1; 24(8):e265-e269.
  608. Hayes CJ, Payakachat N, Li C. Evaluation of opioid use among patients with back disorders and arthritis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2018 Nov 1; 27(11):3021-3035.
  609. Giannitrapani KF, Glassman PA, Vang D, McKelvey JC, Thomas Day R, Dobscha SK, Lorenz KA. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management. BMC family practice. 2018 Jul 3; 19(1):107.
  610. Giannitrapani KF, Ahluwalia SC, McCaa M, Pisciotta M, Dobscha S, Lorenz KA. Barriers to Using Nonpharmacologic Approaches and Reducing Opioid Use in Primary Care. Pain medicine (Malden, Mass.). 2018 Jul 1; 19(7):1357-1364.
  611. Wyse JJ, Morasco BJ, Dobscha SK, Demidenko MI, Meath THA, Lovejoy TI. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified. Journal of opioid management. 2018 Jul 1; 14(4):295-303.
  612. Minegishi T, Garrido MM, Pizer SD, Frakt AB. Effectiveness of policy and risk targeting for opioid-related risk mitigation: a randomised programme evaluation with stepped-wedge design. BMJ open. 2018 Jun 27; 8(6):e020097.
  613. Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J, Lu L. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry. 2019 Dec 1; 24(12):1868-1883.
  614. Young SD, Zheng K, Chu LF, Humphreys K. Internet searches for opioids predict future emergency department heroin admissions. Drug and Alcohol Dependence. 2018 Sep 1; 190:166-169.
  615. Koppen L, Suda KJ, Rowan S, McGregor J, Evans CT. Dentists' prescribing of antibiotics and opioids to Medicare Part D beneficiaries: Medications of high impact to public health. Journal of the American Dental Association (1939). 2018 Aug 1; 149(8):721-730.
  616. Hawkins EJ. Opioid and Benzodiazepine Co-prescribing and Mortality among VA Patients with Posttraumatic Stress Disorder. HSR&D CyberSeminars [Cyberseminar]. HSR&D. 2018 Jun 11.
  617. Klueh MP, Hu HM, Howard RA, Vu JV, Harbaugh CM, Lagisetty PA, Brummett CM, Englesbe MJ, Waljee JF, Lee JS. Transitions of Care for Postoperative Opioid Prescribing in Previously Opioid-Naïve Patients in the USA: a Retrospective Review. Journal of general internal medicine. 2018 Oct 1; 33(10):1685-1691.
  618. Darnall BD, Humphreys KN. An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain. [Letter to the Editor]. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1552-1553.
  619. Dash GF, Wilson AC, Morasco BJ, Feldstein Ewing SW. A Model of the Intersection of Pain and Opioid Misuse in Children and Adolescents. Clinical psychological science : a journal of the Association for Psychological Science. 2018 Sep 1; 6(5):629-646.
  620. Lewis ET. Data-Based Case Reviews of Patients with Opioid Related Risk Factors as a Tool to Prevent Overdose and Suicide. SoSP (Suicide Prevention) [Cyberseminar]. HSR&D. 2018 Jun 4.
  621. Butler JM, Becker WC, Humphreys K. Big Data and the Opioid Crisis: Balancing Patient Privacy with Public Health. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 2018 Jun 1; 46(2):440-453.
  622. Minegishi T, Frakt A. Reducing Long-term Opioid Use in the Veterans Health Administration. [Editorial]. Journal of general internal medicine. 2018 Jun 1; 33(6):781-782.
  623. Saraswathula A, Chen MM, Mudumbai SC, Whittemore AS, Divi V. Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2019 Mar 1; 160(3):380-387.
  624. Ashrafioun L, Allen KD, Pigeon WR. Utilization of complementary and integrative health services and opioid therapy by patients receiving Veterans Health Administration pain care. Complementary therapies in medicine. 2018 Aug 1; 39:8-13.
  625. Dindo L, Zimmerman MB, Hadlandsmyth K, StMarie B, Embree J, Marchman J, Tripp-Reimer T, Rakel B. Acceptance and Commitment Therapy for Prevention of Chronic Postsurgical Pain and Opioid Use in At-Risk Veterans: A Pilot Randomized Controlled Study. The journal of pain : official journal of the American Pain Society. 2018 Oct 1; 19(10):1211-1221.
  626. Frank JW, Gilmartin HM. Pain Management and Opioid Safety. https://www.hsrd.research.va.gov/news/podcasts/listen.cfm?ID=28; 2018 May 4. Available from: https://www.hsrd.research.va.gov/news/podcasts/listen.cfm?ID=28.
  627. Hecht MI, Hanks D, Gilmartin HM, Frank JW. Podcast: Pain Management and Opioid Safety. 2018 May 4. 2 (10). Available from: https://www.hsrd.research.va.gov/news/podcasts/default.cfm.
  628. Alzeer AH, Jones J, Bair MJ. Review of Factors, Methods, and Outcome Definition in Designing Opioid Abuse Predictive Models. Pain medicine (Malden, Mass.). 2018 May 1; 19(5):997-1009.
  629. Carey EP, Nolan C, Kerns RD, Ho PM, Frank JW. Association Between Facility-Level Utilization of Non-pharmacologic Chronic Pain Treatment and Subsequent Initiation of Long-Term Opioid Therapy. Journal of general internal medicine. 2018 May 1; 33(Suppl 1):38-45.
  630. Finley EP, Schneegans S, Tami C, Pugh MJ, McGeary D, Penney L, Sharpe Potter J. Implementing prescription drug monitoring and other clinical decision support for opioid risk mitigation in a military health care setting: a qualitative feasibility study. Journal of the American Medical Informatics Association : JAMIA. 2018 May 1; 25(5):515-522.
  631. Hill KP, Saxon AJ. The Role of Cannabis Legalization in the Opioid Crisis. JAMA internal medicine. 2018 May 1; 178(5):679-680.
  632. Humphreys K. How Medicaid Can Strengthen the National Response to the Opioid Epidemic. American journal of public health. 2018 May 1; 108(5):589-590.
  633. Lovejoy TI, Morasco BJ, Demidenko MI, Meath THA, Dobscha SK. Clinician Referrals for Non-opioid Pain Care Following Discontinuation of Long-term Opioid Therapy Differ Based on Reasons for Discontinuation. Journal of general internal medicine. 2018 May 1; 33(Suppl 1):24-30.
  634. Lozier CC, Nugent SM, Smith NX, Yarborough BJ, Dobscha SK, Deyo RA, Morasco BJ. Correlates of Use and Perceived Effectiveness of Non-pharmacologic Strategies for Chronic Pain Among Patients Prescribed Long-term Opioid Therapy. Journal of general internal medicine. 2018 May 1; 33(Suppl 1):46-53.
  635. Quinn PD, Hur K, Chang Z, Scott EL, Krebs EE, Bair MJ, Rickert ME, Gibbons RD, Kroenke K, D'Onofrio BM. Association of Mental Health Conditions and Treatments With Long-term Opioid Analgesic Receipt Among Adolescents. JAMA pediatrics. 2018 May 1; 172(5):423-430.
  636. Matthias MS, Donaldson MT, Jensen AC, Krebs EE. "I Was a Little Surprised": Qualitative Insights From Patients Enrolled in a 12-Month Trial Comparing Opioids With Nonopioid Medications for Chronic Musculoskeletal Pain. The journal of pain : official journal of the American Pain Society. 2018 Sep 1; 19(9):1082-1090.
  637. Adams MH, Dobscha SK, Smith NX, Yarborough BJ, Deyo RA, Morasco BJ. Prevalence and Correlates of Low Pain Interference Among Patients With High Pain Intensity Who Are Prescribed Long-Term Opioid Therapy. The journal of pain : official journal of the American Pain Society. 2018 Sep 1; 19(9):1074-1081.
  638. Lovejoy TI, Dobscha SK, Morasco BJ, Smith CL, Meath T, Demidenko M, McPherson S. Changes in pain intensity following discontinuation of long-term opioid therapy. [Abstract]. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2018 Apr 11; 52(1):S165.
  639. Dana R, Azarpazhooh A, Laghapour N, Suda KJ, Okunseri C. Role of Dentists in Prescribing Opioid Analgesics and Antibiotics: An Overview. Dental clinics of North America. 2018 Apr 1; 62(2):279-294.
  640. Delgado MK, Shofer FS, Patel MS, Halpern S, Edwards C, Meisel ZF, Perrone J. Association between Electronic Medical Record Implementation of Default Opioid Prescription Quantities and Prescribing Behavior in Two Emergency Departments. Journal of general internal medicine. 2018 Apr 1; 33(4):409-411.
  641. Hah J, Mackey SC, Schmidt P, McCue R, Humphreys K, Trafton J, Efron B, Clay D, Sharifzadeh Y, Ruchelli G, Goodman S, Huddleston J, Maloney WJ, Dirbas FM, Shrager J, Costouros JG, Curtin C, Carroll I. Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial. JAMA surgery. 2018 Apr 1; 153(4):303-311.
  642. Herzig SJ, Calcaterra SL, Mosher HJ, Ronan MV, Groningen NV, Shek L, Loffredo A, Keller M, Jena AB, Nuckols TK. Safe Opioid Prescribing for Acute Noncancer Pain in Hospitalized Adults: A Systematic Review of Existing Guidelines. Journal of hospital medicine. 2018 Apr 1; 13(4):256-262.
  643. Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement From the Society of Hospital Medicine. Journal of hospital medicine. 2018 Apr 1; 13(4):263-271.
  644. Hudson TJ, Painter JT, Gressler LE, Lu L, Williams JS, Booth BM, Martin BC, Sullivan MD, Edlund MJ. Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury. Pain medicine (Malden, Mass.). 2018 Apr 1; 19(4):774-787.
  645. Mosher HJ, Hofmeyer BA, Hadlandsmyth K, Richardson KK, Lund BC. Predictors of Long-Term Opioid Use After Opioid Initiation at Discharge From Medical and Surgical Hospitalizations. Journal of hospital medicine. 2018 Apr 1; 13(4):243-248.
  646. Mosher HJ, Richardson KK, Lund BC. Sedative Prescriptions Are Common at Opioid Initiation: An Observational Study in the Veterans Health Administration. Pain medicine (Malden, Mass.). 2018 Apr 1; 19(4):788-792.
  647. Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ. Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1477-1487.
  648. Raffel KE, Beach LY, Lin J, Berchuck JE, Abram S, Markle E, Patel S. Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care Clinic. The Permanente journal. 2018 Mar 30; 22.
  649. Lembke A, Humphreys K. The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine. Academic Psychiatry : The Journal of The American Association of Directors of Psychiatric Residency Training and The Association For Academic Psychiatry. 2018 Apr 1; 42(2):269-272.
  650. Becker WC, Mattocks KM, Frank JW, Bair MJ, Jankowski RL, Kerns RD, Painter JT, Fenton BT, Midboe AM, Martino S. Mixed methods formative evaluation of a collaborative care program to decrease risky opioid prescribing and increase non-pharmacologic approaches to pain management. Addictive Behaviors. 2018 Nov 1; 86(1):138-145.
  651. Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, Kroenke K, Bair MJ, Noorbaloochi S. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018 Mar 6; 319(9):872-882.
  652. Frakt AB. Overshadowed by the Opioid Crisis: A Comeback by Cocaine. The New York Times. 2018 Mar 5: The Upshot: A3.
  653. Fassio V, Aspinall SL, Zhao X, Miller DR, Singh JA, Good CB, Cunningham FE. Trends in opioid and nonsteroidal anti-inflammatory use and adverse events. The American journal of managed care. 2018 Mar 1; 24(3):e61-e72.
  654. Gressler LE, Martin BC, Hudson TJ, Painter JT. Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain. 2018 Mar 1; 159(3):451-459.
  655. Hayes CJ, Ortiz H, Martin B, Hudson TJ, Robertson D, Aram J, Smith GR. Opioid prescribing in Arkansas and next steps. The Journal of The Arkansas Medical Society. 2018 Mar 1; 114(9):200-202.
  656. Hayes CJ, Li X, Li C, Shah A, Kathe N, Bhandari NR, Payakachat N. Health-Related Quality of Life among Chronic Opioid Users, Nonchronic Opioid Users, and Nonopioid Users with Chronic Noncancer Pain. Health services research. 2018 Oct 1; 53(5):3329-3349.
  657. Hall W, West R, Marsden J, Humphreys K, Neale J, Petry N. It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. [Editorial]. Addiction (Abingdon, England). 2018 Jun 1; 113(6):987-988.
  658. Malte CA, Berger D, Saxon AJ, Hagedorn HJ, Achtmeyer CE, Mariano AJ, Hawkins EJ. Electronic Medical Record Alert Associated With Reduced Opioid and Benzodiazepine Coprescribing in High-risk Veteran Patients. Medical care. 2018 Feb 1; 56(2):171-178.
  659. Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018 Oct 1; 16(10):1569-1584.e2.
  660. Hadlandsmyth K, Mosher H, Vander Weg MW, Lund BC. Decline in Prescription Opioids Attributable to Decreases in Long-Term Use: A Retrospective Study in the Veterans Health Administration 2010-2016. Journal of general internal medicine. 2018 Jun 1; 33(6):818-824.
  661. Humphreys K. A public health approach to opioid addiction in North America - Author's reply. Lancet (London, England). 2018 Jan 20; 391(10117):202.
  662. Argoff CE, Alford DP, Fudin J, Adler JA, Bair MJ, Dart RC, Gandolfi R, McCarberg BH, Stanos SP, Gudin JA, Polomano RC, Webster LR. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations. Pain medicine (Malden, Mass.). 2018 Jan 1; 19(1):97-117.
  663. Wyse JJ, Gordon AJ, Dobscha SK, Morasco BJ, Tiffany E, Drexler K, Sandbrink F, Lovejoy TI. Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps. Substance Abuse. 2018 Jan 1; 39(2):139-144.
  664. Gellad WF, Thorpe JM, Zhao X, Thorpe CT, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Gordon AJ, Suda KJ, Stroupe KT, Hanlon JT, Cunningham FE, Good CB, Fine MJ. Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid Use. American journal of public health. 2018 Feb 1; 108(2):248-255.
  665. Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedmann PD. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatric services (Washington, D.C.). 2018 Apr 1; 69(4):448-455.
  666. Mosher H, Herzig SJ, Danovitch I, Boutsicaris C, Hassamal S, Wittnebel K, Dashti A, Nuckols T. The Evaluation of Medical Inpatients Who Are Admitted on Long-term Opioid Therapy for Chronic Pain. Journal of hospital medicine. 2018 Apr 1; 13(4):249-255.
  667. Tessier CD. Using Opioids Safely After Surgery. Consumer Reports (Choosing Wisely) [Internet]. 2017 Dec 1: Available from: http://www.choosingwisely.org/wp-content/uploads/2018/02/Using-Opioids-Safely-After-Surgery-AUA.pdf.
  668. Frakt AB. Where Is the Prevention in the President's Opioid Report? The New York Times. 2017 Nov 13: The Upshot: A3.
  669. Nugent SM, Yarborough BJ, Smith NX, Dobscha SK, Deyo RA, Green CA, Morasco BJ. Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy. General hospital psychiatry. 2018 Jan 1; 50:104-110.
  670. Tedesco D, Gori D, Desai KR, Asch S, Carroll IR, Curtin C, McDonald KM, Fantini MP, Hernandez-Boussard T. Drug-Free Interventions to Reduce Pain or Opioid Consumption After Total Knee Arthroplasty: A Systematic Review and Meta-analysis. JAMA surgery. 2017 Oct 18; 152(10):e172872.
  671. Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE. 2017 Oct 17; 12(10):e0186315.
  672. Tedesco D, Asch SM, Curtin C, Hah J, McDonald KM, Fantini MP, Hernandez-Boussard T. Opioid Abuse And Poisoning: Trends In Inpatient And Emergency Department Discharges. Health affairs (Project Hope). 2017 Oct 1; 36(10):1748-1753.
  673. Lovejoy TI, Morasco BJ, Kumthekar A, Shull S, Chang M, Barton J. Eradication of hepatitis C among US veterans: examination of changes in pain severity and prescription opioid use following treatment. [Abstract]. Arthritis + Rheuma.. 2017 Sep 27; 69(10):2221.
  674. Taylor SL. Addressing America's Opioid Problem: The Need for Evidence-Based Strategies: Briefing before the Senator and Congressional staffers, organized by PCORI and Anthem Blue Cross; 2017 Sep 19; Wash DC.
  675. Frakt AB. A Helpful Tool to Combat the Opioid Crisis. New York Times. 2017 Sep 11: The Upshot: The New Health Care.
  676. Gerlach LB, Olfson M, Kales HC, Maust DT. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States. Journal of the American Geriatrics Society. 2017 Sep 1; 65(9):2052-2056.
  677. Hadlandsmyth K, Vander Weg MW, McCoy KD, Mosher HJ, Vaughan-Sarrazin MS, Lund BC. Risk for Prolonged Opioid Use Following Total Knee Arthroplasty in Veterans. Journal of Arthroplasty. 2018 Jan 1; 33(1):119-123.
  678. Han L, Allore H, Goulet J, Bathulapali H, Skanderson M, Brandt C, Haskell S, Krebs E. Opioid dosing trends over eight years among US Veterans with musculoskeletal disorders after returning from service in support of recent conflicts. Annals of epidemiology. 2017 Sep 1; 27(9):563-569.e3.
  679. Mosher H, Zhou Y, Thurman AL, Sarrazin MV, Ohl ME. Trends in Hospitalization for Opioid Overdose among Rural Compared to Urban Residents of the United States, 2007-2014. Journal of hospital medicine. 2017 Nov 1; 12(11):925-929.
  680. Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM. Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid. [Letter to the Editor]. JAMA : the journal of the American Medical Association. 2017 Aug 22; 318(8):750-752.
  681. Balbale SN, Trivedi I, O'Dwyer LC, McHugh MC, Evans CT, Jordan N, Keefer LA. Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review. Digestive diseases and sciences. 2017 Oct 1; 62(10):2668-2685.
  682. Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, Dischinger HR, Dobscha SK, Krebs EE. Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review. Annals of internal medicine. 2017 Aug 1; 167(3):181-191.
  683. Ecker AH, Hundt N. Posttraumatic stress disorder in opioid agonist therapy: A review. Psychological trauma : theory, research, practice and policy. 2018 Nov 1; 10(6):636-642.
  684. Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017 Jul 29; 390(10093):437-439.
  685. Becker W, Lovejoy TI. Opioid dose reduction in patients prescribed long-term opioid therapy for chronic pain. HSR&D Career Development Award Enhancement Initiative [Cyberseminar]. VA HSR&D. 2017 Jul 26.
  686. Becker WC, Lovejoy T. Opioid Dose Reduction in Patients Prescribed Long-Term Opioid Therapy for Chronic Pain. Career Development Award Series [Cyberseminar]. HSR&D. 2017 Jul 26.
  687. Hanks D, Hecht MI, Auffrey RR, Hawkins EJ. Podcast-10: Live from the Meeting: Opioid Co-Prescribing and PTSD Mortality. 2017 Jul 20. 1 (10). Available from: https://www.hsrd.research.va.gov/news/podcasts/default.cfm.
  688. Lagisetty P, Bohnert A. Web Exclusives. Annals for Hospitalists Inpatient Notes - The Opioid Epidemic-What's a Hospitalist to Do?. Annals of internal medicine. 2017 Jul 18; 167(2):HO2-HO3.
  689. Cochran G, McCarthy R, Gordon AJ, Tarter RE. Opioid medication misuse among unhealthy drinkers. Drug and Alcohol Dependence. 2017 Oct 1; 179:13-17.
  690. Midboe AM. Best practices for Academic Detailing for Opioid Prescribing: Briefing before the National CMO Chief of Staff; 2017 Jul 10; Teleconference.
  691. Matthias MS, Johnson NL, Shields CG, Bair MJ, MacKie P, Huffman M, Alexander SC. "I'm Not Gonna Pull the Rug out From Under You": Patient-Provider Communication About Opioid Tapering. The journal of pain : official journal of the American Pain Society. 2017 Nov 1; 18(11):1365-1373.
  692. Becker WC, Fenton BT, Brandt CA, Doyle EL, Francis J, Goulet JL, Moore BA, Torrise V, Kerns RD, Kreiner PW. Multiple Sources of Prescription Payment and Risky Opioid Therapy Among Veterans. Medical care. 2017 Jul 1; 55 Suppl 7 Suppl 1:S33-S36.
  693. Lovejoy TI. Discontinuation of Long-Term Opioid Therapy among Veterans is Overwhelmingly Initiated by VA Clinicians. 2017 Jul 1.
  694. Watkins KE, Paddock SM, Hudson TJ, Ounpraseuth S, Schrader AM, Hepner KA, Stein BD. Association between process measures and mortality in individuals with opioid use disorders. Drug and Alcohol Dependence. 2017 Aug 1; 177:307-314.
  695. Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA surgery. 2017 Jun 21; 152(6):e170504.
  696. Kroenke K, Cheville A. Management of Chronic Pain in the Aftermath of the Opioid Backlash. JAMA. 2017 Jun 20; 317(23):2365-2366.
  697. Mundkur ML, Gordon AJ, Kertesz SG. Will strict limits on opioid prescription duration prevent addiction? Advocating for evidence-based policymaking. Substance Abuse. 2017 Jul 1; 38(3):237-238.
  698. Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BDL. Reply to Osborne & Serdarevic (2017): Potential impact of exposure definition when examining non-medical use of prescription opioids among US veterans. [Letter to the Editor]. Addiction (Abingdon, England). 2017 Aug 1; 112(8):1510-1511.
  699. Nugent SM, Dobscha SK, Morasco BJ, Demidenko MI, Meath THA, Frank JW, Lovejoy TI. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test. Journal of general internal medicine. 2017 Oct 1; 32(10):1076-1082.
  700. Bastian LA, Driscoll MA, Heapy AA, Becker WC, Goulet JL, Kerns RD, DeRycke EC, Perez E, Lynch SM, Mattocks K, Kroll-Desrosiers AR, Brandt CA, Skanderson M, Bathulapalli H, Haskell SG. Cigarette Smoking Status and Receipt of an Opioid Prescription Among Veterans of Recent Wars. Pain medicine (Malden, Mass.). 2017 Jun 1; 18(6):1089-1097.
  701. Becker WC, Fiellin DA. Abuse-Deterrent Opioid Formulations - Putting the Potential Benefits into Perspective. [Editorial]. The New England journal of medicine. 2017 Jun 1; 376(22):2103-2105.
  702. Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans. Pain. 2017 Jun 1; 158(6):1039-1045.
  703. Cochran G, Rosen D, McCarthy RM, Engel RJ. Risk Factors for Symptoms of Prescription Opioid Misuse: Do Older Adults Differ from Younger Adult Patients?. Journal of gerontological social work. 2017 Aug 1; 60(6-7):443-457.
  704. Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR, Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO, Guyatt GH. Guideline for opioid therapy and chronic noncancer pain. CMAJ: Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 2017 May 8; 189(18):E659-E666.
  705. Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21:Results from a Qualitative Rapid Analysis: Briefing before the National Pharmacy Benefits Management Advisory Board; 2017 May 2; San Diego, CA.
  706. Bossi KE. HSR&D e-Pub Briefs-3: Summaries of select journal articles published by HSR&D investigators on Acute Pain, Chronic Pain, C. Diff Infection, Hypertension, and Opioids. 2017 May 1; 9(3).
  707. Cochran G, Gordon AJ, Gellad WF, Chang CH, Lo-Ciganic WH, Lobo C, Cole E, Frazier W, Zheng P, Kelley D, Donohue JM. Medicaid prior authorization and opioid medication abuse and overdose. The American journal of managed care. 2017 May 1; 23(5):e164-e171.
  708. Gellad WF, Good CB, Shulkin DJ. Addressing the Opioid Epidemic in the United States: Lessons From the Department of Veterans Affairs. [Editorial]. JAMA internal medicine. 2017 May 1; 177(5):611-612.
  709. Lin LA, Bohnert ASB, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans. Pain. 2017 May 1; 158(5):833-839.
  710. Demidenko MI, Dobscha SK, Morasco BJ, Meath THA, Ilgen MA, Lovejoy TI. Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. General hospital psychiatry. 2017 Jul 1; 47:29-35.
  711. Suda KJ, Smith BM, Bailey L, Gellad WF, Huo Z, Burk M, Cunningham F, Stroupe KT. Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D. Journal of the American Pharmacists Association : JAPhA. 2017 May 1; 57(3):333-340.e3.
  712. Becker WC, Gordon K, Edelman EJ, Kerns RD, Crystal S, Dziura JD, Fiellin LE, Gordon AJ, Goulet JL, Justice AC, Fiellin DA. Erratum to: Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV. AIDS and behavior. 2017 Apr 1; 21(4):1228.
  713. Gordon AJ, Harding JD. From education to practice: Addressing opioid misuse through health care provider training: A special issue of Substance Abuse journal. Substance Abuse. 2017 Apr 1; 38(2):119-121.
  714. Lovejoy TI, Demidenko MI, Morasco BJ, Meath T, Dobscha SK. Suicidal ideation and behaviors following clinician-initiated prescription opioid discontinuation among long-term opioid users. [Abstract]. The journal of pain : official journal of the American Pain Society. 2017 Apr 1; 18(4):S36.
  715. Morasco BJ, Yarborough BJ, Smith NX, Dobscha SK, Deyo RA, Perrin NA, Green CA. Higher Prescription Opioid Dose is Associated With Worse Patient-Reported Pain Outcomes and More Health Care Utilization. The journal of pain : official journal of the American Pain Society. 2017 Apr 1; 18(4):437-445.
  716. Winograd RP, Davis CS, Niculete M, Oliva E, Martielli RP. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings. Substance Abuse. 2017 Apr 1; 38(2):135-140.
  717. Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ (Clinical research ed.). 2017 Mar 14; 356:j760.
  718. Friedmann PD, Andrews CM, Humphreys K. How ACA Repeal Would Worsen the Opioid Epidemic. The New England journal of medicine. 2017 Mar 9; 376(10):e16.
  719. Hawkins EJ, Malte CA, Hagedorn HJ, Berger D, Frank A, Lott A, Achtmeyer CE, Mariano AJ, Saxon AJ. Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans. Pain medicine (Malden, Mass.). 2017 Mar 1; 18(3):454-467.
  720. Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications. Journal of opioid management. 2017 Mar 1; 13(2):95-103.
  721. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain. 2017 Mar 1; 158(3):526-534.
  722. Oliva EM, Christopher ML, Wells D, Bounthavong M, Harvey M, Himstreet J, Emmendorfer T, Valentino M, Franchi M, Goodman F, Trafton JA, Veterans Health Administration Opioid Overdose Education and Naloxone Distribution National Support and Development Workgroup. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. Journal of the American Pharmacists Association : JAPhA. 2017 Mar 1; 57(2S):S168-S179.e4.
  723. Hanks D. QUERI e-News-1: Pain Management and Opioid Use. [Newsletter] 2017 Feb 28. 9 (1). Available from: https://www.queri.research.va.gov/qnews/feb17/default.cfm.
  724. Krebs E, Urada D, Evans E, Huang D, Hser YI, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction (Abingdon, England). 2017 May 1; 112(5):838-851.
  725. Frakt AB. Assessing and Reducing Opioid Prescription Risk: VA Response to the Comprehensive Addiction and Recovery Act of 2016. QUERI eNews. 2017 Feb 3; Feb 2017(1): 1.
  726. Oliva EM, Bowe T, Tavakoli S, Martins S, Lewis ET, Paik M, Wiechers I, Henderson P, Harvey M, Avoundjian T, Medhanie A, Trafton JA. Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychological Services. 2017 Feb 1; 14(1):34-49.
  727. Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BD. Reply to Ruan et al. (2017): Non-medical use of prescription opioids is associated with heroin initiation among US veterans. [Letter to the Editor]. Addiction (Abingdon, England). 2017 Apr 1; 112(4):728-729.
  728. Guillod P, Edens EL, Becker WC. Ultra-High-Dose Opioids With Low Efficacy and Significant Harm-Time to Make a Change: A Teachable Moment. [Editorial]. JAMA internal medicine. 2017 Jan 1; 177(1):17-18.
  729. Quinn PD, Hur K, Chang Z, Krebs EE, Bair MJ, Scott EL, Rickert ME, Gibbons RD, Kroenke K, D'Onofrio BM. Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain. 2017 Jan 1; 158(1):140-148.
  730. Stein BD, Mendelsohn J, Gordon AJ, Dick AW, Burns RM, Sorbero M, Shih RA, Liccardo Pacula R. Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities. Journal of addictive diseases. 2017 Jan 1; 36(1):14-22.
  731. Krebs E, Min JE, Evans E, Li L, Liu L, Huang D, Urada D, Kerr T, Hser YI, Nosyk B. Estimating State Transitions for Opioid Use Disorders. Medical Decision Making. 2017 Jul 1; 37(5):483-497.
  732. Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST. Interim Buprenorphine vs. Waiting List for Opioid Dependence. [Letter to the Editor]. The New England journal of medicine. 2016 Dec 22; 375(25):2504-2505.
  733. Gellad WF, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Mor M, Hale JA, Radomski T, Hausmann LR, Fine MJ, Good CB. Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D. Substance Abuse. 2017 Jan 1; 38(1):22-25.
  734. Brennan PL, Del Re AC, Henderson PT, Trafton JA. Healthcare system-wide implementation of opioid-safety guideline recommendations: the case of urine drug screening and opioid-patient suicide- and overdose-related events in the Veterans Health Administration. Translational behavioral medicine. 2016 Dec 1; 6(4):605-612.
  735. Ducoffe AR, York A, Hu DJ, Perfetto D, Kerns RD. National Action Plan for Adverse Drug Event Prevention: Recommendations for Safer Outpatient Opioid Use. Pain medicine (Malden, Mass.). 2016 Dec 1; 17(12):2291-2304.
  736. Grogan CM, Andrews C, Abraham A, Humphreys K, Pollack HA, Smith BT, Friedmann PD. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health affairs (Project Hope). 2016 Dec 1; 35(12):2289-2296.
  737. Moore BA, Fiellin DA, Cutter CJ, Buono FD, Barry DT, Fiellin LE, O'Connor PG, Schottenfeld RS. Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment. Journal of substance abuse treatment. 2016 Dec 1; 71:54-57.
  738. Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BD. Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. Addiction (Abingdon, England). 2016 Nov 1; 111(11):2021-2031.
  739. Bastian LA. Cigarette Smoking as a Risk Factor for Chronic Opioid Use. Spotlight on Pain Management [Cyberseminar]. 2016 Nov 1.
  740. Bossi KE. HSR&D e-Pub Briefs-1: Summaries of select journal articles published by HSR&D investigators on Hepatitis C, Opioids, Surgery, Bipolar Disorder, and Obesity. 2016 Nov 1; 9(1).
  741. Choo EK, Feldstein Ewing SW, Lovejoy TI. Opioids Out, Cannabis In: Negotiating the Unknowns in Patient Care for Chronic Pain. JAMA. 2016 Nov 1; 316(17):1763-1764.
  742. Edelman EJ, Gordon KS, Tate JP, Becker WC, Bryant K, Crothers K, Gaither JR, Gibert CL, Gordon AJ, Marshall B, Rodriguez-Barradas MC, Samet JH, Skanderson M, Justice AC, Fiellin DA. The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy. HIV Medicine. 2016 Nov 1; 17(10):728-739.
  743. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Justice AC, Fiellin DA. The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality. Journal of addiction medicine. 2016 Nov 1; 10(6):418-428.
  744. Lin LA, Hosanagar A, Park TW, Bohnert AS. Opioid Overdose: Risk Assessment and Mitigation in Outpatient Treatment. Journal of addiction medicine. 2016 Nov 1; 10(6):382-386.
  745. Naples JG, Gellad WF, Hanlon JT. The Role of Opioid Analgesics in Geriatric Pain Management. Clinics in geriatric medicine. 2016 Nov 1; 32(4):725-735.
  746. Roberts AW, Gellad WF, Skinner AC. Lock-In Programs and the Opioid Epidemic: A Call for Evidence. [Editorial]. American journal of public health. 2016 Nov 1; 106(11):1918-1919.
  747. White W, Galanter M, Humphreys KN, Kelly JF. The Paucity of Attention to Narcotics Anonymous in Current Public, Professional, and Policy Responses to Rising Opioid Addiction. Alcoholism Treatment Quarterly. 2016 Oct 5; 34(4):437-462.
  748. Henry SG, Chen M, Matthias MS, Bell RA, Kravitz RL. Development of the Chronic Pain Coding System (CPCS) for Characterizing Patient-Clinician Discussions About Chronic Pain and Opioids. Pain medicine (Malden, Mass.). 2016 Oct 1; 17(10):1892-1905.
  749. Rogal S, Mankaney G, Udawatta V, Good CB, Chinman M, Zickmund S, Bielefeldt K, Jonassaint N, Jazwinski A, Shaikh O, Hughes C, Humar A, DiMartini A, Fine MJ. Association between opioid use and readmission following liver transplantation. Clinical Transplantation. 2016 Oct 1; 30(10):1222-1229.
  750. Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21: Results from a Qualitative Rapid Analysis. Presented at: VA Academic Detailing Leadership Training Meeting; 2016 Sep 21; San Diego, CA.
  751. Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA. 2016 Sep 20; 316(11):1211-1212.
  752. Lembke A, Chen JH. Use of Opioid Agonist Therapy for Medicare Patients in 2013. JAMA psychiatry. 2016 Sep 1; 73(9):990-2.
  753. Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder. The Journal of clinical psychiatry. 2016 Sep 1; 77(9):1182-1188.
  754. Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Lo Re V, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. Journal of substance abuse treatment. 2016 Sep 1; 68:62-7.
  755. Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21: Translating Lessons Learned. Presented at: VA Center for Innovation to Implementation (Ci2i) Annual Steering Committee Meeting; 2016 Aug 30; Menlo Park, CA.
  756. Lagisetty P, Heisler M, Bohnert A. Re-purposing anticoagulation clinics: expanding access to opioid agonist therapy in primary care settings. Addiction (Abingdon, England). 2017 Mar 1; 112(3):384-385.
  757. Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21: Results from a Qualitative Rapid Analysis: Briefing before the National Pharmacy Benefits Management (PBM); 2016 Aug 23; Teleconference.
  758. Gellad WF. University of Pittsburgh Efforts to Address the Opioid Epidemic: Briefing before the Assistant Secretary for Financial Resources, United States Department of Health and Human Services; 2016 Aug 9; Pittsburgh, PA.
  759. Hanks D. In Progress-2: Improving the Safety of Prescription Opioid Use among Veterans. 2016 Aug 3; 1(2).
  760. Chen JH, Hom J, Richman I, Asch SM, Podchiyska T, Johansen NA. Effect of opioid prescribing guidelines in primary care. Medicine. 2016 Aug 1; 95(35):e4760.
  761. Tobin DG, Andrews R, Becker WC. In Reply: Prescribing opioids. Cleveland Clinic journal of medicine. 2016 Aug 1; 83(8):554-5.
  762. Heapy AA, Becker WC, Midboe AM. Improving Opioid Therapy among Veterans with Chronic Pain. In Progress. 2016 Jul 29; 2016(2): http://www.hsrd.research.va.gov/publications/inprogress/jul16/default.cfm?InProgressMenu=jul16-1.
  763. Barry DT, Sofuoglu M, Kerns RD, Wiechers IR, Rosenheck RA. Prevalence and correlates of coprescribing anxiolytic medications with extensive prescription opioid use in Veterans Health Administration patients with metastatic cancer. Journal of opioid management. 2016 Jul 1; 12(4):259-68.
  764. Becker WC. Rigorous Epidemiologic Work Shows Positive Impact of VHA's Efforts to Rein in Opioid Prescribing. Pain medicine (Malden, Mass.). 2016 Jul 1; 17(7):1209-1210.
  765. Becker WC, Tetrault JM. Medical Marijuana in Patients Prescribed Opioids: A Cloud of Uncertainty. Mayo Clinic proceedings. 2016 Jul 1; 91(7):830-2.
  766. Bedson J, Chen Y, Hayward RA, Ashworth J, Walters K, Dunn KM, Jordan KP. Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study. Pain. 2016 Jul 1; 157(7):1525-31.
  767. Gordon AJ, Saba SK. Confronting the opioid epidemic through publication, promotion, and dissemination of evidence-based addiction scholarship. [Editorial]. Substance Abuse. 2016 Jul 1; 37(3):379-380.
  768. Krebs EE, Kroenke K, Wu J, Bair MJ, Kozak MA, Yu Z. Opioid Use as a Predictor of Health Care Use and Pain Outcomes: Analysis of Clinical Trial Data. Pain medicine (Malden, Mass.). 2016 Jul 1; 17(7):1261-1268.
  769. Mosher HJ, Richardson KK, Lund BC. The 1-Year Treatment Course of New Opioid Recipients in Veterans Health Administration. Pain medicine (Malden, Mass.). 2016 Jul 1; 17(7):1282-1291.
  770. Lembke A, Humphreys K, Newmark J. Weighing the Risks and Benefits of Chronic Opioid Therapy. American Family Physician. 2016 Jun 15; 93(12):982-90.
  771. Krebs EE. ACP representative to the AMA Task Force to reduce Opioid Abuse and spoke on a panel at the AMA Delegates meeting. What practical tools exist-or are needed-to help physicians better manage patients with chronic non-cancer pain? Presented at: American Medical Association Annual Meeting; 2016 Jun 13; Chicago, IL.
  772. Bohnert AS, Bonar EE, Cunningham R, Greenwald MK, Thomas L, Chermack S, Blow FC, Walton M. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug and Alcohol Dependence. 2016 Jun 1; 163:40-7.
  773. Gellad WF. Opioids and Dual Healthcare System Use. HSR&D Forum. 2016 May 31.
  774. Frank JW, Levy C, Matlock DD, Calcaterra SL, Mueller SR, Koester S, Binswanger IA. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study. Pain medicine (Malden, Mass.). 2016 Oct 1; 17(10):1838-1847.
  775. Saver JA, Zhao X, Jing T, Abotsi EJ, Thorpe JM, Thorpe CT, Skledar S. Use of Performance Measures to Quantify Opioid Misuse Risks. Poster session presented at: Pharmacy Quality Alliance Annual Meeting and Innovation Forum; 2016 May 18; Arlington, VA.
  776. Burgess DJ, Nelson DB, Gravely AA, Bair MJ, kerns RD, Higgins D. Healthcare system level factors: Racial differences in prescription of opioid analgesics for chronic non-cancer pain. Presented at: American Academy of Pain Medicine Annual Meeting; 2016 May 12; Austin, TX.
  777. Burgess DJ, Nelson DB, Gravely AA, Bair MJ, Kerns RD, Higgins D, Van Ryn M, Farmer Coste MM. Healthcare system level factors: Racial differences in prescription of opioid analgesics for chronic non-cancer pain. Paper presented at: American Pain Society Annual Meeting; 2016 May 12; Austin, TX.
  778. Frank JW, Lovejoy TI, Becker W, Morasco BJ, Koenig CJ, Dischinger HR, Dobscha SK, Krebs EE. Dose Reduction and Discontinuation of Long-Term Opioid Therapy: A Systematic Review. Paper presented at: Society of General Internal Medicine Annual Meeting; 2016 May 11; Hollywood, FL.
  779. Mosher HJ, Richardson KK, Lund BC. The One Year Treatment Course of New Opioid Recipients in Veterans Health Administration. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2016 May 11; Hollywood, FL.
  780. Robbins JL, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Gaither JR, Gordon KS, Barry D, Crystal S, Justice AC, Kraemer K. Predictors of Initiating Opioid Agonist Therapy in a Large US Cohort of HIV-Infected and Uninfected Patients. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2016 May 11; Hollywood, FL.
  781. Merlin JS, Young SR, Azari S, Becker WC, Liebschutz JM, Pomeranz J, Roy P, Saini S, Starrels JL, Edelman EJ. Management of problematic behaviours among individuals on long-term opioid therapy: protocol for a Delphi study. BMJ open. 2016 May 6; 6(5):e011619.
  782. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Poster session presented at: American Pain Society Annual Meeting; 2016 May 2; Austin, TX.
  783. Bohnert AS, Logan JE, Ganoczy D, Dowell D. A Detailed Exploration Into the Association of Prescribed Opioid Dosage and Overdose Deaths Among Patients With Chronic Pain. Medical care. 2016 May 1; 54(5):435-41.
  784. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. Journal of general internal medicine. 2016 May 1; 31(5):478-85.
  785. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Justice AC, Fiellin DA. The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality. Journal of general internal medicine. 2016 May 1; 31(5):492-501.
  786. Ilgen MA, Bohnert AS, Ganoczy D, Bair MJ, McCarthy JF, Blow FC. Opioid dose and risk of suicide. Pain. 2016 May 1; 157(5):1079-84.
  787. Krebs EE, Paudel M, Taylor BC, Bauer DC, Fink HA, Lane NE, Ensrud KE, Osteoporotic Fractures in Men (MrOS) Study Research Group. Association of Opioids with Falls, Fractures, and Physical Performance among Older Men with Persistent Musculoskeletal Pain. Journal of general internal medicine. 2016 May 1; 31(5):463-9.
  788. Matusiewicz AK, Ilgen MA, Bonar EE, Price A, Bohnert AS. The Relationship Between Non-Medical Use of Prescription Opioids and Sex Work Among Adults in Residential Substance Use Treatment. Journal of substance abuse treatment. 2016 May 1; 64:24-8.
  789. Diulio AR, Demidenko MI, Lovejoy TI. Multidisciplinary pain clinics, in Treating comorbid opioid use disorder and dependence in chronic pain. Ed. Matthews, AM. Springer International Publishing, 2016: pp. 177-184. SpringerPlus. 2016 Apr 30.
  790. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. [Abstract]. Pain. 2016 Apr 1; 17(4):s87.
  791. Martin BC, Hayes C, Austen M, Hudson T. Author response to "Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion". [Letter to the Editor]. Pharmacoepidemiology and drug safety. 2016 Apr 1; 25(4):477-8.
  792. Timko C, Gupta S, Schultz N, Harris AH. Veterans' Service Utilization Patterns After Alcohol and Opioid Detoxification in VHA Care. Psychiatric services (Washington, D.C.). 2016 Apr 1; 67(4):460-4.
  793. Finlay AK, Binswanger I, Timko C, Rosenthal J, Clark S, Blue-Howells J, McGuire J, Hagedorn H, Wong J, Van Campen J, Sox-Harris AH. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence. Paper presented at: Academic and Health Policy Conference on Correctional Health; 2016 Mar 18; Baltimore, MD.
  794. Becker WC, Gordon K, Jennifer Edelman E, Kerns RD, Crystal S, Dziura JD, Fiellin LE, Gordon AJ, Goulet JL, Justice AC, Fiellin DA. Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV. AIDS and behavior. 2016 Mar 1; 20(3):679-86.
  795. Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R. Developing a framework of care for opioid medication misuse in community pharmacy. Research in social & administrative pharmacy : RSAP. 2016 Mar 1; 12(2):293-301.
  796. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence. 2016 Mar 1; 160:222-6.
  797. Fudalej S, Jakubczyk A, Kopera M, Piwonski J, Bielecki W, Drygas W, Wasilewska K, Ilgen M, Bohnert A, Barry K, Ploski R, Blow FC, Wojnar M. DISC1 as a Possible Genetic Contribution to Opioid Dependence in a Polish Sample. Journal of studies on alcohol and drugs. 2016 Mar 1; 77(2):220-6.
  798. Kroll-Desrosiers AR, Skanderson M, Bastian LA, Brandt CA, Haskell S, Kerns RD, Mattocks KM. Receipt of Prescription Opioids in a National Sample of Pregnant Veterans Receiving Veterans Health Administration Care. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2016 Mar 1; 26(2):240-6.
  799. Tobin DG, Andrews R, Becker WC. Prescribing opioids in primary care: Safely starting, monitoring, and stopping. Cleveland Clinic journal of medicine. 2016 Mar 1; 83(3):207-15.
  800. Krebs EE, Gravely AA, Jensen AC, Bair M, Kroenke K. Expectations and analgesic preferences among participants in a 12-month trial comparing opioid versus non-opioid analgesics for chronic pain. Poster session presented at: American Academy of Pain Medicine Annual Meeting; 2016 Feb 20; Palm Springs, CA.
  801. Krebs EE, Kroenke K, Bair MJ, Jensen A. Expectations and Analgesic Preferences Among Participants in a 12-month Trial Comparing Opioid Versus Non-Opioid Analgesics for Chronic Pain. Presented at: American Academy of Pain Medicine Annual Meeting; 2016 Feb 18; Palm Springs, CA.
  802. Ilgen MA. High opioid doses could be marker for suicide risk. VA Research Currents. 2016 Feb 3.
  803. Becker WC, Fiellin DA, Black AC, Kostovich CT, Kerns RD, Fraenkel L. Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):127-36.
  804. Burgess DJ, Gravely AA, Nelson DB, Bair MJ, Kerns RD, Higgins DM, Farmer MM, Partin MR. Association between pain outcomes and race and opioid treatment: Retrospective cohort study of Veterans. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):13-24.
  805. Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of Opioids by Different Types of Medicare Prescribers. JAMA internal medicine. 2016 Feb 1; 176(2):259-61.
  806. Krein SL, Bohnert A, Kim HM, Harris ME, Richardson CR. Opioid use and walking among patients with chronic low back pain. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):107-16.
  807. Lovejoy TI, Dobscha SK, Turk DC, Weimer MB, Morasco BJ. Correlates of prescription opioid therapy in Veterans with chronic pain and history of substance use disorder. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):25-36.
  808. Becker WC, Merlin JS, Manhapra A, Edens EL. Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic. Addiction science & clinical practice. 2016 Jan 28; 11(1):3.
  809. Barry CL, Kennedy-Hendricks A, Gollust SE, Niederdeppe J, Bachhuber MA, Webster DW, McGinty EE. Understanding Americans' views on opioid pain reliever abuse. Addiction (Abingdon, England). 2016 Jan 1; 111(1):85-93.
  810. Binswanger IA, Gordon AJ. From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field. [Editorial]. Substance Abuse. 2016 Jan 1; 37(1):1-3.
  811. Oliva EM, Nevedal A, Lewis ET, McCaa MD, Cochran MF, Konicki PE, Davis CS, Wilder C. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs. Substance Abuse. 2016 Jan 1; 37(1):118-26.
  812. Wright AP, Becker WC, Schiff GD. Strategies for Flipping the Script on Opioid Overprescribing. JAMA internal medicine. 2016 Jan 1; 176(1):7-8.
  813. Fassio V, Aspinall SL, Cunningham J, Zhao X. Trends in Non-Steroidal Anti-Inflammatory Drug Prescriptions Before and After an Opioid Safety Initiative in the Veterans Health Administration. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; 2015 Dec 6; New Orleans, LA.
  814. Krans EE, Zickmund SL, Rustgi VK, Park SY, Dunn SL, Schwarz EB. Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study. Substance Abuse. 2015 Nov 16; 37(1):88-95.
  815. Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, Stein BD. Policies Related To Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013. Substance Abuse. 2015 Nov 13; 37(1):63-9.
  816. Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R. A Continuum of Care Model for Opioid Misuse in Community Pharmacy. Paper presented at: Association for Medical Education and Research in Substance Abuse Annual Meeting; 2015 Nov 6; Washington, DC.
  817. Bachhuber MA, Roberts CB, Metraux S, Montgomery AE. Screening for homelessness among individuals initiating medication-assisted treatment for opioid use disorder in the Veterans Health Administration. Journal of opioid management. 2015 Nov 1; 11(6):459-62.
  818. Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM. Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program. Journal of addiction medicine. 2015 Nov 1; 9(6):470-7.
  819. Hayes CJ, Hudson TJ, Phillips MM, Bursac Z, Williams JS, Austin MA, Edlund MJ, Martin BC. The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiology and drug safety. 2015 Nov 1; 24(11):1180-8.
  820. Lin LA, Bohnert AS, Ilgen MA, Pfeiffer PN, Ganoczy D, Blow FC. Outpatient Provider Contact Prior to Unintentional Opioid Overdose Among VHA Service Users. Psychiatric services (Washington, D.C.). 2015 Nov 1; 66(11):1149-54.
  821. Maughan BC, Bachhuber MA, Mitra N, Starrels JL. Prescription monitoring programs and emergency department visits involving opioids, 2004-2011. Drug and Alcohol Dependence. 2015 Nov 1; 156:282-8.
  822. Pacula RL, Stein B, Gordon AJ, Dick A, Burns RM, Leslie DL, Sorbero MS. The Impact of State Policies on the Use of Buprenorphine Among Medicaid Enrollees Identified with Opioid Use Disorders. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 16; Marina del Rey, CA.
  823. Stein B, Paula RL, Sorbero M, Gordon AJ, Leslie DL, Burns RM, Shih RA, Dick AW. Disparities in Opioid Agonist Therapy by Race/Ethnicity and HIV Status Among Medicaid-Enrollees with Opioid Use Disorders. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 16; Marina del Rey, CA.
  824. Finlay AK, Bowe T, Sox-Harris AH. Changes in receipt of pharmacotherapy for opioid use disorder among veterans from fiscal years 2012-2013. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina del Rey, CA.
  825. Stein BD, Mendelsohn J, Gordon A, Pacula RL, Burns RM, Sorbero M, Dick A. Physician Community Network Structure and Clinically Questionable Prescribing Practices for Medicaid-Enrollees With Opioid Use Disorder. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina Del Rey, CA.
  826. Evans E, Kelleghan A, Li L, Min J, Huang D, Urada D, Hser YI, Nosyk B. Gender differences in mortality among treated opioid dependent patients. Drug and Alcohol Dependence. 2015 Oct 1; 155:228-35.
  827. Hawkins EJ, Malte CA, Grossbard JR, Saxon AJ. Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with Post-traumatic Stress Disorder, 2003-2011. Pain medicine (Malden, Mass.). 2015 Oct 1; 16(10):1943-54.
  828. Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD, Wood E, Montaner JS. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Oct 1; 61(7):1157-65.
  829. Schulte M, Hser Y, Saxon A, Evans E, Li L, Huang D, Hillhouse M, Thomas C, Ling W. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. Journal of community health. 2015 Oct 1; 40(5):940-7.
  830. Trafton JA, Henderson P, Paik M, Tavakoli S, Bowe T, Oliver J, Midboe AM, Lewis ET. VA Opioid Therapy Clinical Practice Guideline Adherence Report: Customizable intranet-based report of facility-level adherence to guideline recommended care practice to improve the safety and efficacy of opioid prescribing for pain. 2015 Oct 1. Available from: http://vssc.med.va.gov/VSSCAgreements/Default.aspx?locn=http%3A//vssc.med.va.gov/uat.asp..
  831. Hawkins EJ, Malte CA, Saxon AJ, Sayre G. Evaluating a Medication Alert to Reduce Concurrent Opioid and Benzodiazepine Use at a Single VA Health Care System. Paper presented at: Society for Implementation Research Collaboration Biennial Conference on Advancing Efficient Methodologies Through Community Partnerships and Team Science; 2015 Sep 10; Seattle, WA.
  832. Gordon AJ, Oliva EM, Wells DL, Harding JD. Opioid overdose education and naloxone distribution to prevent opioid overdose mortality [Buprenorphine Initiative in the VA Monthly Webinar Series]. [Cyberseminar]. 2015 Sep 8.
  833. Buscaglia AC, Lewis ET, Trafton JA, VA Opioid Metric Development Team. Baseline Variation in Use of VA/DOD Clinical Practice Guideline Recommended Opioid Prescribing Practices Across VA Health Care Systems. The Clinical Journal of Pain. 2015 Sep 1; 31(9):803-812.
  834. Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties. The Milbank Quarterly. 2015 Sep 1; 93(3):561-83.
  835. Ashrafioun L, Bohnert AS, Jannausch M, Ilgen MA. Evaluation of the current opioid misuse measure among substance use disorder treatment patients. Journal of substance abuse treatment. 2015 Aug 1; 55:15-20.
  836. Bair MJ, Bohnert AS. Overdoses in Patients on Opioids: Risks Associated with Mental Health Conditions and Their Treatment. [Editorial]. Journal of general internal medicine. 2015 Aug 1; 30(8):1051-3.
  837. Broyles LM. Getting evidence into real-life practice and systems of care: what SBIRT, opioid agonist treatment, and integrated care look like in the VA. Presented at: Institute for Research, Education, and Training in Addictions Annual Meeting; 2015 Jul 10; Pittsburgh, PA.
  838. Hawkins EJ, Malte CA, Grossbard JR, Saxon AJ. Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with PTSD 2003-2011. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 10; Philadelphia, PA.
  839. Bohnert AS, Levine DA, Ganoczy D, Blow FC. Factors associated with opioid overdose death among VHA patients age 50 and older prescribed opioids. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  840. Lovejoy TI, Meath THA, Morasco BJ, Demidenko MI, Dobscha SK. Changes in pain intensity and pain treatment utilization in Veterans following discontinuation of long-term opioid therapy. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  841. Suda KJ, Bailey LA, Smith BM, Gellad WF, Huo Z, Cunningham F, Burk M, Stroupe KT. Opioid use in Veterans eligible for VA and Medicare Part D and predictors for overlap within and among VA and Medicare Part D-reimbursed pharmacies. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  842. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Justice-involved Veterans with Other Veterans. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  843. Mudumbai S, Unger-Hu K, Oliva EM, Lewis ET, Trafton JA, Mariano ER, Stafford RS, Wagner TH, Clark D. Time to Cessation of Postoperative Opioids: A National-level, Cross-sectional Analysis of the Veterans Affairs Healthcare System. Paper presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  844. Oliva EM, McCaa MD, Lewis ET, Cochran MF, Konicki PE, Wilder CM. Formative Evaluation of Life-Saving Opioid Overdose Education and Naloxone Distribution (OEND) in VISNs 10 and 21. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  845. Im JJ, Shachter RD, Oliva EM, Henderson PT, Paik MC, Trafton JA, PROGRES Team. Association of Care Practices with Suicide Attempts in US Veterans Prescribed Opioid Medications for Chronic Pain Management. Journal of general internal medicine. 2015 Jul 1; 30(7):979-91.
  846. Oliva EM. Saving Veterans Lives through Implementation of Opioid Overdose Education and Naloxone Distribution (OEND). Presented at a Public Hearing on Exploring Naloxone Uptake and Use. Federal Drug Administration Center for Drug Evaluation and Research; 2015 Jul 1; Silver Spring, MD. 2015 Jul 1.
  847. Barry DT, Sofuoglu M, Kerns RD, Wiechers IR, Rosenheck RA. Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration. Psychiatry Research. 2015 Jun 30; 227(2-3):324-32.
  848. Bohnert AS, Blow FC, Cunningham R, Thomas L, Greenwald MK, Chermack S, Bonar EE, Walton M. A randomized clinical trial of a behavioral intervention to reduce opioid overdose risk behavior. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2015 Jun 15; Phoenix, AZ.
  849. Marcus SC, Olfson M, Amos T, Durkin M. Patient characteristics and acute care service use of Medicare beneficiaries meeting opioid overutilization criteria. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 15; Minneapolis, MN.
  850. Maughan B, Bachhuber MA, Mitra N, Starrels J. Prescription monitoring program implementation was not associated with changes in emergency department visits involving opioid analgesics. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 15; Minneapolis, MN.
  851. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Veterans in Veterans Justice Programs with other Veterans. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 14; Minneapolis, MN.
  852. Banerjee G, Edelman EJ, Barry DT, Becker W, Cerda M, Crystal S, Gaither JR, Gordon A, Kerns R, Martins SS, Fiellin DA, Marshall BD. Incident Non-Medical Use of Prescription Opioids is Associated with Heroin Initiation Among US Veterans: A Prospective Cohort Study. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2015 Jun 13; Phoenix, AZ.
  853. Edelman E, Tate J, Gordon K, Becker W, Bryant K, Crothers K, Gaither J, Gibert CL, Gordon A, Marshall BD, Rodriguez-Barradas M, Samet JH, Skanderson M, Justice A, Fiellin D. Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy? Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2015 Jun 13; Phoenix, AZ.
  854. Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ (Clinical research ed.). 2015 Jun 10; 350:h2698.
  855. Dick AW, Pacula RL, Gordon AJ, Sorbero M, Burns RM, Leslie D, Stein BD. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11. Health affairs (Project Hope). 2015 Jun 1; 34(6):1028-34.
  856. Weisberg DF, Gordon KS, Barry DT, Becker WC, Crystal S, Edelman EJ, Gaither J, Gordon AJ, Goulet J, Kerns RD, Moore BA, Tate J, Justice AC, Fiellin DA. Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients. Journal of acquired immune deficiency syndromes (1999). 2015 Jun 1; 69(2):223-33.
  857. Comer S, Cunningham C, Fishman MJ, Gordon AJ, Kampman K, Langleben D, Nordstrom B, Oslin D, Woody G, Wright T, Wyatt S. American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. 2015 May 27.
  858. Dobscha SK. Changes in Pain Intensity Over Time in a National Cohort of Older Veterans: Exploring Associations of Pain Scores with Prescription Opioids. [Cyberseminar]. 2015 May 5.
  859. Mosher HJ, Krebs EE, Carrel M, Kaboli PJ, Weg MW, Lund BC. Trends in prevalent and incident opioid receipt: an observational study in Veterans Health Administration 2004-2012. Journal of general internal medicine. 2015 May 1; 30(5):597-604.
  860. Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, DiMartini AF. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2015 May 1; 13(5):1009-16.
  861. Westanmo A, Marshall P, Jones E, Burns K, Krebs EE. Opioid Dose Reduction in a VA Health Care System--Implementation of a Primary Care Population-Level Initiative. Pain medicine (Malden, Mass.). 2015 May 1; 16(5):1019-26.
  862. Becker W, Tate JP, Edelman EJ, Gaither J, Akgun K, Barry D, Crystal S, Gordon A, Merlin JS, Kerns RD, Justice AC, Fiellin DA. The Relationship Among Opioid Use, HIV, and Accidental Death: Is It In the Eye of the Beholder? Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 24; Toronto, Canada.
  863. Krebs EE, Kroenke K, Wu J, Bair MJ, Yu Z. Baseline opioid use as a predictor of telecare collaborative pain management outcomes. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 23; Toronto, Canada.
  864. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA VISN 11 Opioid Safety Initiative and Pain Management Seminar; 2015 Apr 22; Fort Wayne, IN.
  865. Edelman EJ, Tate JP, Gordon KS, Becker WC, Bryant K, Crothers K, Gaither J, Gibert CL, Gordon A, Marshall BD, Rodriguez-Barradas M, Samet JH, Skanderson M, Justice AC, Fiellin DA. Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 22; Toronto, Canada.
  866. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA Palo Alto Center for Innovation to Implementation Seminar Series; 2015 Apr 20; Palo Alto, CA.
  867. Ilgen MA. Opioid dose and risk of suicide mortality. Paper presented at: American Association of Suicidology Annual Conference; 2015 Apr 17; Atlanta, GA.
  868. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: Kaiser Permanente Division of Research Annual Meeting; 2015 Apr 16; San Francisco, CA.
  869. Farmer CM, Lindsay D, Williams J, Ayers A, Schuster J, Cilia A, Flaherty MT, Mandell T, Gordon AJ, Stein BD. Practice guidance for buprenorphine for the treatment of opioid use disorders: results of an expert panel process. Substance Abuse. 2015 Apr 6; 1-8.
  870. Bachhuber MA, Saloner B, Barry CL. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality--reply. JAMA internal medicine. 2015 Apr 1; 175(4):656-7.
  871. Finney JW, Humphreys K, Harris AH. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality. [Letter to the Editor]. JAMA internal medicine. 2015 Apr 1; 175(4):655-6.
  872. Hughes HK, Korthuis PT, Saha S, Eggly S, Sharp V, Cohn J, Moore R, Beach MC. A mixed methods study of patient-provider communication about opioid analgesics. Patient education and counseling. 2015 Apr 1; 98(4):453-61.
  873. Lovejoy TI, Dobscha SK, Turk DC, Weimer MB, Morasco BJ. Predictors of prescription opioid therapy in patients with chronic pain and a history of substance use disorder. [Abstract]. The journal of pain : official journal of the American Pain Society. 2015 Apr 1; 16(1):S84.
  874. Bohnert AS. Prescription drug abuse, overdose, and responsible opioid prescribing. Paper presented at: Oakland County Health Division, Prescription Drug Abuse and Overdose Prevention Collaborative Meeting; 2015 Mar 20; Pontiac, MI.
  875. Finlay AK, Binswanger I, Frayne SM, Harris A. Receipt of pharmacotherapy for opioid use disorder: Comparing justice-involved Veterans with other Veterans. Presented at: Academic and Health Policy Conference on Correctional Health; 2015 Mar 19; Boston, MA.
  876. Lee JD, Friedmann PD, Boney TY, Hoskinson RA, McDonald R, Gordon M, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, O'Brien CP. Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial. Contemporary clinical trials. 2015 Mar 1; 41:110-7.
  877. Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF. Defining nonmedical use of prescription opioids within health care claims: a systematic review. Substance Abuse. 2015 Feb 11; 36(2):192-202.
  878. Krebs EE. Opioid therapy for chronic pain. Pain, Opioids, and Addiction education series. 2015 Feb 10.
  879. Larney S, Bohnert AS, Ganoczy D, Ilgen MA, Hickman M, Blow FC, Degenhardt L. Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011. Drug and Alcohol Dependence. 2015 Feb 1; 147:32-7.
  880. Oliva EM. Implementing Opioid Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose Mortality. Presented at: VA / Department of Defense Suicide Prevention Annual Conference; 2015 Jan 28; Dallas, TX.
  881. Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Journal of substance abuse treatment. 2015 Jan 1; 48(1):128-31.
  882. Dick A, Pacula R, Gordon AJ, Sorbero M, Burns RM, Farmer C, Leslie D, Stein BD. Increasing access to opioid agonist treatment in US treatment shortage areas. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:E266.
  883. Gordon AJ, Jenkins JA. The Time Is Now: The Role of Pharmacotherapies in Expanding Treatment for Opioid Use Disorder. [Editorial]. Substance Abuse. 2015 Jan 1; 36(2):127-8.
  884. Gordon AJ, Lo Ciganic W, Cochran G, Gellad WF, Donohue JM. Characteristics of buprenorphine opioid agonist treatment in a longitudinal US Medicaid population. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:E126.
  885. Morasco BJ, Krebs EE, Cavanagh R, Hyde S, Crain A, Dobscha SK. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy. Journal of opioid management. 2015 Jan 1; 11(1):45-51.
  886. Pacula RL, Gordon AJ, Dick AW, Burns RM, Farmer C, Leslie D, Sorbero M, Stein BD. Expansion of buprenorphine opioid agonist therapy in the United States: facility-level factors. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:E179.
  887. Peng X, Robinson RL, Mease P, Kroenke K, Williams DA, Chen Y, Faries D, Wohlreich M, McCarberg B, Hann D. Long-term evaluation of opioid treatment in fibromyalgia. The Clinical Journal of Pain. 2015 Jan 1; 31(1):7-13.
  888. Stein BD, Gordon AJ, Dick A, Burns RM, Pacula R, Farmer C, Leslie D. Physician supply for the treatment of opioid use disorders: the influence of state policies. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:e107-e108.
  889. Tierney M, Finnell DS, Naegle MA, LaBelle C, Gordon AJ. Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers. Substance Abuse. 2015 Jan 1; 36(4):389-92.
  890. Dorflinger L, Moore B, Goulet J, Becker W, Heapy AA, Sellinger JJ, Kerns RD. A partnered approach to opioid management, guideline concordant care and the stepped care model of pain management. Journal of general internal medicine. 2014 Dec 1; 29 Suppl 4:870-6.
  891. Vanderlip ER, Sullivan MD, Edlund MJ, Martin BC, Fortney J, Austen M, Williams JS, Hudson T. National study of discontinuation of long-term opioid therapy among veterans. Pain. 2014 Dec 1; 155(12):2673-9.
  892. Mudumbai S, Unger-Hu K, Oliva E, Lewis E, Trafton J, Mariano ER, Stafford RS, Wagner T, Clark D. Adverse Outcomes associated with Types of Postoperative Opioid Use: A Population-level Study of the Veterans Affairs Healthcare System. Paper presented at: American Society of Regional Anesthesia and Pain Medicine Annual Pain Medicine Meeting; 2014 Nov 13; San Francisco, CA.
  893. Cochran G, Woo B, Donohue J, Gordon A, Lo-Ciganic W, Gellad W. Defining non-medical use of prescription opioids within health insurance claims data: a systematic review. Paper presented at: Association for Medical Education and Research in Substance Abuse Annual Meeting; 2014 Nov 7; San Francisco, CA.
  894. Lewis ET. What we know about opioid adherence might surprise you: findings from a qualitative study of opioid use behaviors. HSR&D Spotlight on Pain Management. [Cyberseminar]. 2014 Nov 4.
  895. Bachhuber MA, Saloner B, Cunningham CO, Feingold J, Barry CL. Could Delaware's medical marijuana law reduce harms from opioid analgesics? Delaware medical journal. 2014 Nov 1; 86(11):341-3.
  896. Edlund MJ, Austen MA, Sullivan MD, Martin BC, Williams JS, Fortney JC, Hudson TJ. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014 Nov 1; 155(11):2337-43.
  897. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Weisberg DF, Justice AC, Fiellin DA. Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans. The journal of pain : official journal of the American Pain Society. 2014 Nov 1; 15(11):1130-40.
  898. Krebs EE, Bergman AA, Coffing JM, Campbell SR, Frankel RM, Matthias MS. Barriers to guideline-concordant opioid management in primary care--a qualitative study. The journal of pain : official journal of the American Pain Society. 2014 Nov 1; 15(11):1148-55.
  899. Morasco BJ, O'Hearn D, Turk DC, Dobscha SK. Associations between prescription opioid use and sleep impairment among veterans with chronic pain. Pain medicine (Malden, Mass.). 2014 Nov 1; 15(11):1902-10.
  900. Good CB. VA response to FDA abuse-deterrent opioid medications initiative [invited presentation]. Presented at: Development and Regulation of Abuse-Deterrent Opioid Medications FDA Public Meeting; 2014 Oct 30; Silver Spring, MD.
  901. Bauhoff S, Stein BD, Pacula RL, Dick AW, Gordon AJ, Burns RM, Leslie DL. Do Substance Abuse Policies Influence Opioid Agonist therapies in Substance Abuse Treatment Facilities. Poster session presented at: Addiction Health Services Research Conference; 2014 Oct 16; Boston, MA.
  902. Stein BD, Dick SW, Sorbero M, Burns RM, Pacula RL, Gordon AJ, Leslie DL. Patterns of buprenorphine use among Medicaid-enrolled individuals with opioid use disorders. Poster session presented at: Addiction Health Services Research Conference; 2014 Oct 16; Boston, MA.
  903. Mudumbai S, Unger-Hu K, Oliva E, Lewis E, Trafton J, Mariano ER, Stafford RS, Wagner T, Clark D. Time to Cessation of Postoperative Opioids: A National-level, Cross-sectional Analysis of the Veterans Affairs Healthcare System. Paper presented at: American Society of Anesthesiologists Annual Meeting; 2014 Oct 11; New Orleans, LA.
  904. Cavanagh R, Gritzner S, Dobscha SK, Morasco BJ. Aberrant medication-related behaviors do not differ based on opioid dose: Results from a comprehensive medical record review. Presented at: International Association for the Study of Pain Annual Meeting; 2014 Oct 7; Buenos Aires, Brazil.
  905. Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA internal medicine. 2014 Oct 1; 174(10):1668-73.
  906. Park TW, Friedmann PD. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. Rhode Island medical journal. 2014 Oct 1; 97(10):20-4.
  907. Krebs EE. Opioid Risk Mitigation and Adherence Monitoring in Practice. Presented at: National Institutes of Health Office of Disease Prevention Quarterly Workshop; 2014 Sep 30; Bethesda, MD.
  908. Trafton JA. Implementing Guideline Recommendations for Improving the Safety and Effectiveness of Opioid Therapy: Strategies and Lessons Learned From the VHA. Presented at: Conquering Pain Locally, Regionally and Nationally Conference; 2014 Sep 20; Stanford, CA.
  909. Humphreys KN. Damned If We Do... Can We Relieve Pain and Stop Opioid Abuse At the Same Time? Presented at: Conquering Pain Locally, Regionally and Nationally Conference; 2014 Sep 19; Stanford, CA.
  910. Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014 Sep 15; 71(18):1539-54.
  911. Oliva EM. Opioid Interventions: Naloxone and Other Option. Teleconference. Presented at: VA VISN 23 Substance Use Disorders Programs Conference; 2014 Sep 11; Menlo Park, CA.
  912. Oliva EM. Spotlight on Pain Management - Opioid Overdose Education and Naloxone Distribution (OEND): Preventing and Responding to an Opioid Overdose. [Cyberseminar]. 2014 Sep 2.
  913. Grossbard JR, Malte CA, Saxon AJ, Hawkins EJ. Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines. Drug and Alcohol Dependence. 2014 Sep 1; 142:24-32.
  914. Back SE, Gros DF, McCauley JL, Flanagan JC, Cox E, Barth KS, Brady KT. Laboratory-induced cue reactivity among individuals with prescription opioid dependence. Addictive Behaviors. 2014 Aug 1; 39(8):1217-23.
  915. Lewis ET, Cucciare MA, Trafton JA. What do patients do with unused opioid medications? The Clinical Journal of Pain. 2014 Aug 1; 30(8):654-62.
  916. Trafton JA, Oliva EM. Legislative strategies other than legalizing illicit opioids may help to reduce overdose fatalities. Addiction (Abingdon, England). 2014 Aug 1; 109(8):1243-4.
  917. Oliva EM, Midboe AM, Lewis ET, Henderson PT, Dalton AL, Im JJ, Seal K, Paik MC, Trafton JA. Sex differences in chronic pain management practices for patients receiving opioids from the Veterans Health Administration. Pain medicine (Malden, Mass.). 2015 Jan 1; 16(1):112-8.
  918. Bohnert AS, Ilgen MA, Trafton JA, Kerns RD, Eisenberg A, Ganoczy D, Blow FC. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. The Clinical Journal of Pain. 2014 Jul 1; 30(7):605-12.
  919. Matthias MS, Krebs EE, Bergman AA, Coffing JM, Bair MJ. Communicating about opioids for chronic pain: a qualitative study of patient attributions and the influence of the patient-physician relationship. European journal of pain (London, England). 2014 Jul 1; 18(6):835-43.
  920. Goulet JL, Becker WC, Kerns RD, Justice AC, Fiellin D. Guideline-concordant management of opioid therapy among patients with and without unhealthy alcohol use. Poster session presented at: Research Society on Alcoholism Annual Scientific Meeting; 2014 Jun 21; Bellevue, WA.
  921. Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 19; San Juan, Puerto Rico.
  922. Dick A, Pacula R, Gordon AJ, Sorbero M, Burns RM, Farmer C, Leslie D, Stein BD. Increasing access to opioid agonist treatment in US treatment shortage areas. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  923. Edelman EJ, Gordon KS, Becker W, Gaiter JR, Gordon AJ, Samet J, Justice A, Fiellin D. The impact of prescription opioids on CD4 count in HIV: a longitudinal analysis. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  924. Gordon AJ, Lo Ciganic W, Cochran G, Gellad WF, Donohue JM. Characteristics of buprenorphine opioid agonist treatment in a longitudinal US Medicaid Population. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  925. Pacula RL, Gordon AJ, Dick AW, Burns RM, Farmer C, Leslie D, Sorbero M, Stein BD. Expansion of buprenorphine opioid agonist therapy in the United States: facility-level factors. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  926. Stein BD, Gordon AJ, Dick A, Burns RM, Pacula R, Farmer C, Leslie D. Physician supply for the treatment of opioid use disorders: the influence of state policies. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  927. Fiellin D, Justice AC. Using the VACS index to track health outcomes associated with abstinence among HIV-infected patients receiving opioid agonist treatment. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 14; San Juan, Puerto Rico.
  928. Justice AC, Goulet JL, Becker WC, Fiellin D. Receipt of opioid therapy guideline-concordant care among HIV-infected and uninfected Veterans. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 14; San Juan, Puerto Rico.
  929. Krein SL, Bohnert AS, Kim M, Harris ME, Richardson CR. Opioid Use and Walking Among Patients with Chronic Low Back Pain. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 10; San Diego, CA.
  930. Hudson TJ, Williams S, Austen MA, Martin B, Sullivan M, Fortney JC, Edlund MJ. Opioid use among OEF/OIF Veterans with Traumatic Brain Injury. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 9; San Diego, CA.
  931. Justice AC, Becker WC, Fiellin D, Kerns RD. Racial differences in receipt of opioid therapy guideline-concordant care. Poster session presented at: International Conference on Opioids; 2014 Jun 8; Boston, MA.
  932. Broyles LM. Getting evidence into real-life practice and systems of care: what SBIRT, opioid agonist treatment, and integrated care look like in the VA (Presentation for Advanced Medical Student Fellowship in Alcohol and Other Drug Dependency; Institute for Research, Education and Training in Addictions, Pittsburgh, PA). 2014 Jun 4.
  933. Burgess DJ, Phelan S, Workman M, Hagel E, Nelson DB, Fu SS, Widome R, van Ryn M. The effect of cognitive load and patient race on physicians' decisions to prescribe opioids for chronic low back pain: a randomized trial. Pain medicine (Malden, Mass.). 2014 Jun 1; 15(6):965-74.
  934. Clarke TK, Crist RC, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH. Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. The Pharmacogenomics Journal. 2014 Jun 1; 14(3):303-8.
  935. Oliva EM, Konicki PE. Opioid Risk Mitigation and the Role of Naloxone Rescue. Oral presentation (Adobe Connect webinar) to VA SCAN-ECHO (Specialty Care Access Network-Extension for Community Healthcare Outcomes). [Cyberseminar]. 2014 May 27.
  936. Okunseri C, Okunseri E, Xiang Q, Thorpe JM, Szabo A. Prescription of opioid and nonopioid analgesics for dental care in emergency departments: Findings from the National Hospital Ambulatory Medical Care Survey. Journal of public health dentistry. 2014 May 26; 74(4):283-92.
  937. Oliva EM, Burgard J, Drexler K. Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose. Oral presentation (telephone conference) to the VISN 23 Substance Use Disorder (SUD) Leads. 2014 May 2.
  938. Bachhuber MA, Southern WN, Cunningham CO. Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States. Medical care. 2014 May 1; 52(5):428-34.
  939. Kerns RD, Goulet JL, Dorflinger L, Moore BA. Opioid prescribing and the Stepped Care Model of Pain Management in the Veteran's Health Administration. Poster session presented at: American Pain Society Annual Meeting; 2014 May 1; Tampa, FL.
  940. Becker WC. Recent trends and regional variation in opioid analgesic exposure in the Veterans Health Administration. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 26; San Diego, CA.
  941. Justice AC, Becker WC, Goulet JL, Kerns RD, Moore BA, Fiellin D. Association of Long-Term Opioid and/or Benzodiazepine Receipt and Medication Count with Mortality among HIV-Infected and Uninfected Patients. Paper presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 23; San Diego, CA.
  942. Krebs EE, Paudel M, Taylor BC, Bauer D, Fink HA, Lane N, Ensrud KE. Association of opioid use with falls and fractures among older men. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 23; San Diego, CA.
  943. Hudson TJ, Martin BC, Sullivan M, Fortney JC, Austen MA, Williams S, Edlund MJ. Population-level analysis of opioid use among Veterans. Poster session presented at: Association for Clinical Research Training / Society for Clinical and Translational Science / American Federation for Medical Research Translational Science Meeting; 2014 Apr 11; Washington, DC.
  944. Matthias MS. Communicating about Opioids for Chronic Pain: What Really Happens in Clinic Visits? [Cyberseminar]. 2014 Apr 1.
  945. Donohue JM, Lo-Ciganic WH, Cochran G, Gordon AJ, Zemaitis MA, Gellad WF. Opioid use, opioid use disorder and buprenorphine use in Pennsylvania Medicaid. Philadelphia, PA: Commonwealth of Pennsylvania Department of Public Welfare, Office of Medical Assistance Programs; 2014 Mar 31. 42 p.
  946. Trafton JA, Oliva EM. Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose. Oral presentation (telephone conference) to the VA Chiefs of Staff. 2014 Mar 27.
  947. Justice AC, Goulet JL, Kerns RD, Fiellin D. Receipt of opioid therapy guideline-concordant care among HIV-infected and uninfected Veterans. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Mar 7; Boston, MA.
  948. Sullivan M, Vanderlip E, Hudson TJ, Edlund MJ, Martin BC, Fortney JC, Landes RD, Austen MA, Williams S. National study of discontinuation of chronic opioid therapy among Veterans. Paper presented at: American Academy of Pain Medicine Annual Meeting; 2014 Mar 7; Phoenix, AZ.
  949. Trafton JA. Spotlight on Pain Management: Quality Improvement and Implementation Support to Improve Use of Guideline Recommended Practices for Chronic Opioid Therapy. [Cyberseminar]. 2014 Mar 4.
  950. Scherrer JF, Svrakic DM, Freedland KE, Chrusciel T, Balasubramanian S, Bucholz KK, Lawler EV, Lustman PJ. Prescription opioid analgesics increase the risk of depression. Journal of general internal medicine. 2014 Mar 1; 29(3):491-9.
  951. Mosher HJ, Jiang L, Vaughan Sarrazin MS, Cram P, Kaboli PJ, Vander Weg MW. Prevalence and characteristics of hospitalized adults on chronic opioid therapy. Journal of hospital medicine. 2014 Feb 1; 9(2):82-7.
  952. Burgess DJ, Nelson DB, Gravely AA, Bair MJ, Kerns RD, Higgins DM, van Ryn M, Farmer M, Partin MR. Racial differences in prescription of opioid analgesics for chronic noncancer pain in a national sample of veterans. The journal of pain. 2014 Apr 1; 15(4):447-55.
  953. Bonar EE, Ilgen MA, Walton M, Bohnert AS. Associations among pain, non-medical prescription opioid use, and drug overdose history. The American journal on addictions. 2014 Jan 1; 23(1):41-7.
  954. Park TW, Bohnert AS, Austin KL, Saitz R, Pizer SD. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy. Psychiatric services (Washington, D.C.). 2014 Jan 1; 65(1):4.
  955. Porucznik CA, Johnson EM, Rolfs RT, Sauer BC. Specialty of prescribers associated with prescription opioid fatalities in Utah, 2002-2010. Pain medicine (Malden, Mass.). 2014 Jan 1; 15(1):73-8.
  956. Thorson D, Biewen P, Bonte B, Epstein H, Haake B, Hansen C, Hooten M, Hora J, Johnson C, Keeling F, Kokayeff A, Krebs EE, Myers C, Nelson B, Noonan MP, Reznikoff C, Thiel M, Trujillo A, Van Pelt S, Wainio J. Acute Pain Assessment and Opioid Prescribing Protocol. Bloomington, MN: Institute for Clinical Systems Improvement; 2014 Jan 1. 44 p.
  957. Bachhuber MA, Cunningham CO. Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs. JAMA. 2013 Dec 25; 310(24):2671-2.
  958. Morasco BJ, Cavanagh R, Gritzner S, Dobscha SK. Care management practices for chronic pain in veterans prescribed high doses of opioid medications. Family Practice. 2013 Dec 1; 30(6):671-8.
  959. Saxon AJ, Hser YI, Woody G, Ling W. Medication-assisted treatment for opioid addiction: methadone and buprenorphine. Journal of food and drug analysis. 2013 Dec 1; 21(4):S69-S72.
  960. Gros DF, Back SE, McCauley J, Mercer MA, LaRowe S, Brady KT. Examination of prescription opioid cue-induced subjective, physiological, and neuroendocrine reactivity. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 21; Nashville, TN.
  961. Gros DF, De Leo JA, Back SE. Comparing self-report mood-related symptomatology and addiction severity in a sample of prescription opioid dependent and non-dependent individuals. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 21; Nashville, TN.
  962. Gros DF, De Leo JA, Back SE, Milanak ME, Brady KT. Comparing clinical profiles of prescription opioid dependent individuals with and without comorbid mood and anxiety disorders. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 21; Nashville, TN.
  963. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Poster session presented at: International Society for Pharmacoepidemiology Annual Conference; 2013 Nov 3; Washington, DC.
  964. Bachhuber MA, Cunningham CO. For-profit treatment of opioid addiction. [Letter to the Editor]. Health affairs (Project Hope). 2013 Nov 1; 32(11):2060.
  965. Matthias MS, Krebs EE, Collins LA, Bergman AA, Coffing J, Bair MJ. "I'm not abusing or anything": patient-physician communication about opioid treatment in chronic pain. Patient education and counseling. 2013 Nov 1; 93(2):197-202.
  966. Edlund MJ, Sullivan M, Martin BC, Fortney JC, Landes RD, Austen MA, Williams S, Hudson TJ. Patterns of opioid use among Veterans with chronic non-cancer pain. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  967. Hayes C, Phillips M, Martin BC, Bursac Z, Williams S, Hudson TJ. The influence of the propoxyphene withdrawal on opioid use and opioid related adverse events in Veterans. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  968. Hudson TJ, Edlund MJ, Martin BC, Sullivan M, Fortney JC, Landes RD, Austen MA, Williams S. National analysis of opioid use among Veterans. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  969. Hudson TJ, Pope R, Williams S, Martin BC, Sullivan M, Fortney JC, Landes RD, Edlund MJ. Opioid use among OEF/OIF/OND Veterans with traumatic brain injury. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  970. Stein BD, Gordon AJ, Dick AW, Burns RM, Pacula RL, Farmer CM, Leslie DL, Sorbero M. Physician supply for the treatment of opioid addiction: the influence of state policies. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 24; Portland, OR.
  971. Grossbard J, Malte CA, Saxon AJ, Hawkins EJ, Hawkins EJ. Clinical Monitoring and High-Risk Conditions Among Patients With SUD Newly Prescribed Opioids and Benzodiazepines. Presented at: Addiction Health Services Research Conference; 2013 Oct 23; Portland, OR.
  972. Becker WC, Fraenkel L, Kerns RD, Fiellin DA. A research agenda for enhancing appropriate opioid prescribing in primary care. Journal of general internal medicine. 2013 Oct 1; 28(10):1364-7.
  973. Dobscha SK. Prescription opioids and benzodiazepines: moving beyond "just say no". Pain medicine (Malden, Mass.). 2013 Oct 1; 14(10):1447-9.
  974. Ford AC, Brenner DM, Schoenfeld PS. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis. The American journal of gastroenterology. 2013 Oct 1; 108(10):1566-74; quiz 1575.
  975. Trafton JA, Henderson P, Paik M, Tavakoli S, Bowe T, Oliver J, Midboe AM, Lewis ET. VA Opioid Therapy Clinical Practice Guideline Adherence Report/Too: Customizable intranet-based report of facility-level adherence to guideline recommended care practice to improve the safety and efficacy of opioid prescribing for pain (Updated quarterly). 2013 Oct 1.
  976. Humphreys KN. Responding to opioid and methamphetamine addiction. Paper presented at: Kanawha County Methamphetamine Task Force Meeting; 2013 Sep 19; Charleston, WV.
  977. Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology. 2013 Sep 1; 38(10):2003-10.
  978. Hawkins EJ, Malte CA, Grossbard J, Saxon AJ, Imel ZE, Kivlahan DR. Comparative safety of benzodiazepines and opioids among veterans affairs patients with posttraumatic stress disorder. Journal of addiction medicine. 2013 Sep 1; 7(5):354-62.
  979. Roy-Byrne P, Sullivan MD, Sherbourne CD, Golinelli D, Craske MG, Sullivan G, Stein MB. Effects of pain and prescription opioid use on outcomes in a collaborative care intervention for anxiety. The Clinical Journal of Pain. 2013 Sep 1; 29(9):800-6.
  980. Ford AC, Brenner DM, Schoenfeld PS. Don't forget about constipation with opioid treatment of chronic non-cancer pain. BMJ (Clinical research ed.). 2013 Jul 16; 347:f4492.
  981. Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). Journal of studies on alcohol and drugs. 2013 Jul 1; 74(4):605-13.
  982. Rigg KK, Murphy JW. Understanding the etiology of prescription opioid abuse: implications for prevention and treatment. Qualitative Health Research. 2013 Jul 1; 23(7):963-75.
  983. Becker WC, Fraenkel L, Edelman EJ, Holt SR, Glover J, Kerns RD, Fiellin DA. Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review. Pain. 2013 Jun 1; 154(6):905-16.
  984. Brenner DM, Ford AC, Schoenfeld P. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation, systematic review and meta-analysis. Poster session presented at: Digestive Disease Week Annual Meeting; 2013 May 18; Orlando, FL.
  985. Deyo RA, Smith DH, Johnson ES, Tillotson CJ, Donovan M, Yang X, Petrik A, Morasco BJ, Dobscha SK. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine (Philadelphia, Pa. : 1986). 2013 May 15; 38(11):909-15.
  986. Hausmann LR, Gao S, Lee ES, Kwoh CK. Racial disparities in the monitoring of patients on chronic opioid therapy [Spotlight on Pain Management Cyberseminar Series]. [Cyberseminar]. 2013 May 7.
  987. Porucznik CA, Johnson EM, Rolfs RT, Sauer BC. Opioid prescribing knowledge and practices: provider survey following promulgation of guidelines-Utah, 2011. Journal of opioid management. 2013 May 1; 9(3):217-24.
  988. Becker WC. Trends in and correlates of opioid receipt among Veterans with and without HIV. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 26; Denver, CO.
  989. Becker WC, Edelman EJ, Gordon K, Kerns RD, Crystal S, Fiellin LE, Gordon AJ, Goulet JL, Justice AC, Fiellin DA. Trends and correlate of opioid analgesic receipt among Veterans with and without HIV: 1999-2010. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 25; Denver, CO.
  990. Mosher HJ, Kaboli PJ. Chronic Opioid Therapy of Hospitalized Patients. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 25; Denver, CO.
  991. Tetrault J, Tate J, Edelman J, Gordon AJ, Vin LR, Crystal S, Fiellin L, Bryant K, Justice AC, Fiellin DA. Use and safety of buprenorphine in HIV-infected and uninfected opioid dependent patients. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 25; Denver, CO.
  992. Bair MJ. Prescribing Opioids for Chronic Pain: A Primary Care 'Toolbox' for Employing Rational Analgesia, Managing Risk, and Enhancing Communication. Paper presented at: American College of Physicians Annual Meeting; 2013 Apr 11; San Francisco, CA.
  993. Johnson EM, Lanier WA, Merrill RM, Crook J, Porucznik CA, Rolfs RT, Sauer B. Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009. Journal of general internal medicine. 2013 Apr 1; 28(4):522-9.
  994. VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives with, Gordon AJ, Kivlahan D, Liberto J, McNicholas L, Oslin DW, Saxon A, Trafton J. Buprenorphine / Naloxone and Buprenorphine Sublingual Formulations for Opioid Dependence. Criteria for Use for Office-Based Opioid Treatment (OBOT) Settings. 2013 Apr 1.
  995. Gordon AJ, Krumm MM. Buprenorphine for opioid dependence. In: Miller PM, editor. Interventions for Addiction: Comprehensive Addictive Behaviors and Disorders. San Diego, CA: Elsevier Inc.; 2013. 417-426 p.
  996. Bohnert AS, Eisenberg A, Whiteside L, Price A, McCabe SE, Ilgen MA. Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use. Addictive Behaviors. 2013 Mar 1; 38(3):1776-81.
  997. Carbone LD, Chin AS, Lee TA, Burns SP, Svircev JN, Hoenig HM, Akhigbe T, Weaver FM. The association of opioid use with incident lower extremity fractures in spinal cord injury. The journal of spinal cord medicine. 2013 Mar 1; 36(2):91-6.
  998. Mallya A, Purnell AL, Svrakic DM, Lovell AM, Freedland KE, Gott BM, Sayuk GS, Cicero TJ, Brawer PA, Trafton JA, Scherrer JF, Lustman PJ. Witnessed versus unwitnessed random urine tests in the treatment of opioid dependence. The American journal on addictions. 2013 Mar 1; 22(2):175-7.
  999. Oliva EM, Trafton JA, Harris AH, Gordon AJ. Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand? The American journal of drug and alcohol abuse. 2013 Mar 1; 39(2):103-7.
  1000. Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2013 Mar 1; 19(2):72-7.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.